incivo works by stopping the virus that causes hepatitis c infection . incivoc is used to treat chronic hepatis b infection in adults aged 1865 years and over : - in combination with peginterferon alfa - 2b , ribavirin , and telaprevir . these are medicines called ns3 - 4a protease inhibitors . the nns1 - 5a proteace inhibitor is a natural substance produced by the hep c virus . it works in the same way as pegInterferon all of a single dose , when combined with rib avirine . what is inciva used for incive is used for the treatment of chronic hempatitistis  C infection in adult patients with chronic hpatititis
do not use incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if the combination of peginterferon alfa and ribavirin is not suitable for you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using inciva . pegInterferon allfa - 2b or ribovirin may interact with inciVO in ways that are not known ( cannot be estimated from the available data ). your doctor may prescribe incivoc alone or together with peg interferon ALfa or ricavirine when their contradications ( e . g . pregnancy precautions ) are not applicable in this case . when using a combination of the two active substances together with acceps , inciv may be used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the appropriate dose regimen for you based on your age and body weight . the recommended dose regimen is 3 to 6 mg per day for adults , adolescents and children from 2 to 8 years of age who weigh at least 6 kg . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , the recommended dosage regimen is a 3 mg per night dose taken twice a day , taken once a week , for at least 8 mg per week . this is because incivo is eliminated from the body by the body . you should continue to take incivoc for as long as your physician has told that it is safe for you to do so . it is important that you follow the instructions of your
like all medicines , this medicine can cause side effects , although not everybody gets them . if you develop rash , or get an itchy skin rash that gets worse , tell your doctor or nurse immediately . the rash may also be associated with other symptoms . when the r is severe skin reaction , you should tell your physician or nurse immediate . in case of a skin r , your doctor should notify you immediately ; if your rash becomes severe , other symptoms or signs of  a rash occur , contact your doctor immediately , as the occurrence of rash can be life - threatening . tell your caregiver immediately if : you develop such a reaction ; you develop it ; or you develop other symptoms associated with a such rash such as fever , tiredness , swelling of the face or swelling of lymph glands ; and 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the tablets . the bottle contains a desiccant protecting the tablets from moisture and may cause temporary damage .
what incivo contains the active substance is telaprevir . each tablet of inciva contains 375 mg of telalapreVir . the other ingredients are : tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coating polyvinyl alcohol , macrogol , the talc , titanium dioxide ( e171 ), and iron oxide yellow ( encoding ). what if you see inciVO looks like and contents of the pack film  shaped , yellow cap - shaped tablets , imprinted with " gsi " on one side . they are
the active substance of zinbryta is daclizumab beta , a monoclonal antibody ( a type of protein designed to recognise and attach to a specific target substance in the body ). what zinbeta can be used for zinblita belongs to  a group of medicines called ' recombinant dna technology ' ( rdns ). zinbinbrytes is used in adults who have relapsing multiple sclerosis ( ms ) and have failed to respond to therapy . it is used alone or in combination with other treatments which reduce inflammation . this protects the protective sheath ( called myelin ) around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelina is called demyelinerin . in relapses 
do not take zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . talk to your doctor if this applies to you . warnings and precautions talk to you doctor , pharmacist or nurse before taking zinblita and during treatment : - patients with liver problems . tell your doctor before taking your first dose of zinbirta about any other autoimmune disorders . - your doctor may want to monitor you more closely . do not use any other medicines , including herbal supplements . taking any medicines or supplements that you take with zinbeta may increase the risk of liver side effects . these medicines may reduce the efficacy and the amount of  Zinbrytes you take . you have depression or have in the past had  a seriously infection ( such as
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of zinbryta is 150 mg . your doctor will ask you to have a blood test to check how well your liver is working before you start using zinblita . if your doctor has told me that you can inject zinbirrytta yourself , you must pay a monthly subscription of 40 mg , one injection per month . depending on the results of this blood test your doctor may decide that it is safe for you to inject  Zinbrytes yourself zinblastryte is usually injected under the skin on your thigh , stomach or back , or upper arm . instructions for injecting zinbrita at the end of section 7 . you or your caregiver should read the instructions for use
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this is important to make sure you get the best results and reduce the risk of side effects during your treatment . look out for serious side effects in addition to liver problems ( common , may affect up to 1 in 10 people ): unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affect less than 1 in 100 people ). severe inflammation of the liver , which may lead to death . tell your doctor immediately if any of the following happen . liver problems can affect upto 1 in every 100 people taking zinbryta 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled syere in original package in order to protect from light . after first opening , a new sYringe / pen may be stored in tilting water or direct light , such as direct sunlight or direct sunlight . zinblita syingringes / pens are stable at room temperature ( not above 30 ). you can use zinbeta up to 30 for up to 7 days without being exposed to moisture . you should record the date that zinblichta is
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of daclizuab Beta in 1 ml solution . every pre – filled pen contains 150 micrograms of daklizumabeta in 1ml solutions . the other ingredients are sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinblita has a low level of sodium '). what zbrytoa looks like and contents of the pack zin Brytta is a clear to slightly opalescent , colourless to slightly yellow solution for injection . it is available as a sYringe / pen or pre  - loaded pen with an attached needle .
wilzin belongs to a group of medicines known as metabolism products . wilson ' s disease is a rare inherited defect in copper excretion , which occurs naturally in the liver , the eyes and in the brain . this results in liver damage and neurological disorders . it breaks down copper in the intestine and causes its further accumulation in the body . what willson 's disease looks like and contents of the pack this medicine is for use in adults only . the medicine is formulated and marketed in the united kingdom only , as well as for other uses .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin . warnings and precautions talk to your doctor or pharmacist before using wulzin wifzin will be prescribed to you by your doctor . you should receive wlzin during initial therapy because signs and symptoms of witson ' s disease have not improved . if your doctor has told you that you are currently taking another anti - copper agent called penicillamine , you will receive a lower dose of whistler 's medicine . your doctor will assess the initial treatment with other anti  - Copper agents including penicilamine . when your symptoms are controlled , the treatment may be continued . blood and urine will be monitored regularly to ensure that you have sufficient treatment . monitoring 25 if there is insufficient treatment ( copper excre
what wilzin is available in each of the different dose regimens . the doses are 25 mg or 50 mg . take 1 tablet of willzin 50 mg or 2 tablets of witzin 25 mg / 1 tablet or of pwd 50 mg taken orally at 2 - hour intervals , depending on the dose you are taking . wilszin 25mg / 2 tablet of 1 tablet / 3 tablet : wILzin 50mg or 2 tabletes of tue / ml : each dose of fmu / 30 mg is 1 tablet in the morning and 1 tablet at midday . in the evening , the usual dose of the day is 2 tablets / 35 mg , while the dose of one tablet of 2 mg - 30 mg or more . you should continue to take wlzin 25 mg
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affecting 1 to 8 users in 1 , 000 ) rare ( affectating 1 to 9 users in 10 000 ), very rare (affecting less than 1 users in10 ,000 ) very rare non - indicative effect of wilszin intake is not known ( frequency cannot be estimated from the available data ). gastric irritation during treatment may occur . it is possible that patients may experience changes in blood tests that show an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects 10 if you get any side effects talk to your doctor or pharmacist .
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of zine acetate dihydrate ). each capsule contains 50 mg of gold ( equivalent à 167 . 85 mg of Zine ace dihydrate and magnesium stearate ). the capsule shell contains : gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( 8000 ). what ilzin looks like and contents of the pack wilszin 25 mg hard capsules are blue and marked " wlzin 50 mg " in black ink . the printing ink contains black iron oxide ( electron ) and shellac . what if the pack looks like like and content of the bottle wulzin 25mg hard capsule : the bottle is white and marked with " n
what biktarvy is biktarivy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . it is a copy of a gene called emtricitabine , which is an antiviral medication known as a nucleoside reverse transcriptaser inhibitor ( nrti ) tenofovir alafenamide which is another antirétroviral drug known as " a nuclear transcriptasese inhibitor ( nutrtis ) ". biktegrany is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . bikritarvies reduces the amount of hiv in your body . this will improve your immune system and reduce the risk of developing illnesses linked to hiv infection
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if not taken immediately , do not combine biktarivy with any ofthe following medicines : - rifampicin , which is used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ). biktegrany is a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking bikkarvy as it may cause some problems : liver problems if your doctor has told you that you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor may prescribe antacids to treat stomach ulcers , heartburn and acid reflux , which may be caused by exposure to aluminium or magnesium hydroxide mineral supplements to help control vitamins , magnesium , and iron ( see section 2 under " what biktarvy is used for "). if your doctor has prescribed bikTARvy for you on dialysis , please read the information under " how to take biktarivy " in section 4 under " possible side effects ". if the doctor prescribes this medicine on its own , you may be more likely to get side effects . you must contact your doctor immediately , or go to the emergency department of your nearest hospital if any of the above apply to you ( or you are also
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should contact your doctor immediately : - inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . these are called autoimmune disorders , when the immune system attacks healthy body tissue . as with all medicines used to treat hiv disease , there is a risk that you may get infections more easily . reporting of side effects 23 if your doctor gets any side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the seal after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . seal the container tightly closed in order for storage and administration .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bic tegrevir sodium equivalent to 50 mg bicTegraVir and 200 mg emetricitatabine / tenovir altafeenamide fumarate equivalent to 25 mg ten ofovir alefenaf . the other ingredients are tablet core microcrystalline cellulose , microscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide , macrogol , the talc , iron oxide red ( e172 ), iron oxide black (  e168 ). what bikinatarvying looks like and contents of the pack biktegracy
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panccreases does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic patients as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . none of the ingredients in novonoderm can be taken with metformin , another medicine for diabetes . it is important that you continue to follow any diet and lifestyle advice from your doctor while taking novon orm .
do not take novonorm : if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). if your doctor has told you that you have type 1 diabetes . it is important that you discuss with your doctor if the acid level in your blood is raised ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking novonourm if : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 you have liver problems . novonlorm is not recommended in patients with moderate liver disease as the use of novonmorm is therefore not recommended if any of these apply to you . if for some reason you are not sure , talk to you doctor before starting to take novoorm as it may affect your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably in a light snack or snack . alternatively , you may take the tablets for up to 4 weeks before returning to the normal dose . if your blood sugar is too low , talk to a hypo . do not take more novonorm than your doctor tells you to . you may find it easier to take it at the same time each day . this will help to keep your diabetes under control . your doctor will monitor your treatment carefully . it is important that you take this tablet at the right times every day , as instructed by your doctor .
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypoglcaemia which may affect up to 1 in 10 people ( see a hypo in section 2 ). hypogLYcaemic reactions are generally mild / moderate but may occasionally develop into hypogliescaem unconsciousness or coma . allergy allergy is very rare ( may affect less than 1 in 1 , 000 people ). symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this could be anaphylactic reaction . if you have any of these effects  contact your doctor immediately . other side effects very common ( may effect more than 1 user in 10 ) reactions are usually mild - moderate and may progress to a more severe allergic reaction , e .g . swelling
what novonorm contains the active substance is repaglinide . the other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . also the tablet coating is made of iron oxide yellow ( oe172 ) and iron oxide red ( 0 . 2 %). what novovonorme looks like and contents of the pack novonlorm tablets are round and convex and engraved with the inscription " nvr " on one side and " r " one side . 1 mg tablets are orange and inscriptions " on the other side , with the following code " ph0 - 2 "
pumarix is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandelic flu is  a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandem flu are similar to those of ordinary flu but may be more serious . how pumarize works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarisse may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to anything else that may be present in very small amounts such as : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if any of these apply to you , do not receive the vaccine and you may require medical treatment . in the unlikely event of an allergy reaction , you should not receive pumarize . this vaccine should not contain 33 any of the ingredients in pumarice . tell your doctor if your child had any allergic reaction other than a spontaneous life – threatening allergy to any component of this vaccination , to any other ingredient contained in
pumarix should only be given by a doctor or nurse . a child under 18 years old may receive pumarx in combination with a similar h5n1 as03 . this patient group must be at least 18 years of age or older . pumarize should be given as a single dose or as an injection . the recommended dose of pumarice is based on bodyweight . your doctor will determine the appropriate dose for you . use in children and adolescents pumarisse is given to children 3 - 9 years of old , with an additional dose to be given to adolescents 3 , 10 - 17 years of aged . how pumarisk is given pumaris is given as an injectable injection into a muscle . it is usually given in the upper arm . for further information on the use of this vaccine , see ' handling instructions ' at the end of this leaflet
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . your doctor will tell you what you can do and when emergency treatment may be needed . other side effects very common ( may affect more than 1 in 10 people ) pain where the injection is given headache feeling tired aching muscles and joint pain common ( might affect up to 1 in every 10 people that are given ) redness or swelling where the injecting is given fever sweating shivering diarrhoea feeling sick common ( will affect upto 1 in 100 people ). if you get any of these side effects tell your doctor , nurse or pharmacist .
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / vietnam / 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - 2 ) in 0 . 5 ml dose * propagated in eggs ** expressed in microgram haemagglutinin this vaccine complies with the who recommendation and eu decision for the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvan contains squalene , Dl - 1 - tocopherol , polysorbate 80 and other adjutants ( see section 2 ). the other ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate / potassium dihydrogen phosphat
somakit toc is a radiopharmaceutical product that contains an active substance called edotreotide . the powder in the vial contains a small amount of a nuclear medicine ( neuraminidase ) called gallium ( 68ga ) chloride , known as gallium( 68Ga  ) edeotretide which is used in medical and healthcare professionals to investigate the use of this procedure . gallium is injected into a vein in one of your body areas , in a medical imaging procedure called positron emission tomography ( pctf ). this medicine is pet - free . because somatakit tc is made from this medical procedure , images are obtained to help the abnormal cells and tumours that have spread to other parts of your disease . using somama
do not use somakit toc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if there is a possibility of allergic reaction ( see section 4 , " what somamakit tc is used for "). warnings and precautions talk to your doctor before using somma kit toc and during treatment : if your doctor thinks you may have kidney or liver problems . if the medicine is not working properly ( renal or hepatic disease ). children and adolescents do not give this medicine to children and teenagers under 18 years of age because there is no experience of dehydration during the examination . children and young people the medicine may not be suitable for children and teens under 28 years of height because it has not been studied in this age group . other medical conditions that affect other parts of the body
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . it will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . they will take appropriate measures to protect the environment . this will help protect the public from harming other animals . the nuclear medicine doctor supervising the procedure the usual dose of somamakit tc is 100 to 200 mbq ( megabecquerel , the unit used to express radioactivity ). administration of somatakit in a controlled area is the unit that produces radiolabelling . administration of the product and conduct of the procedure after radiolaabeling , somat toc is given
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . you should seek urgent medical attention if you experience symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions such as stinging at the injection site and ionising radiation ( which may be associated with cancer and hereditary abnormalities ). reporting of side effects tell your doctor or nurse if your child gets any side effects talk to your doctor , pharmacist or nurse about any side effect you may get . this includes any possible side effects not listed in this leaflet . if any of the side effects gets serious , or if a side effects becomes serious : - you get a free initial consultation with your doctor and / or your
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : - for radiolabelling of somakit toc , please refer to section 4 for medical and healthcare professionals . - the following data are intended for healthcare professionals only . do not use somakkit toch after the expiry date which is stated on the label after exp . chemical and physical in - use stability has been demonstrated for 4 hours at 25 and protected from light . store in the original package to protect from moisture and radioactive products .
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 micrograms of edeotreotroline . - other ingredients are : 10 - phenanthroline , gentisic acid , indigo carmine ( e132 ), mannitol , formic acid ; sodium hydroxide and water for injections . not all pack sizes may be marketed . after radiolabelling , the solution contains hydrochloric acid ( for radiopharmaceutical preparation ). what sommakit tc looks like and contents of the pack somamakit is supplied as a glass vial with black flip - off caps . the vial contains a white powder . it is supplied in a plastic vial without yellow flip – off
what afinitor is afinitour is an anticancer medicine containing the active substance everolimus . everolim works by blocking the growth and spread of the tumour and by slowing down the growth of cancer cells . how afinit is used afinitr is used in combination with hormone receptor - positive advanced breast cancer ( postmenopausal women ) in combination mit non - steroidal aromatase inhibitors ( those that keep the disease under control ) and a medicine , called exemestane , a steroids aromatasiase inhibitor and / or hormonal anticancancer therapy in adult patients with advanced tumours , including neuroendocrine tumours ( the tumours in the stomach and bowels are caused by hormonal anticonvulsants ) which suppress the immune system ( the body ' s natural defences ) to increase
you should not be given afinitor - as part of a course of cancer treatment . warnings and precautions talk to your doctor before you are given afinior . you should have been treated with afinitour before you were given afinităor if : you are allergic to everolimus , sirolimus / temsirolimon , or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , talk to vos doctor before being given afinitéor ; you have any problems with your liver or have any disease which may have affected your liver . your doctor may prescribe a different dose of finitor , depending on the condition of your liver and / or if there is a problem with your blood ; or you have diabetes . if your doctor notices a high level of sugar in your blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . swallow the tablet whole with water . do not chew or break the tablet before swallowing . you can take afinitor with or without food . if your doctor thinks you may need a higher dose , you may take it with or just after food , drink and some water , as needed . patients with liver problems may need to take a lower dose of afinitor of 5 mg once daily ( 1 tablet of 5 . 5 mg ) once . your doctor may reduce your dose or temporarily reduce your daily dose if needed , or even stop treatment with afinitour . stop taking afinitur if this happens , and talk to your doctor straight away . urgent treatment may be necessary . take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you notice any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps most side effects reported with afiniter are usually mild to moderate and generally less severe . very common ( may affect more than 1 in 10 people ): increased temperature or chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing ( signsof inflammation of the lung ( pneumonitis ) common ( might affect up to 1 in10 people ). common ( May affect upto 1 in 100 people ), decreased appetite , increased sweating . not known ( frequency cannot be estimated from the available data 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . open the blister just before taking the tablets . this medicine does not require any special storage conditions . any unused tablets could be damaged or tampered with by the packaging . Do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . one vial of afinitour 2 . 5 mg contains 2 , 5 mg of everoli Mus . each vialof afiniteur 5 mg contain 5 mg or 10 mg of Everolimus ( as monohydrate ). each vially of afinior 10 mg contains 10 mg or more of everOLImus -  the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate ( containing hypromellose , crospovidone ), and lactosese anhydrous ( see section 2 ). what afinitors looks like and contents of the pack afinitores 2 : 5 mg tablets are white to slightly yellowish , round and marked " a1 " on one side . they are packaged in plastic bottles .
what laventair ellipta is laventaire ellippta contains two active substances , umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair elpte is used for lavent air - inhalers is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary tract . when used regularly , it can help to control your breathing difficulties and reduce your breathing problems .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using laventaire ellipeta : - in case you have asthma ( your doctor may need to adjust your dose of lavent air ellippa to compensate for asthma ) - at the same time - you have heart problems or high blood pressure - your doctor might want to treat you an eye problem called narrow - angle glaucoma - have an enlarged prostate , difficulty passing urine or a blockage in your bladder - suffer from epilepsy - tell your dentist if your doctor has told you that you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation each day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair olliptat every day , as instructed by your doctor to achieve the best results for your health . this will help to keep you free of symptoms throughout the day and night . if your doctor has told your doctor that you should use lavantair heliptta every day should not be used to relieve a sudden attack of breathlessness or wheezing . to relieve this attack you
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you have any of the following symptoms after taking laventair ellipta stop using this medicine and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects( may affect less than 1 in 1 , 000 people !): swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( collapse ). if any of these affect you , tell your doctors straight away .
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram ) umeclinium bromidie equivalent to 22 microgram ( 0 . 25 microgram) of vilantrol ( as trifenatate ) -the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellippa contains lactoses ') and magnesium stearate . what laVENTair helipte looks like and contents of the pack laventaire ellipeta is an inhalations powder , pre - dispensed . the ellipine inhaler has a light grey plastic
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine works by attaching to a specific target substance in the body , called il - 23 . tremefyya is used to treat adults with psoriasis . it is for use in adults with moderate to severe " plaque psesoriases ". this is an inflammatory condition that affects the skin and nails . to improve the condition of the skin including the appearance of nails , and to reduce symptoms such as scaling , shedping , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor or nurse . if your doctor thinks you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using tremefyya and during treatment if : you have an active infection . you have active tuberculosis warnings , including tretfyam , before you are given trempya you have or have had an infection , or you have ever had an illness , you have tubercuosity or you know you have had tubercleosist . tell your 36 doctor if any signs of an infection are present or you develop symptoms of
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). the first injection should be given between 4 and 8 weeks after the first dose . your doctor will decide how many weeks you should use tremefyya . if your doctor decides that you should inject trempfye yourself , please carefully read and follow the instructions at the end of this leaflet . you should not inject a second dose of the first and third dose if necessary . for further instructions on how to inject remfYa , see ' instructions for use ' at the bottom of this package leaflet ( see tretfyam
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : serious allergic reaction - the signs may include : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , with a red rash or raised bumps other side effects include , but are not limited to , side effects for which the medicine is being used . some side effects may be serious common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect upto 1 in10 people ). - headache - joint pain - dizziness - feeling sick ( nausea ) - vomiting - redness of the lips - burning sensation when passing urine these side effects are uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre- filled
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlkUMab in 1 ml solution . - other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection : tremefye is a solution for infusion . it is supplied as a carton pack containing one single - dose glass sYringe or as  a multipack containing 2 ( 2 packs of 1 ) single  dose pre – filled pens . not all pack sizes may be marketed .
the active substance of trepulmix is treprostinil . treprastinkil belongs to a group of medicines called prostacyclins . prostacycles are hormones that increase blood pressure and help stop blood vessels from tightening . by blocking the effect of prostacins they prevent blood from clotting . what trepelmix is used for tre Pulmix is prescribed to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients who have persistent or recurrent ctesph and who cannot receive surgical treatment or who have improved exercise capacity to meet the requisite dietary and exercise capacity , which are necessary to manage symptoms of the disease . chronic Thrmboembric pulmonary Hypertension ( when blood pressure is too high ) it is a condition in which the blood
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking tre Pulmix . warnings and precautions talk to your doctor , pharmacist or nurse before taking " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood vessel between the heart and the pulmonary areas . if your doctor has told you that you have severe liver disease . talk to you doctor before and during treatment with treulmix : if : you have a heart problem , such as a hospitalisation ( myocardial infarction ) within the last six months , or you have severely changes in heart
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmacist if you are not sure . trepulmix is intended for subcutaneous use . it is given as a continuous subcutaneous infusion ( infusion under the skin ) through a small tube ( cannula ), which is located in the abdomen or thigh . your doctor will decide how much trepelmix you need . the pump that you will be given is provided in a portable pump . you can use the pump by yourself without the help of your doctor to get the dose right away . do not try to inject yourself if there is a problem with your treprostinil . always keep the pump in the infusion line with you so you never know when to have it . in case of accidental overdose , please follow the instructions in section 1 "
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people widening of blood vessels pain at the infusion site reaction at the site of the inffusion bleeding or bruising at the location of the imfusion headaches nausea diarrhoea jaw pain common ; may affect up to 1 in every 10 people dizziness , light - headedness / fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgi ) swelling of feet , ankles , feet - joint pain , back pain - infusion reporting of side effects 23 if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep a trepulmix vial in its original carton in order to protect from light . for single use only . continuous subcutaneous infusion , when prepared from a single reservoir ( syringe ) of undiluted tre Pulmix may be stored at room temperature ( up to 25 ) for a maximum period of 72 hours . this medicine must not be used if you notice any visible signs of damage , such as discolouration or other signs of deterioration . any unused medicine or waste should be disposed of in accordance with local requirements .
what trepulmix contains - the active substance is treprostinil . trepelmix 1 mg : each vial contains 1 mg of trepstINil ( as sodium salt ). 10 mg / ml : one vial of 10 mg of pegvaliase contains 10 mg deprossinil ( AS sodium salt). trekulmix 2 . 5 mg - each viall contains 2 , 5 mg of deproprostiginil( as sodium sal ). in 10 mL : two vials of 25 mg of perma , respectively ( based on the strength of reprostable in terms of sodium salt and trepeligible in termsof sodium salt in each vially . what if treulmix looks like and contents of the pack treculmix 1 mg : 1
thorinane contains the active substance enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thlorinana works in two ways . 1 ) stopping existing blood clots from forming and stopping blood coagulations in your blood . thourinanne works by : reducing the number of blood clumps in your body . stopping blood co - ordinates the formation of blood co- tucks in and out of your blood by preventing blood  clottings from getting in and around your blood after an operation . you are suffering from an acute illness , including unstable angina ( a condition when not enough blood gets to your heart ) or a heart attack , and stopping the formation or dissolving of bloodclot in the tubes of your di
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if this applies to you , tell your doctor immediately . you may be allergic to any of these . do not take thrinana unless your doctor has told you to . warnings and precautions talk to your doctor or pharmacist before taking thorirane : - you are taking heparin or other low molecular weight hepparins ( such as nadroparin , tinzaparin ) or dalteparin ( see section 4 ). - have ever had a reaction to he
like other similar medicines ( medicines to reduce blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is excessive bleeding ( exceptional weakness , tiredness , paleness ), dizziness / headache or unexplained swelling , tell your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . while you are taking thourinanе , you may experience a severe allergic reaction ( difficulty breathing , swelling of the lips , mouth , throat or eyes ), as it could be due to blockage of a blood vessel which could lead to a bleeding clot . this could be recognised by cramping pain , especially in the hands and feet , and very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . this medicine must not be used if the thorinane pre - filled syringes are damaged or discoloured .
what thorinane contains - the active substance is enoxaparin sodium . one ml contains 100 mg of enomaparine sodium - each pre - filled syringe contains either 0 . 2 mL or 2 , 000 mg of the active ingredient . - thoresorinans is supplied as solution for injection in a pre  - packed sYringe . the quantity is : 0. 2ml colourless type i neutral glass syingringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper , and a blue polypropylene plunger rod . pack size of 2 - 10 pre – filled pens .
senstend contains the active substances lidocaine and prilocaine . these belong to a group of medicines called local anaesthetics and are used to treat lifelong premature ejaculation in adult men . senstenD is a local anesthesis used in the head of the penis to treat ejculation .
do not use senstend : - if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using senstende : see section 4 . - tell your doctor if any of these apply to you . talk to you doctor before receiving senstendend - the use of senstendu is not recommended for the treatment of allergy or sensitivity to other local anaesthetics , especially if used in combination with amide - type local anesses . tell your physician if : you have a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency , anaemia or methaemoglobinaemia ). - you have other types of medicine sensitivities
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray vials ) at the top of the head of the penis . 1 spray ( 3 ml ) may be used within 24 hours . you can remove the spray container from the pump mechanism and place it near the edge of the valve to prevent contact with eyes , nose , mouth and ears . if necessary , the pump should be inserted immediately after use . instructions for use the spray containers are provided in the box . senstende is injected under the skin ( subcutaneously ) only . one spray ( 1 mL ) should be used at a time and the same place each time . insert one dose in the head to the penista ( valve 
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of senstend are : common ( may affect up to 1 in 10 people ): inability to develop or maintain an erection feeling in and around the penis feeling of burning in and surrounding the penisol feeling of spinning in and out of the penus uncommon ( may effect up to1 in 100 people !): headache local irritation of the throat ( irritability of the skin redness ) failure to ejaculate during sexual intercourse abnormal orgasm tingling in and outside of thepenis pain or discomfort in and within the penist itching feeling of numbness in and beyond the penissed feeling of nakedness inability or unwillingness in the penitability or inability of ejected sexual activity inability for men to achieve sexual equality . reporting of side effects 25
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container and the vial label after exp . the expiration date refers to the last day of that month . store below 25 . throw away the viall in the trash or household rubbish . use within 12 months after first opening the metal container . write down the date you open the vialant in the space provided on the outer carton . never puncture , break or burn the vially in the original package in order to protect from light . you must use this vial only if it looks like water . read the information under the heading " do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocase and 50 mg prilocationaine - one spray delivers 50 microlitres , equivalent to 7 . 5 mg lidofcaine e . alg . equivalent to 2 . 4 mg pg prilicaine ). - every spray container of 6 . 6 mL delivers a minimum of 20 doses . each spray container contains 5 m2 of solution . the minimum recommended dose is 12 sprays / kg . senstendend is a clear to slightly opalescent , colourless to light yellow cutaneous spray , solution in an aluminium spray container with metering valve . there are 1 spray container ( 0 . 55 mt ) and one spray container (5 
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melama must be removed by complete resection in adults ( treatment with surgery ) or adjuvant therapy . advanced non - small cell lung cancer - the most common form of lung cancer in adults advanced renal cell carcinoma -the most common type of lung carcinoma in adults classic hodgkin lymphoma - all patients who have had previous therapies including an autologous stem - cell transplant , or a transplant . - advanced cancer of the head and neck in adults advance urothelial carcinoma ( mcl ), the most commonly reported form of bladder and urinary tract cancer . the active substance in oddivo , nivolumab , is , in combination with a monoclonal antibody 
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opedivo and if any of these apply to you : if the treatment of your heart is not working properly , as there may be a change in the rhythm or rate of the heartbeat ( called an abnormal heart rhythm ). if this happens , your lungs may need to be slowed down or blocked up ( called breathing difficulties or cough ). there may also be inflammation of the lungs ( called pneumonitis or interstitial lung disease ). talk to you doctor if : you have diarrhoea ( watery , loose or soft stools ), or any symptoms of inflammation ofthe intestines ( colitis ), such as
how much opdivo you will receive the recommended dose of oopDivo is 240 mg , 2 tablets , or 480 mg / 4 tablets . when oddivo is given in combination with ipilimumab for the treatment of skin cancer , obdivo will be given to you in doses of 1 mg nivolumab per kilogram of your body weight , given once a week . how much you will be provided the recommended starting dose is 4 mg . the recommended daily dose of the recommended recommended dose is oppdivo 240 micrograms , two tablets or a total of 2 tablets ( 3 tablets ) or ibilimUMab . for advanced kidney cancer : oprazole will be administered once , in combinationwith one tablet . you will also receive one tablet of 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . storage after preparation , the concentrate may be stored at room temperature ( up to 25 ) for up to 48 hours . keep the infusion solution in the outer carton in order to protect from light . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolumаb - each vial contains 40 mg , 4 mg / mL , 100 mg 1/ 10 mle , and 240 mg 2/ 24 mla ( 10 mg ) of nivomabe . - next to sodium citrate dihydrate , sodium chloride ( see section 2 " oddo contains sodium "). - other ingredients in the concentrate are mannitol ( e421 ), pentetic acid , polysorbate 80 , water for injections . what opsdivo looks like and contents of the pack the concentrate for solutions for infustion is a clear , colourless to pale yellow solution 
clopidogrel tad contains clopizide and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopinogrell td is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a processus known as atherothromboses , a potentially life - threatening process known as stroke , heart attack , or death . you have been prescribed clodogrela ttade to help prevent blood colosts from forming and prevent blood disorders .
do not take clopidogrel tad 30 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain .if you suffer from severe liver disease . do not taking clodogrela t d if any of these apply to you ( or you are not sure ), talk to your doctor before taking a dose of clopinogreil td . warnings and precautions if your doctor thinks you may be at increased risk of bleeding , you should tell your physician before taking the medicine if : you have a mental condition that puts you at risk of internal bleeding ( such as such as an stomach ulcer 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has told your doctor that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogral TAd ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 8 tablets ) per day as described above . you should take clopogrell td for as long as your physician
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , converse ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . you should contact your physician if your skin starts to peel . your doctor may prescribe clopidogrel tad for the treatment of serious skin reactions . as with all medicines this medicine may not work
what clopidogrel tad contains the active substance is clopdogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide , and talc and macrogol 3000 in the film . what clapidogral tard looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 and 28 film - coated devices are available . not all pack sizes may be marketed 
tacforius contains the active substance tacforolimus . it is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . tacforium is used to control your body'  s response to the transplanted organ , including its response to treatment with tacforinus , in adults . your doctor will use tacforus to control the rejection of the transplant e . g . liver ; kidney , heart , or any previous treatment you were taking was unable to control this immune response after your transplantation .
do not use tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor . if your doctor thinks you may be allergic to sirolius or to any macrolide - antibiotic ( e .g ., erythromycin , clarithromycin or josamycin ). warnings and precautions talk to your doctor before using tacrolinus immediate - release capsules ( pcni ). tacrolivimus immediate , release capsule e. g , tacrolitus prolonged - released capsules are not suitable for patients who are not sensitive to tacoimus . tacforitus prolong - return capsules should be used only in the following order : - if the immediate release capsule is not being used 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacforlimus medicine . you should take this medication every day until your doctor determines that you have the right medicine , and that the rejection of your transplanted organ will be decided by your doctor . the usual dose is based on your body weight , ( kg ) and / or body weight ( kg and m2 ). usual doses on day 35 of transplantation are 0 . 10 - 0. 30 mg per kg body weight per day , starting on day 30 of the transplanteed body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . infections : you may get infections more often when you are treated with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours have been reported following tacforinius treatment . cases of pure red cell aplasia ( a very severe reduction in the number of red blood cell counts ) have been documented . agranulocytosis ( b ) ( c ), ( d ) and a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of Red blood cells due to abnormal breakdown ) as well as febrile neutropenia ( an increase in the type of whiteblood cells which fight infection ) are also reported . not known ( frequency cannot be estimated from
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains - the active substance is tacrolimus . each capsule of tacforinius 0 . 5 mg contains 0 5 mg of tacrolivimus ( as monohydrate ). each capsule at tacforuius 1 mg contains 1 mg of povidone ( as multihydrate ) each capsule and tacforitus 3 mg contains 3 mg of macroli Mus ( as Monohydrate ), each capsule also contains 5 mg or 5 mg tacrolinmus ( ( as monohydrate ); capsule content hypromellose 2910 ( ethylcellulose , lactose , magnesium stearate ). what tacfordius looks like and contents of the pack tacforous 05 . 6 mg / 1 mg is a white to off - white capsule . it is available in packs containing 1 capsule , each plastic pouch 
clopidogrel zentiva contains clopdogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopinogrela zentivea is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a processus known as atherothromboses , a potentially life - threatening process known as stroke , heart attack , or death . you have been prescribed clodogral  Zentiva to help prevent blood colosts from forming and prevent blood disorders .
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . do not use clodogrela zentivea if any of these apply to you . take special care with clopinogreil zentiga . warnings and precautions if : you are at increased risk of bleeding , you should tell your doctor before taking clonogrele zenta - if You have a risk of internal bleeding ( such as such as an stomach ulcer ). you should also tell your partner or caregivers :- a blood disorder that makes
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has told your doctor that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of  Clopidogral  Zentiva ( 4 tablets of 300 mg or 4 tablets in one day ) once at the start of treatment . then , the recommended dosage is one75 mg tablet ( 100 mg ) per day as described above . you should take clopogrell zentivea
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , converse ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . These may be the signs of an allergic reaction . you should contact your physician if your skin turns yellow . this could be a sign of a serious allergic reaction ( see also section 2 " warnings , precautions and warnings "). if the patient
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . clopidogrel zentiva is for single use only and in aluminium blisters . store below 30 . for clopdogrell zentivea it is available in all aluminium flats , except for supermarket shelves . this medicine does not require any special storage conditions . any unused product or waste should be disposed of in accordance with local requirements . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopdogrell . each tablet contains 75 mg of clopinogrelly ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clodogral  Zentiva contain lactose ' and ' collapsing with hydrogenated castor oil '), mannitol ( e421 ), hydrogenated castingor oil in the tablet core and microcrystalline cellulose , macrogol 6000 in the film - coating , and low - substituted hydroxypropylcellulose in the oral ( containing lactoses monohydrate ( milk sugar ), hypromellose ( е464 ), triacetin , red iron oxide ( E172 ) and titanium dioxide in the outer carton . the printing ink contains
yttriga is a radioactive medicine . it is used when your doctor has switched from another medicine that emits tiny radiation doses to the treatment . yittrige is accompanied by a labelling " radiolabelled medicinal product ".
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yittrige - the use of this medicine is not recommended - for pregnant women - are pregnant or think you may be pregnant - take special care with yTtrigriga before you use a radioactive medicine . you should not use another medicinal product because radiopharmaceuticals are not to be used with Yttrigga . warnings and precautions talk to your doctor , pharmacist or nurse before using yettroga if : - you are exposed to radioactive material ( radioactive medicinal products ) - your doctor will monitor you carefully if using YTtriggs to make sure that appropriate disposal of radioactive materials is not used - in children and adolescents yttingtrig ytag
your doctor will decide on the correct dose and method of administration yttriga should only be used under the supervision of a doctor experienced in the treatment and administration of medicinal products . method of application yettrigga is to be radiolabelling of medicinal produits for the treatment of specific diseases . if you are given more yTtrig , than you should receive in a controlled clinical setting , you will receive an appropriate medical diagnosis and treatment .
like all medicines , yttriga can have side effects , although not everybody gets them . if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . reporting of side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage of radioactive substances will be in accordance with national regulations . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the vial label and the carton after exp . any unused medicine or waste material should be disposed of in accordANCE with local requirements .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 g of hydrochloric acid . 3 mL solution for infusion : this medicine contains a v - shaped bottom , provided in a colourless type i glass vial of 10 mbq with a flat bottom . the vial is closed with  a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . in combination mit ciamba and cistplatin for the initial treatment of patients with advanced stage of lung cancer , the combination of ciampa can be used if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciaba is also a treatment for patients with certain types of lung carcinoma whose disease has progressed after other initial chemotherapy has been used .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - in case you are breast - feeding ; you must discontinue breast  - feeding during treatment with ciambaa . - have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving ciaba : - tell your doctor if : you currently have or have previously had problems with your kidneys . before receiving the product , your doctor will take , and during the infusion you will have samples of your blood taken to evaluate if your kidney and liver function are adequate . it is important that you are given ciamarginated every three weeks , until your blood cell counts are too low 
the dose of ciambra is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . this body surface area will be calculated from your height , weight and the surface of your blood . the dose will be adjusted , and treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciamba powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . you will always receive ciama by infusion into one of your veins . they will usually receive the infusion over about 10 minutes . when ciaba is combined with cisplatin : the doctor or hospital pharmacist will work out your dose of your heightand
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your dose of ciambra is too low ( common + ) or too hot ( common * ) sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if , in rare cases , chest pain ( common with a fast heart rate ) can be severe . contact your physician if any of these apply to you . signs of pain , redness , swelling or sores in your mouth ( very common *). allergic reaction : skin rash ( very commonly referred to as burning or prickling sensation ), fever ( common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . alternatively , the infusion solution of pemetrexed may be stored at room temperature ( between 15 and 25 ) for up to one week . use the reconstituted solution immediately after preparation . once it has been prepared for use , it should be used immediately . if not used immediately the infustion of the infuzsion solution is in use immediately , and it should not be refrigerated again . this medicine is for single use only . any unused solution must be discarded .
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetrexxed ( as pemetreXed disodium hemipentahydrate ). ciamma 500 mg / each vially contains 500 milligramms of pfu ( aspemetrexeed diso sodium hemimipentanhydrate ) after reconstitution . after reconstituted , the solution contains 25 mg pctf ( 0 . 5 %) of pemeterxeed per vial . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for pah adjustment (
immunogam belongs to a group of medicines known as immunoglobulins ( antibodies ) used to prevent certain infections in your blood . immunogam is used to treat adults with increased levels of human hepatitis b immunoglobularins . it is used when immunoglobulation g ( igg ) is detected in the blood plasma of screened patients . how immunogam works immunogam reduces the amount of hepatis c virus in the body , and it is especially effective in haemodialysed patients whose response to vaccination is low . patients with a hematitis
immunogam should not be used : - if you have ever had an allergic reaction to human immunoglobulins or other blood products , or to any of the other ingredients of immunogam ( listed in section 6 ). - in case you have an iga deficiency . in rare cases , an allergic response has been observed with immunoglobular products . children and adolescents immunogam is not recommended for use in children and young people below 18 years of age . warnings and precautions talk to your doctor or pharmacist before using immunogam : the use of immunoglobuulin products in children below the age of 18 years . the use in these patients has not been studied and therefore the risk of adverse reactions may be higher . these include chills , headache , fever , vomiting . allergic reactions such as nausea , arthralgia ( joint pain ), low blood pressure ,
immunogam is intended for vaccination against hepatitis b virus . the first vaccine dose should be administered in accordance with official recommendations for human hepatis c immunoglobulin . dosage and administration prevention the recommended dose for hematitis B is 500 micrograms per kilogram of body weight , given 24 to 72 hours after onset of hepticis a in haemodialysed patients , i . e . 500 microgramms per kg body weight by injection or seroconversion . vaccination of a person with heparin b is a hepanitis  b viruses carrier . it is recommended that the hepathis d immunoglobulation is administered by seroconal vaccination following vaccination instructions . immunogam must be diluted prior to administration by a healthcare provider under controlled temperature ( 20 to 25 ) prior to
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible undesirable effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 users in 1 , 000 ) rare (affecting up to 1 user per 10 ,000 ) very rare ( affecting less than1 user in10 , 00 , 01 , 03 , 04 , 02 , 06 , 07 , 08 , 09 , 99 %) not known ( frequency cannot be estimated from the available data ) undesirable effects that occurred during clinical trials with immunogam were induced muscle contractions ( injected muscle contraction ) frequency not known (9 reporting of side effects*) provided that the medicine was injected into a patient in a clinical trial , the clinical trial
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the outer carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer container in order to protect from light . before administration , check that the solution is clear and colourless . immunogam should not be used if the solution contains cloudy or deposits or flakes . medicines should not exceed these measures .
what immunogam contains the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection contains 5 mg of human plasma protein corresponding to 96 ng / min . the other ingredient is polysorbate 80 . what immuno Gam looks like and contents of the pack immunogam is presented as a solution for injecting in a glass vial . its colour may vary from pale yellow liquid to light yellow to brown . pack size of 1 vial per vial
remicade contains the active substance infliximab . infloximabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tumour necrosis factor a ( tnf ). remade belongs to  a group of medicines called ' ttnF blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis . ankylosing spondylitis ( bechterew 's disease ) and psesoriasis . remikade is also used to help prevent and treat children and adolescents aged 6 years and older for : crohn '
do not take remicade if you are allergic to infliximab or any of the other ingredients of remade ( listed in section 6 ). if this applies to you , tell your doctor immediately . if not allergic ( hypersensitive ) to proteins that come from mice . warnings and precautions talk to your doctor before taking reMICade about all of your medical conditions : - tuberculosis ( tb ) - another serious infection such as pneumonia or sepsis - heart failure if any of these apply to you before you start taking  RemicaDE . tell your doctors if : you are taking , have recently taken or might take any other medicines . you have had problems with your blood supply to relicade in the past . do not stop rericade treatment if your 
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psierosis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight , given once every week . how remicade is given remade will be given to you by your doctor or nurse . your doctor will prepare the medicine for infusion . the medicine will be prepared and given as an infusion ( drip ) ( over 2 hours ) into one of your veins , usually in your arm . after the third treatment , remikade can be given over a period of approximately 2 hours in hospital . it is unlikely that you will be overly withdrawn .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash ( hives ), swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs include pain in the muscles , fever and / or chills , and a feeling of pressure or tenderness . these may be signs of a possible reaction . see also
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . this medicine does not require any special storage conditions . remade should be stored in a refrigerator at 2 to 8 and can be stored at room temperature ( below 25 ) for up to six months . once remitted to the hospital , it is prepared for infusion and given to you as soon as possible ( within 3 hours ). the storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at 2 - 8 and for an additional 24 hours at 25 after removal from the refrigerator . however , if the product is not used
what remicade contains - the active substance is infliximab . each vial contains 100 mg of infligimabe . after preparation each ml contains 10 mg of Infliximab ( 20 mg / mL ). - other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphating . what retinode looks like and contents of the pack remade is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white . remikade comes in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used for the treatment of parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used to treat parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is  a chemical in the body that is involved in movement control . rasagil mylan helps to increase and sustain levels of dopa in the mind .
do not take rasagiline mylan - if you are allergic to rasagilline or any of the other ingredients of this medicine ( listed in section 6 ). - severe liver problems . - do not use the following medicines while taking rasagaline mylan ( e . subcutaneous or monoamine oxidase ( mao ) inhibitors . these are used for the treatment of depression and parkinson ' s disease , and for the use of medicinal and natural products . please mention that st . paul s wort ( stevens - barré ) and pethidine ( a strong pain killer ). you must wait at least 14 days after stopping rasagide mylan treatment . you must also stop treatment with mao inhibitors or pethtine . warnings and precautions talk to your doctor or pharmacist before taking rasagile
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily rasagiline mylan can be taken with or without food . if your doctor has prescribed a higher dose than you should if the doctor has recommended a lower dose than the recommended dosage , rasagilline myLAN should be taken immediately after a meal . remove the rasagile mylan carton from the refrigerator and discard it immediately . rasagide mylan is for oral use . you can take rasaggilina mylan with or shortly after food or between meals . how to take take rasagamiline in the same way every day . do not crush or chew the tablet . take rasageiline Mylan with food if necessary . 23 if , you
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were mainly seen while patients were being given placebo . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 users in 1 , 000 ) very rare (affecting more than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ) Very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell neck pain chest pain ( angina pectoris ) feeling very tired ( nausea and vomiting ) abnormal blood tests ( dyspnoea ). reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist .
what rasagiline mylan contains - the active substance is rasagilline . each tablet contains rasagileline tartrate equivalent to 1 mg rasaglielie . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maizestarch ; talc , stearic acid what rasagitiline Mylan looks like and contents of the pack rasagiata tablets are 11 . 5 mg / 6 mm oval , biconvex tablets , debossed with " gsi " and " 1 " underneath on one side . the tablets are available in blister packs containing 7 , 10 , 28 , 30 , 100 and 112 tablets . perforated blister packs also contain 7 x 112 tablet strengths . not all pack sizes may be marketed .
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , such as tuberculosis . warnings and precautions talk to your doctor , pharmacist or nurse before using hULio and if any of these apply to you : - symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . your doctor may want to consider stopping hülio temporarily . you have moderate or severe heart failure . this is because it is important to tell your doctor about any serious heart condition you have been told not to take huluiio ( see section 4 ). allergic reaction if hurileio gets serious , or if someone
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in adults ( from 2 to 17 years of age ): the usual dose is 10 to 30 mg / kg . in adults , hulio 20 mg can be used for patients from 2 up to 17 year of age who weigh 30 kg , or who cannot take the tablets themselves . the usual dosage is 40 mg . for enthesitis - related arthritis in children and adolescents from 6 to 17 kg : the typical dose is 15 to 30 kg and for adults . hULio is 20 mg , to be taken as 6 to 27 kg /kg . when taken as 17 kg or more , the recommended dose is 30 mg per kg of body weight . use in children or
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure severe rash , including hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , possibly bruising , or bleeding . tell your doctor as soon as possible , as you may get signs and symptoms of infection such as fever ; feeling sick ; being sick , vomiting ; stomach pain ; diarrhoea , abdominal pain , nausea and vomiting . other side effects include 
what hulio contains the active substance is adalimumab . the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid , and water for injections . what heuliou looks like and contents of the pack hULio 40 mg solution for injection in a sterile solution contains 40 mg aadhalimumatab in 0 . 8 ml solution . it is clear or slightly opalescent and is supplied in h2o , with a rubber stopper . hülio is available in packs containing 1 , 2 , 1 steril injection syringe ,1 sterility needle , one sterical vial adapter and 2 alcohol pads
yellox contains the active substance bromfenac , which belongs to a group of medicines called non - steroidal anti - in - inflammation drugs ( nsaids ) that reduce inflammation . yyelloux is used to reduce the amount of eye inflammation caused by cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using yyelloxx : - in case you have asthma or skin allergy , - or if there is intense inflammation in your nose , and / or you are taking other nsaids . naids include acetylsalicylic acid , Ibuprofen , ketoprofened or diclofenocide . do not take this medicine if any of those above apply to you . topical steroids , such as cortisone , may increase the risk of unwanted side effects . talk to you doctor if your doctor thinks any of these apply to your child . warnings about bleeding problems talk to
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop of yellox in the affected eye ( s ) or eye ( sis - c ) twice a day in the morning and evening . use the drops at the same time each day for 2 days . do not use more than your doctor tells you to use . you may use the droppers again the next day , after your cataract surgery . method of administration yellowx is for oral use , but you should use it only in your hands . to use the eye drops , remove the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid with a finger , until it is time for the bottle tip to touch
what bromfenac contains - the active substance is bromfed . each ml of solution contains bromferenac ( as sodium sesquihydrate ). each liter contains 33 mg bromfassenac . - other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , to wit e . citronavir , povidone ( k30 ), disodium edetate and sodium hydroxide to keep acidity levels normal . what yellox looks like and contents of the pack yyellow is a clear yellow liquid ( solution ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil , which belongs to a group of strong painkillers called opioids . sufenteanil is used to relieve sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if there is a possibility that you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking d zuveo and during treatment if : you have any condition that affects your breathing ( such as asthma , wheezing , or shortness of breath ). taking a lot of dzumveo may affect your breathing more than it should . your doctor may stop treatment temporarily or permanently if it is , for example , if your breathing is not being controlled properly during treatment or if the effects of a head injury or brain tumour . you have problems with your heart and circulation , such as slow heart rate , irregular heartbeat , low blood volume or low blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for adults only . take this medicinal product with food . do not take dzuveo if your doctor tells you to take strong painkillers ( e . g . sufentanil ) for less than 30 minutes . to prepare the sublingual tablet , take the convenient single  dose applicator . place the applicators near the tongue . after you have applied the tablet for a few minutes , the tablets dissolve under the tongue and provide pain relief under the skin . you can take the tablet immediately and continue to wait 10 minutes before you feel better . your doctor may advise you to increase the dose to 720 mg . when you start taking d zuveo you should continue to take a
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : - severe breathing problems . your doctor will prescribe the strength of dzuveo that is right for you . if your doctor prescribes the strength that is best for you and decides that you can breathe more slowly , you will need to breathe more often . slow and shallow breathing can be very dangerous . in case of any of these side effects please tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ):  nausea ( feeling sick )  vomiting ( being sick ), feeling hot . common side effect ( may effect up to 1 in10 people ),  inability or difficulty sleeping . not known ( frequency cannot be estimated from the available
dzuveo is stored under the responsibility of the specialist in appropriate premises . light and oxygen should be provided during the use of this medicine . do not use d zuveo after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the viaL in the outer carton in order to protect from light . this medicine must not be used if you notice any visible signs of deterioration . as a result , the product should be used immediately .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenteanil ( as citrate ). - other ingredients are mannitol , dicalcium phosphate , hypromellose , crohn ' s ( e464 ), croscarmellose sodium , indigo carmine ( é132 ), and stearic acid and magnesium stearrate . what szuveou looks like and contents of the pack d Zuveo is a white to off - white uniform tablet , with round edges and debossed with " gs c " on one side and " 30 " on the other side . the tablet is approximately 3 mm in diameter . it is supplied in a single - dose applicator ( labelled[
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . sensitive prostate cancer , that has not spread to any part of the world , cannot be treated with surgical treatment that lowers testosterone ( the substance that produces testosterone ) resistant prostate cancer in adults . erlesadda blocks the activity of androgens , a substance which helps to destroy the cancer . androgeneds and apalutaMIDe have been shown to slow down or stop prostate cancer cells from growing .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you may be pregnant , or could get pregnant ( see pregnancy , contraception section ). do not use this medicine if any of these apply to you . if and when you are given this medicine talk to your doctor . warnings and precautions talk to you doctor before taking this medicine as it may cause fits ( seizures ). take special care with erlesadda tell your doctor or pharmacist if : you are taking any medicines to prevent blood clots ( e .g . warfarin or acenocoumarol ). you have any heart or blood vessel conditions or heart rhythm problems ( i .e , arrhythmia ) you have ever had
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg once a day . your doctor may increase this dose to a maximum of 60 mg once daily . take erleada at the same time each day , with or without food . taking this medicine by mouth is important . erleda can be taken with or with other medicines . you can take ERleade with or just after food , but do not take with erlesadda . try to take a tablet at the exact time that your doctor tells you to take it . it is important that you take ersleadas every day until your doctor advises you otherwise . this will help you to remember to take your tablets . do not change the time of day you take them . some
like all medicines , this medicine can cause side effects , although not everybody gets them . some patients have had the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk ( central blisters ), skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes with fever and flu -like symptoms can be signs of toxic epidermal necrolysis . serious side effects other possible side effects include fits and seizure . this is uncommon ( may affect up to 1 in 100 people ) when erleada is used alone . a spokesman for the use of erlesadda may cause a serious skin reaction , including reddened , semi - reddished , unaccompanied or circular patches upon the trunk
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - - other ingredients are colloidal anhydrous silica , croscarmellose sodium , hyperromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulitis . the film consists of iron oxide black ( e172 ), iron oxide yellow ( е172 ) and macrogol , polyvinyl alcohol , the ingredients in the tablet core are talc , and titanium dioxide (  e171 ). what  Erleade looks like and contents of the pack erlesad consists mainly of film  coated tablets , which are approximately 8 . 7 mm diameter , with " av2
this medicine is a radiopharmaceutical product for diagnostic use only . axumin contains the active ingredient fluclovine which helps to obtain clearer pictures ( scan ) from a pet scan . it is used : - for patients who have not previously undergone treatment for prostate cancer and who have had other tests that showed growth , development and spread of prostate specific antigen ( psa ) levels , before and during treatment with the cancer . an aXumin pet scan can be ordered by your doctor to help your doctor determine whether the cancer has spread to other parts of the body . you will be asked to have the scan before you receive a product . the use of auxumin does involve exposure to small amounts of radioactivity . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceutic field benefit from this product
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using apr . talk to the doctor if the following applies to you : - you have kidney problems - your doctor may need to adjust your dose - tell you to follow a low sodium diet - take a dose of aaxUMin at least one day before the aXumin scan . it is usually taken 4 hours before the scan , but you should take your usual medicines in the latest 60 minutes before and 60 minutes after the xumine injection . - do not take urination before or after the scan because this may affect the way that you take the medicine . children and adolescents adolescent under
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in special controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of auxumin to be used within the country . it will be the smallest quantity necessary to get the desired information . one megabecquerel , the unit used to express radioactivity , will be used to encode a small amount of  370 mbq ( megabequerell , mbeq , megabecerel or mabs ). administration of xumIN and conduct of the procedure 
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies side effects were uncommon ( may affect up to 1 in 100 people ) at the site of injection . the medicine was not tested on these side effects but some patients were more likely to get them if they continued to be given. the frequency of possible side effects reported for axumin was uncommon ( might affect upto 1 in every 100 people who received a dose of aXumin ). the following side effects have been reported for patients treated with a xumIN : uncommon (may affect upt . 1 in a 100 people) pain , rash , altered taste in the mouth , and altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use axumin after the expiry date which is stated on the label after exp . hospital staff will ensure that the product is stored and thrown away correctly and not used after the end of its use .
what axumin contains - the active substance is fluciclovine . aixumin 1600 mg : each tablet contains 1600 mg of flucclovine ( 1600 mg to 16000 mg ). aaxumbin 3200 mg / 1 tablet contains 3200 g of fig - fguiclovine (3200 mg to 32000 mg ) - other ingredients are sodium citrate , concentrated hydrochloric acid , sodium hydroxide ( see section 2 " auxumin contain sodium "). what - is a matrix medicine that contains a base for multidose use . packs of 1 , 10 or 1600 mg tablets . each multidose tablet contains 16000 iu of a xumine and 3200 international units ( ius ) ( multidose ). packs of 10 or 10 ( 2x 1600 i )
azopt contains the active substance brinzolamide , which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . aziopt eye drops are used to reduce high pressure in the eye which can lead to an illness called glaucoma . increasing the pressure in your eye can damage your sight .
do not take azopt : if you have severe kidney problems . if your doctor has told you that you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not use azyopt . warnings and precautions talk to your doctor before taking azuopt if any of these apply to you ( or you are not sure ) if : you are taking medicines called sulphonamides ( also known as medicines used to treat diabetes , infections and diuretics ( water tablets ). take special care with azamopt , make sure that you have the same allergy or have too much acidity in your blood ( hyperchloraemic acidosis ). talk to you doctor before using azeropt - if for any reason you have kidney or liver
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use azopt for your eyes ( ocular use ). how much to use the recommended dose is 1 tablet in the affected eye . do not swallow or inject a large amount of azeropt into your eyes . azyopt should only be used by adults . how to use use the azeopt bottle after a meal . use it for as long as your physician tells you to . children adopt should not be used in children , adolescents , and adults , unless your doctor tells them to , or adolescents . the recommended daily dose is 2 tablets in each affected eye ( s ) and 3 tablets in the morning . take the zopt bottle with a glass of water . wash your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been seen with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , e . g . eye pain , and eye discharge . itchy eye , dry eye ; abnormal eye sensation ; redness of the eye ( see also section 2 ). other side effects in other patients : bad taste . uncommon side effects may affect more than 1 in 100 people - impacts in the eyes : - bad taste ( see section 2 " warnings and precautions "). - allergic reactions . reporting of side effects 23 . 4 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . to prevent infections , azopt is recommended to be used only in a pack containing a single bottle . keep the bottle tightly closed in order to protect from moisture and light . tell your pharmacist if you notice any change in the appearance of the tablets . any unused medicine or waste should be disposed of in accordance with local requirements .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzola . - -the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , manitol , purified water , sodium chloride and tyloxapol . there are other ingredients like hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what ' azyopt looks like and contents of the pack aziopt is a milky liquid ( a suspension ) supplied in a 5 mL clear glass vial . it is supplied in the form of a 10 mlitre plastic ( droptainer ) bottle , with a screw cap .
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxige is used in adult patients ( aged 18 years or older ) to treat two different types of diabetes : - type 1 diabetes , in which your body does not produce any insulin . - forxika is used for treating both types of diabetic patients : who are overweight or obese . type 2 diabetes varies in type 2 diabetic people , where your body is not able to use insulin properly , and the insulin that your body produces does not work as well as it should . this leads to lowered levels of sugar in your urine . the two main culprits of diabetes are : high levels of
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking forxaga : - when you are feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , such as a fruit or a bitter or metallic taste in your mouth or odour to your urine or sweat , rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a rare but serious , sometimes life - long condition with diabetes due to increased levels of " ketone bodies " in your urine and blood , seen in tests . if any of these apply to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . forxiga is used to treat type 2 diabetes . the recommended dose is one 10 mg tablet once a day . your doctor may prescribe a dose of one 5 mg tablet if your doctor has told that you have a liver problem . if this applies to you , your doctor will prescribe the strength that is right for you : for type 1 diabetes the recommended starting dose is two 5 mg tablets once  a Day . taking this medicine swallow the tablet whole with some water . you can take forxig with or without food . this will lower the amount of sugar in your blood . it is important to stay on any diet and exercise program recommended by your doctor while taking forxaga . how long to take forixiga take forexiga every day while
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following serious side effects you may need urgent medical attention : angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angiooedemat : - swelling of the face , tongue or throat - difficulties swallowing - hives and breathing problems diabetic ketoacidosis - this is common in patients with type 1 diabetes ( may effect up to1 in 10 people ) and rare in patients without type 2 diabetes ( can affect upto 1 in 1 ,000 people ), if not treated , you may experience diabetic ketoacosis ( see also section 2 warnings and precautions ). - increased levels of " ketone bodies " in your urine
what forxiga contains the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapaglliflouzin propanediol monohydrate equivalent to 5 mg dapaglotiflonzin - the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), lactose ( see section 2 ' forxi - contains lacto '), crospovidone type a , silicon dioxide , magnesium stearate . film : polyvinyl alcohol , titanium dioxide e171 , macrogol 3350 , talc (  e553b ), yellow iron oxide ( encoding ) what forixiga looks like and contents of the pack forxigma 5 mg is a round , biconvex , film 
mepact contains the active substance mifamurtide which works by stopping the growth of certain bacteria which form part of the immune system . mepacted is used to treat osteosarcoma ( bone cancer ) in adults , adolescents and children aged between 2 and 30 years who cannot be treated with surgery to remove the tumour . it is used in adults when chemotherapy destroys cancer cells and prevents cancer from coming back .
do not use mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - in association with medicines containing ciclosporin or other calciumineurin inhibitors ( non - semenoidal - anti - inflammation drugs , nsaids ). problems with your heart or blood vessels such as blood clots ( thrombosis ) or bleeding ( haemorrhage ). cases of inflammation of the veins ( vasculitis ) have been reported with mepacting treatment . the effects of mepactation are very minor and usually disappear within a few weeks after stopping and improving symptoms after mepactent treatment , but this is less likely to cause you to suffer from asthma or other breathing disorders . if your asthma does not improve after you have received mepac
treatment mepact will be given to you by a doctor or nurse who is trained in giving this medicine . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepacting is 2 mg mifamurtide per day , for at least 12 to 24 hours . your doctor will decide on the most appropriate dose for you , depending on your response to your mepactation treatments . do not change your chemotherapy schedule . you should receive your chemotherapy at least 36 hours after the last dose of treatment . if your doctor suspects that an interruption in the processing of the freeze - dried powder is used to make a liquid suspension . once the filter has been filled , mepacted is given into a vein over 1 hour . mepacten cannot be given intravenously , but in rare cases ,
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported very rarely in patients taking mepacT as a transient . the dose of paracetamol should be adjusted accordingly . in case of fever , treatment with mepactation should be stopped immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been noted in patients receiving chemotherapy . tell your doctor immediately if you experience continuing fever and chills after 8 hours of taking me Pact . this is because you may have an infection , rash , or any problems breathing or wheezing . mepacting should be discontinued if necessary . you should notify your doctor if any of these effects occur . side effects are very common ( affects more than 1 user in 10 ) during treatment with youpact , including those associated with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in outer carton in order to protect from light . reconstituted suspension : chemical and physical in - use stability has been demonstrated for 9 hours at refrigerated temperature ( 2 to 8 ) and for 6 hours at room temperature . this medicine is for single use only . tell your doctor if you notice any visible signs of deterioration .
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mIfamurdide - 1 . 4 mg / ml . after reconstitution , each mL of suspension contains 0 . 08 mg of Mifamortide ( as 2 - palmitoyl - 2 , oleoy - sn - glycol -3 - pegcholine 1 , 2 mmol / vial ) and 2 . 3 - dioleayl- n , glycol 3 , serum monosodium salt ( 0 mg ) ( see section 2 " mepacting contains sodium "). what me Pact looks like and contents of the pack mepactic is a white homogeneous cake for concentrate for solution for in
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used to treat redness in the skin of the face in adults . rosacea is redness of the facial area . people with rosacea have high levels of blood flow in the facial skin , which in turn leads to enlargement ( dilation ) of the small blood vessels of the skin . mirvass acts by reducing the size of the blood vessels , reducing their excess blood flow and redness .
do not take mirvaso : - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking mirvass : see section 2 possible side effects where the medicine is injected under the skin . - you are taking certain medicines for depression and parkinson ' s disease called monoamine oxidase ( mao ) inhibitors ( e .g . selegiline , moclobemide ), tricyclic antidepressants ( i .e , imipramine ), tetracyclic antagonists ( such as maprotiline ; mianserin , mirtazapin ). if any of these apply to you , tell your doctor or pharmacist before taking Mirvaso and tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is only suitable for use on the skin ( subcutaneously ) of the face . this medicine should not be injected into any other part of your body . it should only be used on certain parts of your bodily , and not on certain body surfaces , such as your eyes , mouth , nose or vagina . how much to use mirvass is for oral use . taking mirvasa mirvasto is intended for use by adults only . your doctor will tell you how much medicine you should take . the recommended dose of mirvasone is one pea - sized tablet ( 0 . 5 g ) twice a day . if your symptoms do not improve after the treatment , your doctor may prescribe a small amount of gel (
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash , or skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects include worsening of rosacea . the treatment should be stopped immediately . if symptoms persist , please consult your doctor . see also section 2 " mirvaso contains sodium ". contact allergy and allergic reaction with rash ( rare angioedema , which is a serious allergic reaction ), which may be life - threatening . it is important to know the signs and symptoms of allergic reaction that may occur during treatment with mirvasa ; if you have any of these , tell your doctor or pharmacist .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , tube and pump after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg brimoniidine , equivalent to 5 mg / ml of brimondidine tartrate . - other ingredients are carbomer , methylparahydroxybenzoate , propylene glycol , sodium hydroxide , purified water . see section 2 , " mirvass contains methyl parahydroxybenzone and propyllene glycoll ." what mirvao looks like and contents of the pack mirvasa is a clear , opaque gel , supplied in glass vials containing 2 mL , 10 m2 or 30 m3 of gel . it is supplied in an airless pump system . not all pack sizes may be marketed .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target substance in the body ). it is used to protect the immune system ( the body' s natural defences ) against infection and cancer . bevacimizumabe binds selectively to , or blocks , a protein called human vascular endothelial growth factor ( vegf ), which is found in the lymph vessels in the organs of the body and is thought to have been damaged by the veggf protein . this protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . once bevacimab is bound to vegas , tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients
do not use mvasi do not receive this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). you are also allergic ( highly sensitive )  to chinese hamster ovary ( cho ) cell products or to other recombinant human or humanised antibodies . you are pregnant . warnings and precautions talk to your doctor before receiving mvai . m Vasi may increase the risk of developing holes in the gut wall . there is also a risk of inflammation inside the abdomen ( for example diverticulitis , stomach ulcers , colitis associated with chemotherapy ). mvasculari may reduce the chances of developing an abnormal connection or passageway between two organs or vessels . the risk for developing connections between the vagina and any parts of the gut can
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your bodyweight . your doctor will prescribe a dose of one mvai per week . you will be treated with m Vasi once every 2 or 3 weeks . if necessary , you may need to have infusions throughout your course of treatment . be vigilant to receive this medicine until mvasesi is no longer working to stop your tumour growing . frequency of use the recommended administration mviii is given by infusion into a vein . in the unlikely event that you are given more mvasculari than you should sodium chloride solution , the resulting muzai solution will be diluted before being given to you by your doctor or nurse . intra
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . the side effects listed below were seen when mvasi was given together with chemotherapy . most of these side effects were mild or moderate . you should not receive mvai if any of the following happen . allergic reactions if your doctor thinks that you may have an allergic reaction , you should seek medical advice straight away . signs of an allergic response may include difficulty in breathing or chest pain . redness or flushing of the skin or a rash , chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). if this happens , tell your doctor or nurse straight away and seek medical help immediately . severe side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 to be stored in the refrigerator . once the infusion processes have been prepared they should be administered in  a sterile environment . after diluted , the product should be placed in : - immediately stored in ' freeze prior to administration ' and dilsution in steril
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacitzumabe , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . a single dose of 4 milliards provides 100 mg of Bevacizub , equivalent to 1. 4 mg . this equals 16 mbq of diluted bevacinumab at 16 - hourly . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if mvai looks like and contents of the pack m Vasi is a concentrate for solution for infusion . it is essentially sterile , colourless to slightly yellow liquid in a glass vial with a rubber stop
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . tecARTus is used with other medicines to treat relapsed mantles cell lymphopenia ( when your own white blood cells are destroyed ) are destroyed by autologous anti - cd19 - transduced cc3 + cells . mantled cell lymphhoma is  a cancer that affects the immune system ( the group of cells called b - lymphocytes ) that has not improved or cannot be eliminated in the body . in mantlet cell lymphma the number of b- lymph cells is reduced . when you have mantLE cell lymphome this is caused by a problem with b cells that has spread to an uncontrolled way . it is passed from donor to donor through the lymph tissue to the bone marrow ( where blood
do not use tecartus - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or to any of those components of the medicine ( see section 6 " what tecARTus contains "). if the medicine does not contain enough white blood cells . if there are too few of them in your blood ( lymphodepleting chemotherapy ). warnings and precautions talk to your doctor , pharmacist or nurse before using tecArtus . the number of white blood cell in your body is reduced ( autologous use ). tests and checks your doctor will do before and during treatment with tec artus , to check your lungs , heart , kidney and blood pressure . signs of infection or inflammation relating to your cancer . this condition is called graft - against - host disease . after having a
tecartus is made from your own white blood cells . your cells will be collected from you using a catheter placed in your vein ( a procedure call leukapheresis ). if you have enough of your white blood cell in your blood , this will be given to you by a healthcare professional . tecARTus is for single use only . once tecarthus has been prepared and sent out , your blood is given to your vein . this is for 3 to 6 weeks . the number of your red blood cells in your body is reduced to a minimum of 2 to 3 million cells / m2 after this time period . medicines given before tec artus treatment , including lymphodepleting chemotherapy , will be sent to you in a hospital or clinic . these modified white blood samples are then collected and stored in the body for a period of about 30 to
like all medicines , this medicine can cause side effects , although not everybody gets them . if your side effects get serious , or if you notice any of your side impacts , tell your doctor straight away . these side effects may need urgent medical attention . tell your healthcare professional straight away when you notice the following side effects during the tecartus infusion : very common ( may affect more than 1 in 10 people ): - fever , chills , reduced blood pressure , symptoms such as dizziness or lightheadedness , - build - up of fluid in the lungs , all symptoms of a condition called cytokine release syndrome . not known ( frequency cannot be estimated from the available data ) - loss of consciousness . you may experience decreased level of consciousness as a result of confusion , memory loss , and confusion . your doctor will monitor you for
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the container label and infusion bag . store frozen in vapour phase of liquid nitrogen up to a maximum of 150 ml . this medicine contains genetically modified human blood cells and human - derived material . the expiration date refers to the last day of that month . tecartus is for single use only . any unused medicine or waste material should be disposed of in accordance with local requirements .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cc3 + cells . each patient - specific single infusion bag contains a dispersion of anti  - cad19 car t cells in approximately 68 ml for a target dose of 2 x 106 anti . - other ingredients are sodium chloride , human albumin , water for injections ( see section 2 " tecARTus contains sodium "). what Tecartus looks like and contents of the pack tecArtus is a clear to opaque , white to red dispersed cell for infusion , supplied in an infusion container individually packed in a metal cassette . the contents of a single inffusion bag contain approximately 69 mbq of cell dispersement .
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 diabetic condition . in this case , this medicine can be used alone or in combination with certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which lower blood sugar in your body , and you can continue to follow the advice on diet and exercise given to you by your doctor or
do not take januvia if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking janugavia . warnings and precautions cases of inflammation of the pancreas ( pancreatitis ) have been reported in patients receiving janusvia ( see section 4 ). for example , if your doctor determines that you have blistering of the skin it may be a sign for a condition called bullous pemphigoid . do not receive janutevia , as it may cause a disease of the Pancreases ( such as pancreatictitis ). tell your doctors if any of these apply to you ( or you are not sure ), as taking a tablet may increase the risk of getting gallstones , alcohol dependence
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once daily by mouth if your doctor thinks that you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this medication with or without food and drink . your doctor will prescribe this medicine alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and activity recommended by your doctor while taking januvia . if the amount of janusvia that you take is too low , talk to your doctor immediately . take janugavia once a day , preferably at the same time each day . you should not take more than one tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects you may need to take : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreaticitis ). a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . these could all be signs that you may have these symptoms . swallow the tablets whole with a glass of water . do not chew or crush the tablets . if possible , you may take
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg sitaglin - other ingredients are : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film coat of the tablet contains : poly ( vinyl alcohol ), macrogol 3350 , and talc ( 8000 ), titanium dioxide ( е171 ), red iron oxide and yellow iron oxide ( encoding in pfizer ). what junuvia looks like and contents of the pack round , pink film  opaque blisters ( in pvc / pctfe / alkaline ) and white film .
what xultophy is xULtophy contains the active substance lusutrombopag . xkultophy lowers blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this type of diabetes occurs when your body does not make enough insulin to control the level of sugar in your blood . the insulin that your body makes does not work as well as it should . it helps your body to control blood sugar . insulin degludec is a long - acting basal insulin , used to control your blood sugar levels . in addition , it can be used in combination with liraglutide or glp - 1 , which are two different strengths and should be used together during meals . how xcultophy works xulation is used with oral medicines for diabetes xültophy can be taken with or without oral medicines to
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if your doctor has told you that you have been given too much of a sulfonylurea ( e . g ., glimepiride or glibenclamide ). warnings and precautions your doctor may need to adjust your sulphonyllurea dose , depending on your blood sugar levels . talk to your doctor or pharmacist before taking xULtophy and if any of these apply to you . you should tell your doctor if : you have type 1 diabetes mellitus or ' ketoacidosis ', which is a condition in which substances like xelephy accumulate in the blood and which can be
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . xultophy is for oral use . take the pen as soon as you are able to get clearer pictures or have better eyesight . your doctor will tell you how much xULtophy to take . the recommended dose is 41 mg / kg body weight once a day . you can take xkultophy with or without food . follow your doctor' s instructions for fast and easy . do not take more than the recommended daily dose . how to use xcultophy 41 xpultophy can be used in adults , adolescents and children aged 8 years and over . read the " instructions for use " provided at the end of this leaflet before you start using xulation . when to use the pen xele
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common , may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out and become unconscious . serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , take special care with xultophy and see your doctor immediately . your doctor will monitor your blood glucose level and may change if needed to treat low blood sucre ( hypoglacy ). please see also the box at the end of this section . very serious allergic reaction ( anaphylactic reaction ) not known ( frequency cannot be estimated from the available data ). talk to your doctor if a serious allergic response is necessary . local reactions have also been reported in patients taking xULtophy
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . alternatively , you may remove xultophy from the refrigerator and store it not above 30 for one single period of up to 8 weeks . once removed from the fridge , the product must be used within 21 days or discarded . you must use the viaL after 21 days of storage at room temperature . this product is for single use only . discard any unused medicine appropriately . any discarded medicine must be discarded after first use .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , equivalent to 3 . 6 mg lilraglutile . one vial contains 3 mmol / m2 of solution , corresponding to 300 units insulin dégludecec - equivalent to 10 . 8 mg /ml of linraglutiide . the other ingredients are glycerol , Phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xULtophy contain sodium ". what if you need to know before you use xulationphy , you will find a package of 2 vials of sodium in each vial 
giotrif is a medicine that contains the active substance afatinib . it works by blocking proteins called egfr [ epidermal growth factor receptor ] ( eggfr ]) and ebb1 , her2 [ erbb2 ] and erbe3 . these proteins help cancer cells to grow and divide . this medicine can kill cancer cells . giotrf is used for the treatment of cancer of the lung ( non - small cell lung cancer ). giotratrif can be used as your first treatment if you have received prior chemotherapy treatment of a type called squamous type . you should not receive prior chemotherapy treating a different type of cancer .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor wants to change your dose if this applies to you . warnings and precautions talk to your doctor before taking giotricf : if any of your medical conditions apply to you ( or you are not sure ): - you have low body weight less than 50 kg - your doctor may want to reduce your dose of gioTRIf - if anyone you have kidney problems , as the risk of side effects may be higher - lung inflammation ( interstitial lung disease ) talk to the doctor if the medicine is not suitable for you - liver problems - some liver tests may be necessary before starting treatment with this medicine if a severe liver disease is suspected - eye problems ( for example , severe dry eyes 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . take this medication at about the same time each day , preferably at the same times each day ( e . g . in the morning and evening ). you can take giotrif with or without food . taking this medicine you can start by taking this medication about 1 hour before or 3 hours after taking this dose . you can continue taking this tablet any time before or after the end of the day if it is almost time for your next dose , but you should continue to take this tablet at the exact time each morning . this will help you remember to take it . swallow the tablet whole with a glass of water . do not open or crush the tablet . to make sure there are no other ways to take 
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with giotricf . contact your doctor immediately if you experience any of the following symptoms during or after treatment : diarrhoea ( very common , occurring in more than 1 in 10 patients ) diarhooeal , usually at the beginning of 2 weeks . severe diaroeo with fluid loss ( common - occurring in less than 1 per 10 patients and patients in more severe cases ) low blood potassium , worsening kidney function ( common in more then 1 per 100 patients ). if your doctor suspects diarrolhoa , you should contact your physician immediately . your doctor will decide upon appropriate antidiarrhofeal treatment and / or antidiarrheal medicine prior to starting gio
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinibe . - other ingredients are : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide , polysorbate 80 . what gitrif looks like and contents of the pack giotricif 20 mg film  coated tablets are presented as white to off - white , round curved tablets with " aft " debossed on one side and " gsi " on the other side . the tablets are available in packs containing 1 , 2 or 4 film – coated tablets 
orkambi contains two active substances : lumacaftor and ivacaftingor . orkamba is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and adolescents aged 6 years and older with f508del mutation , a protein that is normally called cystic fibrosis transmembrane conductance regulator ( kftr )- 4 . the mutation affects a part of the cfietr protein , making it easier for the lungs to work properly . your doctor will test you for the mutation . this will help your doctor to find out if ork Ambi is the right treatment for you . what orkam is used for orkami is lumamacaffetor / ivacaltor work by altering the abnormal caff
do not take orkambi if you are allergic to lumacaftor , ivacaftingor  or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . ork ambient has not been studied in patients receiving orkubi with the f508del mutation . talk to the doctor or nurse before taking any of these medicines if : you have liver or kidney disease . your doctor may need to adjust the dose of orkacco . you have had abnormal blood tests of the liver while you were taking orkedambi . if any of those symptoms occur , tell your doctor straight away . these may be signs of liver problems : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite vomiting or being sick
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one orkambi tablet once a day for 6 or 12 weeks . take the ork Ambi tablet at about the same time each day . you can take the tablet with or without food . children : the recommended starting dose is one or two orkami tablet 6 to 11 years of age . orkham is available in the following pack sizes : 100 mg or 2 tablets in the morning and 2 tablets at about 12 . use in children and adolescents the recommended dosage of orkcham is 200 mg or 1 tablet in the evening , in the afternoon and 2 tablet inthe evening . if your child is a child or adolescent with moderate or severe problems with liver function , then orkacco may be
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of orkambi and ivacaftor of orbambi are usually mild to moderate and of a short duration . serious side effects have been reported in patients taking ork Ambi . they include : raised levels of liver enzymes in the blood , which can lead to liver injury . patients with pre - existing severe liver disease may also experience the worsening of liver function . overall list of possible side effects seen in more than 1 in 100 patients : tell your doctor or pharmacist if you experience any of the following symptoms : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite , feeling sick ( nausea ), vomiting , diarrhoea , abdominal pain or pain
what orkambi contains the active substances are lumacaftor and ivacafting . ork Ambi 100 mg / 125 mg : each capsule contains 100 mg of lumamacaffetor or 125 micrograms ivacastor . Orkambi 200 mg 1/ 125 ml : Each capsule contains 200 mg of the lumumcafTor or the 125- mg ivacalftour . the other ingredients are : orkamba 100 mg or 127 mg ; cellulose , microcrystalline ; microcrystalline ( e460 ); croscarmellose sodium ; and hypromellose acetate ( agate ) ( hdpe ). what orki looks like and contents of the pack the capsules are white to off - white , capsule shaped , and embosse
what lynparza is lyinparza contains the active substance olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by stopping mutations ( changes ) in a gene called brca ( breast cancer gene ). brca is essentially a form of cancer . parp inhibitions can cause the death of cancer cells . they also stop the action of an enzyme that helps repair dna . what LYnparaza is used for lylnparz is used to treat ovarian cancer ( brca ) with a certain type of ovary cancer that is at an advanced stage . it is used when the cancer has responded to previous treatment with standard platinum - coated tablets .
do not take lynparza - if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before taking lyngparza ( see section 2 , " what lyinparza contains "). lyndparza can cause low blood cell counts . your doctor will do testing to check for low counts of red or white blood cells , or low platelet counts , ( see also section 4 , ' possible side effects '). if any of these apply to you , tell your doctor straight away . if 75 you are not sure talk to the doctor . the signs and symptoms can include fever , infection , and bruising and bleeding . more serious problems with the bone marrow called ' myelodysplastic syndrome ',
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual dose of lyngparza is two 100 mg capsules twice a day . your doctor may need to increase your dose to 150 mg once a night . the doses of LYnparaza capsules should be divided into equal doses . it is preferable to take both capsules at the same time , and to take them at the exact same time each day , as it will help you remember to take it . if your doctor prescribes tablets that you take with food , they should swallow them whole with water . do not divide the total daily dose into smaller doses or divide the dose evenly over the day ; this will help to reduce the risk of side effects . adults and adolescents the recommended dose is 8
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , or fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ),: allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . if you get any of these side effects contact your doctor or pharmacist . other side effects include : very common : may affects more than one in 10 users : feeling sick ( nausea ) or vomiting , being sick ( vomiting ), being sick , vomiting ; diarrhoea ; constipation ; dry mouth
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture . once removed from the blister , lynparza capsules should be used within 30 days . throw away 3 capsules at the end of the day . use within 3 days of the last used capsules . discard any capsules that are no longer being used . these measures will help protect the environment .
what lynparza contains the active substance is olaparib . each hard capsule contains 50 mg of olarib - the other ingredients are : capsule contents : lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( elektronic acid ). what llynparaza looks like and contents of the pack lyunparza is a white , opaque , hard capsule containing " olacarib 50 mg " and the astrazeneca logo on the cap . lylnparzan is available in packs containing 112 or 448 capsules or 112 capsules . not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nnaroachone is used to treat opioids , including heroin , methadone , fentanyl , theophylline , buprenorphine , and morphine . the active ingredient in nyxoid is a nasal spray used for the emergency treatment of opioid overdose . opioid overdo not tolerate long periods of time , but some patients have experienced opioid over dose within 14 days . overdose may cause breathing problems and severe sleepiness . in adults , an opioid over dosing of opioids is not known . you must contact your doctor , pharmacist or nurse immediately if you notice any signs of opioid abuse . emergency medical care is needed if your child is being treated for opioid overuse .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyesoide . talk to you doctor / pharmacist if this applies to you . take special care with nnalonson , follow all instructions given to you by your doctor or nurse . if possible , show them the emergency medical care provided at your nearest hospital emergency services . an opioid overdose is not known . the signs and symptoms of an opioidoverdose are not known but talk to a doctor or pharmacist before using this nasal spray . it is recommended that you wait 2 to 3 hours after using a new nasal spray and use a similar product . do not take this medicine if any of those above apply to you (
nyxoid nasal spray should only be used by doctors trained in the use of this type of medicine . instructions for use follow these instructions carefully and follow them exactly . they are given to you by your doctor or nurse . 1 . it is for use in adults only . the dose should be sprayed into the shoulders and ears , as well as into the breastbone and sternum ( just below the ear ). do not touch the tip of your fingernail to clear the mouth and nose of any blockages . prying into the mouth or nose , use the following instructions : 1  . when breathing is the chest moving , the chest can move freely . this makes it easier to hear breathing sounds and to breathe sounds . if you are given more nyes than you should if nasal spray is accidentally injected into the chest , breathe on the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . nyxoid may cause acute withdrawal symptoms associated with opioid drugs . symptoms include fast heart rate and high blood pressure body aches and stomach cramps , feeling sick ( vomiting ), diarrhoea , sweating , fever , goose bumps shivering / trembling changes in behaviour , including violent behaviour . these can cause nervousness or anxiety . tell your doctor straight away if you notice any of the following : very common side effects ( may affect more than 1 in 10 people ): feeling very tired ( nausea ) feeling very sleepy , tiredness , weakness , tremors and trespassing common side effect ( may effect up to 1 in10 people ). common sideeffect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 micrograms of nnadoxone ( as hydrochloride dihydrate ). - other ingredients are : trisodium citrate dihydrate ( e331 ), sodium chloride , hydrochromic acid ( i ) ( k25 ), water for injections , and purified water ( see section 2 ). what if nyesoidu looks like and contents of the pack neomycin is a clear , colourless , clear solution for injection in a pre - filled nasal spray in  a single dose container . nyingxod is supplied in : a carton containing 2 nasal sprays in blisters . the content of each nasal sniffer delivers doses of 20
what ovaleap is this medicine contains the active substance follitropin alfa , which is almost identical to a natural hormone produced by your body called " flh ." fsh is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . in men , this means that the growth and development of the sacs ( fles ) in the ovaries is interrupted by the production of sperm . when a mature egg cell is produced , it is used for treatment with a medicine called " lamifene citrate ". in women undergoing assisted reproductive technology procedures ( procedures that may help you to become pregnant ) it is given together with : amedicine called " leutropin alla " ( also known as " luteinising hormone "), a medication called " human chori
do not use ovaleap if you are allergic to follitropin alfa ( female fsh - positive ) or to csh- positive ( female or flh ) fmsh or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor , pharmacist or nurse before using ovaleeapm : if your partner has a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ) where large ovaries or sacs of fluids accumulate in the back of the oocytes ( ovarian cysts ) are found if the patient has unexplained vaginal bleeding . if this happens , tell your doctor and do not inject the medicine . it may be due to cancer in your oaries ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how is ovaleap given and how much should i take ? this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). your doctor will decide how much medicine is needed . use in men if your period is irregular , your doctor may decide to give you this medicine after the first 7 days of menstrual cycle . your doctor can decide how many days of the cycle you should take and how often . the medicine will be given to you in increments of 75 mg or 150 mg per kilogram body weight . you will usually receive this medicine every day for 7 or 14 days . in women weighing 37 . 5 kg or more , the dose given will be 75 mg . this medicine will also be given in increment of 225
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are described below : serious side reactions in women allergic reactions such as skin rash or raised itchy areas of skin . severe allergic reactions , with weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare : may affect up to 1 in 10 , 000 people if you have this type of reaction , you must stop your ovaleap injection and contact a doctor immediately . serious side effect in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hyper - stimulation . these symptoms may be signs of a condition called ovary - stimulating factor - stimulation . if any of these affect you , or if they happen after your ovulation , tell your doctor or nurse .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the pen label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be used for up to 3 weeks when stored at a temperature below 25 . if you are not using this medicine at home , you may store it at room temperature for a maximum of 3 weeks in the refrigerator ( 20 25 ). once removed from the refrigerator , the cartridge must be used within 28 days when stored below 25 and protected from light until ready to use . once removed by the end of the period the pen can be used again . always keep the pen cap on the ovaleap pen to protect it from light and
what ovaleap contains - the active substance is follitropin alfa . ovaleak 300 iu / 0 . 5 ml : each cartridge contains 300  22 ius ( international units ) flollitropine alfo in 0. 5 millilitre ( mL ) solution . each cartridge of ovalep 450 ii / in . 75 mlitre ( 1 . 450 miu ) contains 33 iis ( i . di - d ) ( 33  dl ). - latent fllotropin all in  0 ( 75 mm ). ovaleeaper 900 i1 / 1 , 5 mm solution , which contains a total of 900 international units ( if ir ) equivalent
voriconazole accord contains the active substance vorikonazole . voricônele accord is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . its primary function is to protect the environment . this is when it is used for the treatment of patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to aspergosporium sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candidasp. infections when the bacterus is resistant to fluconazoles ( another antifungals medicine ), seriously fungal infections caused by scedosporium
do not take voriconazole accord if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). this is particularly important if the patient is taking any other medicines , including herbal medicines . ask your doctor or pharmacist if your child is not sure about the medicines taken in the following list : medicines that may interfere with voricanazole agreement treatment 46 terfenadine ( used for allergy ) astemizole ( used to treat allergy ), cisapride ( used in adult patients for stomach problems ) pimozide ( sometimes used for mental illness ) quinidine ( used when used for irregular heart beat ) rifampicin ( used on tuberculosis ) and efavirenz ( used only to treat tubercusis in children and adolescents ) simva
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will calculate your dose depending on your weight and the type of infection you have . the usual starting dose for adults is 40 mg per kg of body weight once daily . if your doctor determines that the maximum treatment is 40 kg , you will receive a single dose of 40 mg every 24 hours . in the beginning of treatment you will be given 400 mg per kilogram of bodyweight once every 12 hours for the first 24 hours ( injection ), followed by 200 mg every 12 heures for the next 24 hours dose . after the first 48 hours , your doctor may increase your dose to 200 mg perkg of body height once daily and once daily thereafter . you may receive up to 300 mg per dose , which is given every two weeks . for mild to moderate cirrhosis , the recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor immediately : - rash , jaundice , changes in blood tests of liver function , pancreatitis other side effects very common ( may affect more than 1 in 10 people ) - visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision / night blindness and swinging vision ), eye disorder including halofreviation , night vision - night vision and swings in vision . common ( might affect up to 1 in every
what voriconazole accord contains - the active substance is vorikonazole . each tablet contains 50 mg voridonazole ( as voricanazole acord 50 mg film - coated tablets ) and 200 mg vorisconazoles . - voriCONazoleaccord 200 mg film the tablet contains lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , and hypromellose , titanium dioxide ( e171 ), lactoses monohydrate and triacetin . the film  - coating contains an active substance called voricônel . one medicine contains lactitol , which is used to make up the tablet core .
what mvabea is and what it is used for mvbea ( a vaccine to protect you against ebola virus disease in the future ). it is given to adults aged 1 year and older who may possibly come into contact with ebdeno virus . your doctor will decide if you should receive a 2 - dose course of vaccinations to protect your child against a type of evola virus in the coming years . it is made specially for you to help protect your baby from getting ecoloa virus , especially against the zaire eebolovirus , and will give you this vaccine because : this vaccine does not contain the whole eploa virus and will only give you ea virus illness . when you need vaccinations , you will receive zabdena vaccine about 8 weeks later . mvasbea vaccine is not recommended
you should follow the vaccination course and follow the instructions exactly as your doctor has told you . you should not receive mvabea if you have ever had a severe allergic reaction to any ingredient of mvbea ( listed in section 6 ). if your child has had  a severely allergic reaction after receiving an antibiotic called ' gentamicin '. it is important that you tell your doctor if any of these apply to your child . if the vaccine is not working properly , it is not known whether mvasbea will work if there is a risk of a serious allergic reaction . tell your healthcare worker if : you have previously had any other vaccine injection . or you have fainted after the injection , or you are bleeding or bruise easily . currently have a fever or an infection . any of the above applies to your baby 's doctor or
mvabea is given to you or your child by a doctor or nurse as an injection into a muscle ( intramuscular injection ) in the upper arm or thigh , or into , a blood vessel . the first dose of vaccination will be given with zabdeno vaccine , followed 8 weeks later by mvasbea vaccine . your doctor will decide the second vaccine and how often you or the child should receive the second vaccination . how much vaccine is given primary vaccination first vaccination with zbdenone red cap vial ( 0 . 5 ml ). second vaccination with the mvbea yellow cap vially ( 00 mla ), given 8 weeks after the first vaccination mit zabbing with zanbdenon . booster vaccination with either zabeddeno or zabea may be given at least four weeks after zabino
like all medicines , this vaccine can cause side effects , although not everybody gets them . side effects occur at least 7 days after the injection . tell your doctor , pharmacist or nurse if you notice any of the following side effects as they could be signs of a very rare , but very common , effect . very common ( may affect more than 1 in 10 people ) pain , warmth or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people people ), being sick ( vomiting ) itching where the injecting is given uncommon ( may effect up to1 in every 100 people ). redness and skin hardness where the needle is given generalised itching the following other side effects are common and they are usually mild to moderate . they are most common when first starting the injection but decrease over time . if they get worse , tell your healthcare
what mvabea contains - the active substance is zaire ebolavirus . each vial contains 29 million copies of tai forest evolavirus nucleoprotein marburg , corresponding to 0 . 7 x 108 million copies per ml . - this vaccine contains 168 , 000 copies of chicken embryonal fibroblast cells . the remaining 168, 000 mbq is composed of trace residues of gentamicin , sodium chloride , trometamol , water for injections , hydrochloric acid ( for ph adjustment ). what if mvasbea looks like and contents of the pack mVAbea is a suspension in a single - dose glass vial , closed with a rubber stopper and yellow cap . pack size of 20 via
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce other bone problems that may need surgery or radiotherapy bondronatul can also be prescribed if there is a raised calcium level in your blood due to : a tumour . nutrients are lost from your bones . these changes can make your bones weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low levels of calcium in your blood . do not receive this medicine if any of these apply to you . if they are not sure , talk to your doctor before receiving bondronate . warnings and precautions a side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondruat for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonekocrosisation of the Jaw , there are
how it is given bondronat will be given to you by a doctor or nurse who is experienced in the treatment of cancer . it is usually given as an infusion into your vein . your doctor may do regular blood tests while you are given bondruat . how much you will be told how much to receive your doctor will work out how much bondronate you will receive . the amount you will have to receive depends on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg every 3 - 4 weeks as an injection in your vein over at least 15 minutes . you should also tell your doctor if a raised calcium level in your blood is present . this dose may be increased to 1 mg every 2 weeks , depending on the severity of your illness and how well the medicine is tolerated . however , your doctor might adjust your dose and duration of an inf
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the tummy bone . very rare ( might affect upto 1 in 10 ,000 people ), pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if they happen . ear pain . discharge from the ear . this may be a sign of an ear infection . bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after dilution the infusion solution can be stored for up to 24 hours in syringes . this medicine may be used if the solution is not used immediately .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion containing 2 mg i bandronic Acid . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . what bondruat looks like and contents of the pack bondronate is a clear , colourless to pale yellow solution . it comes in two strengths : 1 mg and 2 mg solution for injection , with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that destroy the activity of certain types of white blood cells called lymphocytes . what ZEposiais used for zeposition is used to treat relapsing remitting multiple sclerosis ( rrms ) in adults , a disease that affects physically and emotionally . multiple clerosis (ms is a disabling disease that attacks the immune system and reduces the body ' s defenses ). white blood cell counts are important in : nerves in the brain and spinal cord and nerves at the site of symptoms such as numbness and difficulty in walking .
do not take zeposia : - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ) - when you have a severely weakened immune system - have had a heart attack ( such as angina , stroke , mini - stroke ), transient ischemic attack ( tia ) or severe heart failure within the last 6 months - are unsure of whether you have had irregular or abnormal heartbeats ( arrhythmia or rhythmic ) during treatment - do not have treatment for severe infection ( e . g ., hepatitis , tuberculosis ), cancer , or severe liver problems - or are pregnant or breast - feeding . warnings and precautions talk to your doctor before taking zeposa if any of these apply to
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much zeposia to take your doctor will work out your dose of zeposa based on your heart rate . this is defined as a ' treatment initiation pack '. the first day of treatment contains 4 capsules of 0 . 23 mg ozanimod . the recommended dose is 1 capsule per day . after 4 weeks of treatment , your doctor may increase your dose to 3 capsules ( 4 capsule ) of oznimod ( 6 capsules per day with food ) or 7 . from week 8 onwards , you will find a new ' maintenance pack ’ with orange capsules containing 0. 92 mg / ml of azani mod . regular treatment will
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate urinary tract infection blood pressure uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse about any of these side effects or ask them to talk . very common : may affect up to1 in 10 persons , infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynex ) viruses . low number of a type of white blood cell called lymphocytes common - may affect less than 1in 10 people allergic reaction ( see section 2 ) s
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg : each capsule contains 0. 23 milligrams ( mg ) ozonimod ( as hydrochloride ). zeposition 0: 46 mg - each capsule contient 0 ( 0, 46 milliliters ) of oznimod [ as hydrochrome ]. zepozia 0- 92 mg / 0 debossed : every capsule contains approximately 0
what temybric ellipta is the active substances of temmybric is fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids , often simply called steroids . umeklidiniumbromide or vilantrol belong to  a groupe of medicines known as bronchodilators . what mybrick ellippa is used for temуbric orbital disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles responsible for breathing help the airways and the air sacs in the airway relax , making it easier for air to get in and out of the air .
do not use temybric ellipta : - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temibric alfa . asthma . temmybric is not recommended for the treatment of asthma ; - in patients with heart problems ( high blood pressure ), liver problems , tuberculosis ( tb ) of the lung , or any long standing or untreated infections . tell your doctor about any eye problem called narrow - angle glaucoma , such as an enlarged prostate , difficulty passing urine or a blocking in your bladder . talk to a doctor or pharmacist before using this medicine if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybril ellippta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . temibric is also used to relieve a sudden attack of breathlessness or wheezing . to relieve this attack you must use a quick - acting reliever inhaler ( such as salbutamol ). how to use the inhalers see 
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately . pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your doctor or nurse immediately if you have any of the following while using temybric ellipta : symptoms of a lung infection may include fever or chills , increased mucus production , change in mucusum colour , decreased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose , sinus infection , pneumonia ( infections of the airways ) low white blood cell count ( anaemia ) common sideeffect ( may effect up to1 in 10 persons ) - so
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate . one dose ( an inhaler of 65 microgram ) contains umeklidinium brmide equivalent to 55 microgram umeclinium and 22 microgram (  103 microgram of vilantrol ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temmybric is containing lactoses ') and magnesium stearate . what mybril ellippa looks like and contents of the pack the ellipector inhalers have a light
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforois used for zinforceo is used to treat adults with infections of the skin or the tissues below the skin . this is sometimes called an infection of the lungs . the active ingredient in zinfosaml is a so - called bacterial infection ' that can be killed by ' fungi ' bacteria . that can lead to serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking zin foro . if your doctor thinks you may be allergic to other cephalosporin antibiotics . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if : you have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . do not use zinfo , as the use of zinfordo is not recommended . talk to the doctor or nurse before taking the medicine if any of these apply to you and tell them . before taking your first dose of  Zinforo you should tell your physician if: you suffer from kidney problems . you have ever had seizures ( convul
the recommended dose of zinforo is 600 mg every 12 hours . your doctor will decide how much zinforceo you need and for how long . the recommended starting dose is 600 micrograms every 12 hour . if you get some infections , your doctor may lower your dose to 8 microgram / kg every 12 weeks . it is given as a drip into a vein , over a period of 5 minutes . in some cases the dose may be increased up to 60 microgram to 120 microgram per kg body weight . you will receive an increased dose at the start of treatment , which may be given every 5 to 14 days for skin infections . this period lasts for 5 to 7 days . for pneumonia , the recommended treatment period is 7 microgram ( 1 microgram) per kg of body weight given every 12 months . there is no experience with use in children with kidney problems . patients
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects can be seen while you are taking zinforo : contact a doctor straight away if you notice any of these symptoms as you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinfordo may be started soon after you start taking medicines to slow bowel movement . this can happen commonly ( up to 1 in 10 people ). you will have a blood test called a ' coombs test ', which will be performed before you start using antibiotic . if this test is not correct
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 mg ceftaroline fosamil . the other ingredients are arginine . what zforo looks like and contents of the pack zinfordo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . each pack contains 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neursopathic pain : pregabALin ppfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral nuropathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , torn , hot / burning / shooting , stabbing , sharp , cramping , and aching , or tingling or numbness . pregabaltin pvcfizer can also be used to prevent nagging in patients with dementia or who have had previous stroke . previous strokes has been associated with a very rare but serious condition called posterior revers
do not take pregabalin pfizer if you are allergic to pregabaltin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking pregabalin ppfizer and during treatment : if any of these apply to you , tell your doctor immediately . some patients taking pregalin pipfiser have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of those reactions , stop taking pregamalin and seek medical help immediately , which could cause dizziness and somnolence , an increased risk of accidental injury ( fall ) in elderly patients . therefore , you should be careful until you are used to any effect the medicine might have
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will determine what dose is appropriate for you , depending on your condition . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor to get the desired response . the dose , which has been adjusted for you and your doctor may either 150 mg or 600 mg twice a day . for twice  a week take pregabralin ppfizer once in the morning and once in in the evening , at about the same time each day , preferably in the afternoon . 59 take pregalin pizzeria twice if your morning dose is higher than the recommended dose . you should take
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common  may affect up to 1 in10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , general irritability . disturbance in attention , mood swings , feeling of co - ordination , lack of motivation , depression , anxiety , loss of memory , memory impairment , lost memory / tremor , difficulty with speaking ,tingling feeling of wellbeing , sleepiness . uncommon  might affect upto 1 in 100 people increased heart rate . low blood sugar . change in perception of self , restlessness , emotional instability , disturbance in consciousness , unusual dreams ,
what pregabalin pfizer contains the active substance is pregabaline . each tablet contains 25 mg , 50 mg ; 75 mg / 100 mg . 150 mg 2/ 200 mg : 225 mg 1/ 300 mg pregabALin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , ( containing shellac ; black iron oxide (  e172 ), propylene glycol and potassium hydroxide ). each pen contains 75 mg ( 100 mg, 200 mg and 225 micrograms ). the pen contains sodium hydroxides . not all pack sizes may be marketed .
xadago is a medicine that contains the active substance safinamide . it increases the amount of dopamine in your brain . this helps to control movement in people with parkinson ' s disease . xdagon is used to treat parkinsons ' disease in adults , adolescents and children . these people often have sudden switches in their movements , which may make them less able to move . also , people have difficulties moving . when xedagone is used together with the medicine levodopa and other medicines used to control parkinSON '
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - in addition , if your doctor has told you that you are taking the following medicines : monoamine oxidase ( mao ) inhibitors such as selegiline , rasagiline ; moclobemide , dehydrogenasine , pentazone , isocarboxazid , and tranylcypromine . treatment for parkinson ' s disease and depression ; pethidine ( a strong pain killer ). wait at least 7 days before starting xdagone treatment . do not stop treatment with mao inhibitors or pethtine without talking to your doctor . warnings and precautions talk to your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg once a day by mouth . xdag should be taken with food . patients with moderately reduced liver function should take 50 mg x aday . your doctor may decide to reduce your dose of the tablet if your doctor thinks it is too strong or too weak . you should swallow the tablet whole with a glass of water . do not chew or crush the tablet before swallowing . how much xedagu to take if xpago has been taken with meals for several weeks , your doctor will tell you how long you should take x.ad adogo for as long as your child shows signs of raised blood pressure , anxiety ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure ) may lead to collapse ( neuroleptic malignant syndrome ). you may experience confusion , sweating and muscle rigidity ( hyperthermia ). increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), which can cause confusion / hypertension , muscle stiffness , and hallucinations ( hypotension ). other possible side effects of parkinson ' s disease : safinamide and levodopharm . common side effects ( may affect up to 1 in 10 people ): dizziness ; muscle rigidness . uncommon ( may effect up to 2 in 100 people ). very rare ( may impact up to one in 10 , 000 people ), the frequency of these effects
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg of ssafatinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film coating : ink : shellac , indigo carmine ( e132 ), hypromellose , macrogol , titanium dioxide ( е171 ), iron oxide red ( E172 ). what Xad adorama looks like and contents of the pack xdagon 50 mg are white , oval , biconcave film - coated tablets of 7 mm diameter with metallic gloss , im
zytiga is a medicine containing abiraterone acetate which is used to treat adult men with prostate cancer that has spread to other parts of the body . zytige helps to increase the levels of testosterone in the blood when you have prostate cancer . the active ingredient in zytaga is testosterone , a substance produced naturally by the body when it is not used . it works in a similar way to a treatment that lowers testosterone ( androgen deprivation therapy ). it can be given alone or with another medicine , prednisone or predNisolone , which are used to reduce high blood pressure in the body and prevent fluid retention in your blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - are pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before taking zytigea : - about severe liver damage - have prostate cancer that has not responded to this medicine . talk to you doctor if any of these apply to you . if they do , tell your doctor or pharmacist before taking this medicine and tell your physician . do not use this medicine for longer than the recommended dose . this medicine should not be used in patients with liver problems , high blood pressure , heart failure , low blood potassium . low blood sodium can cause heart rhythm problems or other heart or blood vessel problems . tell your doctors if your doctor has told you that you have an irregular or rapid heart rate
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once a day . taking this medicine take this medication by mouth . zytiga can be taken with or without food . take zytigea about 2 hours before or after a meal . do not take a tablet . try to take it at the same time each day , preferably at the exact same time every day ; this will help you remember to take the tablet , even if it is almost time for the next dose . swallow the tablet whole with water . how long to take ytiga for adults , adolescents and children who cannot take tablets , can take tablets with or just after food , with or if they are not able to swallow the tablets . when zytag
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . the amount of potassium that your doctor will test for is one of the following side effects very common ( may affect more than 1 in 10 people ): - you may have less fluid in your legs or feet ( this may be a sign of low blood potassium ), according to liver function test - high blood pressure - urinary tract infection - diarrhoea . reporting of side effects 23 if your child gets any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abaraterone as the other ingredients are : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " important information about some of the ingredients of zytigea "). what ytiga looks like and contents of the pack - zytaga tablets are white to off - white , oval tablets with " a " debossed on one side and " l " on the other side . the tablets are 9 . 5 mm in diameter . - they are packaged in a plastic bottle with a child - resistant
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases including polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis ; paediatric plaque psoriasis , paediatic crohn ' s disease , and paediatri non - infectious uveitis in adults . the active ingredient in hepiye , amylase , is based on a monoclonal antibody . monoclonous antibodies are proteins that attach to a specific target in the body . aadhalimumabib is designed to attach to the tnf ( tumour necrosis factor ) and is present at increased levels in the inflammatory disorders . this reduces the inflammation in these diseases .
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if the signs or symptoms of infections are fever , wounds , feeling tired , dental problems ( see " warnings and precautions "). if heficiye has been approved for patients with moderate or severe heart failure . it is possible that hepiyo could cause a serious heart condition ( see ' warnings '). allergic reaction if any of these apply to you , tell your dentist or nurse before using he
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the usual starting dose is 40 mg once a day for most patients . your doctor may prescribe a 40 mg dose for more than 20 mg once daily . if your doctor prescribes a 20 mg dose you may decide to give a higher dose , or 40 mg twice a week . polyarticular juvenile idiopathic arthritis age and body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children / adolescents from 2 year of age and adolescents from 10 years of old weighing 10 kg to less than 30 kg 20 mg every third week not recommended for patients with enthesitis - related arthritis age or body weight ways to take the medicine weight how often and how
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as there may be signs and symptoms of infection such as fever , feeling sick , wounds , and dental problems . some of these may be severe . they can get worse over time . stop using heifiyo and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label / blister / carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and protect it at all times . once removed from the refrigerator for room temperature storage , your pre – filled yringer must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date when your pre
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aadhalimumatb in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what HEfia looks like and contents of the pack heifiyan 20 mg solution for injection ( injection ) in pre  - packed sYringe for paediatric use is supplied as a 0. 4 mg clear to slightly opalescent , colourless to slightly yellowish solution in a clear type i glass sprinkled with a stainless steel
ritemvia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritzimabe sticks to its surface , the cell dies . what ritemevia is used for ritemothers the patient ' s body needs to destroy its own cells for their survival . the treatment with ritemas is used to treat the following conditions : a ) non - hodgkin '
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe active infection at the moment you have a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking ritemart if any of your child ' s medical conditions have been troubling you : if the child has severe heart failure or severe uncontrolled heart disease , such as granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not have ritemascaris if their child has ever had or might now have  a hepatitis infection . ritemother could cause hepat
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given ritemevia as a drip ( intravenous infusion ). medicines given before each ritemasvia administration before you are given initiation of ritemother rite mau - giu , you will be prescribed other medicines ( pre - medication ) to prevent or reduce possible side effects and reduce the chance of your treatment - for non - hodgkin ' s lymphoma if you are prescribed ritemigvia alone riteminvia will usually be given once every 4 weeks . repeated treatment courses with ritemail are possible . if your doctor decides to give you ritemorvia together with chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat irritation , cough . very rarely . common side effects ( may affect more than 1 in 10 people ): very common : infusion - related reactions during the first 24- hours of infusion may develop . if they get severe , or if symptoms of infustion or irritation occur , stop
what ritemvia contains the active ingredient in ritememvia is called rituximab . the vial contains 100 mg of ritzimabe . each ml of concentrate contains 10 mg of " ritsimaban ". the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemmvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine tingeva contains capecitationbine , which itself is not a cytotic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitedbine treament is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitingbine tenement is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . Capecitaine tva may be used either alone or in combination with other medicines .
do not take capecitabine teva if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if this applies to you . if your doctor thinks you may have an allergy or over - reaction to this medicine , if there are severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), if the medicines are not effective or have been used in pregnant women , or if they are pregnant , as there may be low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), as there might be severe liver or kidney problems , since there may have been severe reactions against the enzyme dihydropyrime dehydrogenase ( dpd 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , depending on your condition . the dose of capecitebine teva is based on your body surface area . this is calculated from your height and weight . for adults , the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1 , 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times day 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : - diarrhoea : you may have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhooeal at night . - vomiting : do not vomit more than once in a 24 - hour time period . this is called nausea . you lose your appetite , and this is common . these are stomatitis . tell your doctor as soon as possible if you have pain , redness , swelling or sores in your mouth and / or throat . your hand - wash your hands thoroughly afterwards . other side effects very common ( these may occur with capecitebine 
what capecitabine teva contains the active substance is capecitebine . capecitationbine : capeciabine , 150 mg film - coated tablets each film  screen contains 150 mg capetitibine ; capecitedbine e . g ., capevitabine - 500 mg film- coated tablet each film film ­ coated tablet contains 500 mg capécitabine the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , crohn' s sugar , magnesium stearate , macrogol 400 , indigo carmine ( e132 ), hypromllose, titanium dioxide ( е171 ), yellow iron oxide ( ele ) and red iron oxide . what capеcitabine toeva looks like and contents of the pack capeginabine 
what silodosin recordati is sillodosesin recordingi belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sildodsin replayati works by blocking the receptors in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladoosine recordatis is used for silundodoubrado is used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , even at night .
do not take silodosin recordati - if you are allergic to siloudounsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking sildodoulosin recordattai . during eye surgery , some patients had cloudiness of the lens ( cataract surgery ) which affected the clear layer at the back of the eye 26 while taking siladoosine recordatis . this is because this medicine can cause a loss of muscle tone in the iris ( the coloured part of the lining of the eyes ) during such a surgery . so it is important to take appropriate precautions when taking this type of medicine and in combination with surgical techniques . some patients receiving sillodosesin recording should be carefully monitored during cataract surgery and may therefore have faint
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . patients with kidney problems if your doctor has told that you have moderate kidney problems then your doctor may prescribe a different dose . for this purpose siloudodouardati is for oral use . you can take sillodosesin recordingati for up to 4 weeks continuously . if vous take more sil lododonati than you should if , you become dizzy or feel weak , tell your doctor straight away . they may tell you to take your next dose of siladoosine recordatis later the same day 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following allergic reactions : swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives . the most common side effect is a decrease in the amount of semen released during a meal . this effect disappears after discontinuation of silodosin recordati . you should contact your doctor if this happens . dizziness , including dizzination and occasionally fainting , may occur . if your partner feels weak or dizzy , take the plunger and sit or lie down straight away until the symptoms go away . in some cases , dizzines and fainting have been observed in patients taking sillodonosine recordatis . it is possible that complications
what silodosin recordati contains the active substance is siloudoosine . each capsule contains 8 mg of siludonosin . one capsule contains eight mg of Siloodoubsin : each capsule contain 8 mg siloulodsin ( as mesilate ). the other ingredients are mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( е171 ). sil lododostin recordanti 4 mg contains 4 mg of selodosesin per capsule . the other ingredient is sillodossed as slamucosal : mannequinaze ( k29 ), mg steated , and sodium laursulfates .
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance occurring in the body , which causes your blood vessels to narrow , thus increasing your blood pressure . kinzonzalmonio blocks the effect of angiotentsinii so that the blood vessels relax , and your bloodpressure is lowered . this medicine is used to treat essential hypertension ( high blood pressure at any time ). ' essential ' means that the high bloodpressure cannot be controlled . high blood tension , if not treated , can damage blood vessels in several organs , leading sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono - if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). -if you're more than 3 months pregnant . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) - when you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . - in particular if your doctor determines that you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren . do not use kinzonzalmonio if any of the above applies to you . take special care with kinZalmony - tell your doctor or pharmacist if during your
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , preferably at the the same times each day to help you remember to take it . you can take kinzilmono with or without food . it is important that you take kinszalmonio every day until your doctor tells you otherwise . if your doctor has told me that you need to take a higher dose , you should simply take the tablets with some water . when kinzulmona is used for treatment of high blood pressure , the usual dose of the two 40 mg tablets is one 20 mg tablet once a night to control blood pressure over the 24 - hour period . your doctor may
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see section 2 ). if these effects are not treated they could be fatal . possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people ), low blood pressure ( hypotension ) in patients at risk of cardiovascular events . uncommon side effects (1 may affect less
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused medicine or waste should be disposed of in accordance with local requirements .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmeisartans . - other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzilmono 20 mg tablets are white , round and engraved with the code number ' 20 ' on one side . the kinzylmona 20 mg tablet is available in blister packs containing 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
what afstyla is a human clotting ( coagulation ) factor viii product that contains the active substance lonoctocog alfa . what fsylais used for aemophilia a ( inborn factor ixi deficiency ) is based on the work of a specialised coagulant , factor ii , in the blood . people with haemoglobin a do not have enough factor v to clot , leading to an increased tendency to bleed . how aaftylake works in patients with haémophila ia to coagulate , the product is produced by recombinant technology . the product has been designed to rely on the reliable factor  vii product , which makes it easier for blood to clump
do not use afstyla - if you have ever had an allergic reaction to a product of this type . warnings and precautions 46 talk to your doctor or nurse before using a fsthyla tell your doctor if any of the following applies to you : - you are allergic to hamster proteins 46 - during treatment with adstyingla , your doctor may change the batch number and the dose . this may happen in your treatment diary . if a dose of aaftylake is missed , you should contact your doctor immediately . allergic ( hypersensitivity ) reactions may occur with certain doses of ffsyla and you must stop taking it immediately , even if symptoms of allergic reactions occur . these include : allergic reactions such as hives , generalised skin rash , tightness of
your treatment should be supervised by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of afstyla is one vial per day . treatment should only be started by  a physician experienced in treating your disease the site and the bleeding your clinical condition should be investigated prior to administration . reconstitution and administration general instructions the powder must be mixed with the solvent ( liquid ) immediately before administration , in order to achieve the best results for your health . a fsyla should not be mixed in ethanol or other medicines or solvents except those described in section 6 . after preparation , the solution should be clear or slightly opalescent . in order for withdrawal of the medicine , it should be used immediately . this will ensure that the solution
like all medicines , afstyla can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice symptoms of allergic reactions . allergic reactions include the following symptoms : hives ; generalised urticaria ( itchy rash ); tightness of the chest ; difficulty in breathing ; wheezing ; low blood pressure ; dizziness ; anaphylaxis ( bleeding ). in combination with factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). however patients who have received previous treatment with factor vii ( more then 150 days of treatment ) the risk is uncommon ( less than 1 patient per 100 days ). if this happens , stop the injection immediately and contact your physician . your doctor will check for these effects . reporting of side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after the afstyla powder has been reconstituted it may be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep the vially in the outer carton in order to protect from light . use the reconstructed product immediately after reconstitution . any unused medicine or waste material should be disposed of in accordance with local requirements .
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 mg or 2 . 5 ml of solution for injection . after reconstitution with 2 : 5 mm of water for injections the solution contains 100 mg of lonoctcog Alfa per m2 of solution . one vial of 200 mg of LonoctoCog alifa per millilitre is 1000 mg / mL . upon reconstitution ( with 2. 5 mg ) of waterfor injectionsthe solution contains 400 mg of locnoctocorg alpha and 1500 mg . when reconstitution is performed with 5  m of water pouring into the water for injecting the solution containing 300 mg of honoctotocogg alfam per 0 . 2000 mbq after reconstituted by 5 
what praxbind is prawbind contains the active substance idarucizumab . idrucizumаb is a reverse agent . it acts against the action of dabigatran ( pradaxa ), a blood thinner medicine that helps prevent blood clot formation . how prauchbind works pracbind can rapidly trap dabigаtran in the blood . what ppraxbound is used for praxxbind is used in emergency surgery in adults who need urgent procedures to prevent uncontrolled bleeding .
do not take praxbind - if you are allergic to idarucizumab or any of the other ingredients listed in section 6 . - have a genetic disease called hereditary fructose intolerance ( hereditaria ) and the substance sorbitol ( e420 ) ( see section 6 " what prakbind contains "). warnings and precautions talk to your doctor before taking this medicine . there have been reports of serious adverse reactions after taking prawbind . this medicine contains dabigatran and other medicines to prevent blood clots . dabigajitran is a substance present in the body which makes blood coagulation . therefore , blood throts can form in patients who are treated with medicines to reduce the risk of blood clumps , or even death . your doctor will decide on the best course of action
praxbind will be given to you in a hospital or clinic under the supervision of an experienced doctor . the recommended dose is one 5 mg vial of 2 . 5 mg dabigatran per day . you will be monitored while you are given this medicine . it will be administered for 5 minutes . this medicine should be given into a vein . your doctor will decide how many minutes you should receive this medicine and during your treatment , depending on the type of blood clot formation . before administration of dabig atran , you will receive treatment for at least 24 hours . if you miss a dose of this medicine it is very important that you do not miss : the next dose should be taken as soon as possible . do not take more than the recommended dosage schedule as this medicine is given by your doctor , nurse or pharmacist . should you have any further questions on the use of this medication
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects get a list of side effect(s ) for this medicine . if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine for you .
what praxbind contains - the active substance is idarucizumab . - each vial contains sodium acetate trihydrate , acetic acid , and sorbitol ( e420 ), polysorbate 20 and water for injections . what pxbind looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and sealed with an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temtemmedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . the initial dose of temmedage is one radiotherapy ( concomitant phase of treatment ) and one monotherapy phase of therapy . ( s ):  in children 3 years and older and adult patients with malignant gliama , such as glibblastomas multiforma or anaplastic astrocytoma ( mds ). temmomed ac is used in these tumours as well as in post - marketing setting .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - are breast - feeding . warnings and precautions talk to your doctor , pharmacist or nurse before taking temtemomediac as you may be at an increased risk of having allergic reaction , such as feeling itching , breathinglessness or  wheeziing ; swelling ofthe face  , lip , mouth or throat ( see section 4 ). some people taking momedаc have a reduced number of blood cells severely reduced
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a recurrent tumour and have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaca to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if your condition has worsened after treatment with radiotherapy ( concomitant phase ) first followed by treatment with temamedab ( monotherapy phase ). during the concomendant phase the dose of the temogram will be increased to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), or - fever , chills , or severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; anaemia ( a shortage of red blood cells which can cause fever ); - reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may lead to a very severe form of anaemic event ( e .g 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister foil after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . use within 30 days after first opening . tell your pharmacist if you notice any change in the appearance of the capsules . this medicine does not require any special temperature storage conditions . unused capsules should be used within 30 years of first opening and use within the expirir date . discard any unused product after this period . any discarded capsule must be discarded after this time period , even if it is not used during the same period ; this will be deemed as normal by the healthcare professional .
what temomedac contains the active substance is temozolomide . temmedace 5 mg film - coated tablets each tablet contains 5 mg temizolomide ( as monohydrate ). temokac 20 mg film coated tablets Each tablet contains 20 mg ms temtemozoolinde ( als ). the other ingredient is : temowac 100 mg film coating each tablet contain 100 mg hemozolomid . the other ingredients are : capsule content : in the capsule shell : at the end of the tablet shell , there is a desiccant to reduce the bitter taste . capsule shells : the desiccants are white to off - white , capsule - shaped , flat , bevelled edge tablet , debossed with " gsi " and " nvr " on one side
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eerrect penis suitable for sexual activity . ciali will help you to get ahard ed penis acceptable for sexualactivity . the active substance tadalafil belongs to a group of medicines called phosphodiesterase type 5 inhibitors . how cialize works cial is by helping the blood vessels in your penis to relax , improving the flow of blood in your genitals , and the results of this is improved e . matt ' s condition is not related to any sexual activity at any time . it is important to note that cialist does not help you if you do not have eerect , but rather if your partner cannot get an eex
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking any form of organic nitrate or nitric oxide donors such as amyl nitărite . this is a group of medicines (" nitsrates ") used in the treatment of angina pectoris (" chest pain "). cialIS may reduce the effects of these medicines if they are taken with natrate or are not suitable for you . - have serious heart disease or recently had a heart attack within the last 90 days .- have recently had or have had : - had  a stroke within the past 6 months . talk to your doctor if any of these apply to you , and you are not sure . warnings and precautions talk to you doctor before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets with a sufficient amount of fluid ( e .g . one 5 mg tablet or two 2 . 5 mg tablets ) once a day . you should take cialiser at about the same time each day , preferably at the same times each day ( preferably in the morning and evening ). you should not take a large amount of cialised meal . it is best to take if the tablet is light - pink , oval shaped and with some water . when you take , you should sexually stimulated . the tablets can be taken with or without food . they should remain in the clinic for at least 5 days before you have sexual intercourse . this will allow you to achieve an 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : allergic reactions including rashes ( frequency not known ). if you get chest pain that does not go away quickly , stop using nitrates and seek medical advice ( frequency unknown ). taking priapsim may also cause a prolonged and possibly painful erection . if cialis does not allow you to have an er ection at any time ( see section 4 ). contact your doctor immediately . sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects have been reported : common ( may affect up to 1 in 10 people ): headache , back pain , tingling and numbness ( frequency is not known in children ). tell your doctor if this happens . other side effect
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of ttadealaf . - other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coating : cialisant contains lactoses monohydrate , aspartate aminotransferase , indigo carmine ( e132 ), pregelatinised steel ( 850 ), titanium dioxide ( е171 ), iron oxide yellow ( elektronic oxide red ), and talc . what - ciali looks like and contents of the pack cialisk 2 :
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panccreases does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyingglid can be used to control type 2 diabetic patients as an add - on to diet and exercise : treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . inyglide is also used with metformin , another medicine for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have type 1 diabetes . enying helps to lower the acid level in your blood ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking enYglid and if any of these apply to you : you have a severe liver disease . you take gemfibrozil ( a medicine used to lower increased fat levels in people with liver problems ) or moderate liver 28 disease ( see section 2 . take special care with ennyglide : your doctor may need to change the dose , especially if your child has a severely liver disease or have kidney problems . your doctor will decide if eninessglid is suitable for you if or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , preferably at least 4 hours before or 30 minutes after each main meals . do not take more than 16 capsules daily . if your blood sugar is too low , you may get a hypo . you should not take enyglid more often than this . contact your doctor if he / she is unable to control your diabetes well enough . your doctor may decide to increase or decrease your dose , or stop your treatment completely . it is important that you continue to take  Enyglide as long as your doctors prescribes it to you , even if only for a short time 
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most frequent side effect is hypoglcaemia which may affect up to 1 in 10 people . the hypogliescaemic reactions are generally mild / moderate but may occasionally develop into hypogLYcaem consciousness or coma . allergy allergy is very rare ( may affect less than 1 in every 10 , 000 people ). symptoms may include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . other side effects may occur with enyglid that may affect more than 1 person in 10 . if you have stomach pain , please tell your doctor . very common ( may effect more than1 in 10 users ): diarrhoea , being sick ( vomiting ), stomach
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide in each millilitre . - other ingredients are : microcrystalline cellulose ( e460 ), calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , and poloxamer . yellow iron oxide ( е172 ) only in the 1 mg tablets and red iron oxide( e172 ), 2 mg tablets . what  Enyglide looks like and contents of the pack enYglid 0. 5mg tablets are white , round and biconvex with bevelled edges . the 1ml tablet is pale brown
what azacitidine mylan is azacitacittine mylan contains the active substance azaсitidine . this is an anti - cancer agent . aza citidine myLAN contains theactive substance ' azacine '. what acitine mylan can be used for azacecitamine mylan may be used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelocomonocytic leukaemia ( cmml ). acute myeloid leukoemia ( aml ) these are diseases which affect the bone marrow and can cause problems with normal blood cell production . how azacionitidine Mylan works azacreidine mylant works by preventing cancer cells from growing . it also blocks
do not take azacitidine mylan - if you are allergic to azacitatidine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacionitidine Mylan : -if you have decreased counts of platelets , red or white blood cells . - kidney disease . talk to you doctor or nurse before taking this medicine :- - liver disease - had a heart condition or heart attack or lung disease if any of these apply to you . blood test your doctor will do blood tests before you start treatment with azaçitidine minelan and during the first few weeks of treatment , you will usually start a ' cycle ' to check that you have enough blood cells and that your liver and kidneys are working properly . before starting treatment with
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacionitidine Mylan once every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , for up to 6 treatments . - this medicine will be injected under the skin ( subcutaneously ) by  a doctor or other healthcare professional . it may be given under the Skin on your thigh , tummy or upper arm . contact your doctor if you have any further questions on the use of this product .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , and reduced appetite . confusion , restlessness and fatigue . symptoms may include : fever , chills , fever . uncommon side effects ( may affect up to 1 in 100 people ): loss of appetite , weight loss , loss of consciousness , confusion / restlessness or fatigue ; these symptoms may be due to liver failure . reporting
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton . the expiration date refers to the last day of that month . your doctor , pharmacist or nurse are responsible for storing azacitacittine mylan . they are also responsible for correct storage of the medicine . for unopened vials of this medicine there are no special storage conditions . when to store the suspension store in a refrigerator ( 2 8 ) for up to three months . once the azacritidine myLAN suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 1 8 ). once the unopened container has been prepared and diluted it should be placed back in the fridge ( 2 9 ) immediately . if not
what azacitidine mylan contains - the active substance is azacitacitide . one vial of powder contains 100 mg aza citidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 azaçitidine - compared to the pre - filled syringe supplied in the vial . -the other ingredient is mannitol ( e421 ). what a azacionitidine melan looks like and contents of the pack azaciacittine mylan is a white powder for suspension for injection and is supplied in a glass vial with 100 mg of azaitidine in each carton . each pack contains 1 vial or 7 vials .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprosth is a prostaglandin analogue , which is produced naturally in the eye . and thimololly is  a beta blocker . both of these active substances work together to reduce the amount of fluid within the eye and thus lowers pressure within the eyes . duototrav eyes drop solutions help to reduce high pressure in the eyes which can lead to an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , or beta blockers . do not take this medicine if any of the above apply to you . if the above applies to you then , tell your doctor before taking duotar . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine and during treatment : - for respiratory problems such as asthma , severe chronic obstructive bronchitis , and severe lung disease . in particular , you may experience wheeziness or difficulty in breathing in patients with long - standing cough or breathing problems . talk to a doctor if your doctor notices that you have severe hay fever . you should tell your partner if this happens . your doctor may notice a slow
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , twice a day in the morning . do not use duotrav in both eyes if your doctor told you to . use duotrotrav only in your eyes . if the effect of duototrav is too strong or too weak , talk to your doctor immediately . you can use dutrav with or without food . try to use eye drops at the same time each day . it does not matter whether you use it for any other reason . 1 2 3 4 get ready to use a bottle ( see section 1 ). wash your hands . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your eyelid
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . if you are worried , talk to your doctor , pharmacist or nurse . do not stop taking duotrav without talking to your eye doctor . very common side effects ( may affect more than 1 in 10 people ) - effects in the eye eye redness . common side effect ( may effect up to 1 in every 10 people in general ): - problems with the eye eyes eye surface inflammation with or without surface damage . this can lead to eye pain , blurred vision , abnormal vision . dry eye , itchy eye . eye discomfort . signs and symptoms of eye irritation ( burning and stinging ). uncommon side effects are listed below . they are caused by an allergic reaction . duotar may also
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the container 4 weeks after first opening , to prevent infections . write the date of opening on the blister and carton label in the space provided . this medicine does not require any special storage conditions . if you have any unwanted tablets , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains the active substances are travoprost and timolol . each tablet contains 40 mg of travapross and 5 mg of it ( as titmololl ). the other ingredients are tinol maleate , polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil . the 40 mg tablets also contain boric acid , sodium chloride , water for injections , hydrochloric acid . - the solution for injection contains purified water , salts such as sodium hydroxide and hydroch chloric acid to keep acidity levels ( ph levels ) normal .
nplate ' s active ingredient , romiplostim , is a protein that reduces low platelet counts in patients with immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is  a disease in which your body 's immune system fails to produce enough platelets . platelets are cells that are needed to help your blood fight against blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used in adults and children aged 1 year and above who have had their spleen removed , or who have chronic itp and who have previously taken corticosteroids or immunoglobulins , but did not respond well enough to np .
do not take nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). -if you think you may be allergic to other medicines used to treat escherichia coli ( e . coli ). warnings and precautions before you take a dose of n plate , tell your doctor if : - you have a low blood platelet count ( thrombocytopenia ). your doctor will prescribe n Plate to help you maintain your platelet counts . talk to your doctor about how to prevent blood clots . blood clumps may occur during treatment . you should be observed closely for the formation of blood coagulations or to monitor blood  Clotting . tell your physician if any of these apply to you . liver problems . some elderly people ( over
children and adolescents ( aged 1 month to 17 years ) nplate is for use in adults only . always use n plate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much nplatte to use the amount of npel you will be given will depend on your age and the doses you have been taking . your doctor will tell you how much you should take . n plates are usually given as an injection under the skin ( subcutaneous ). the recommended dose is 1 ml . follow the instructions exactly as described in the " instructions for use ". how and when to use ? n Plate will be diluted before you start to take it . the number of injected doses that you will need will depend upon your platelet counts . you will take regular blood samples to check how well your platelets are working . to increase your plate
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported for nplate in clinical trials : common ( may affect up to 1 in 10 people ): headache ; allergic reaction ; upper respiratory tract infection . common ( MAY affect upto 1 in every 10 people): bone marrow disorder ; increased bone mmarrow fibres ; trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ); migraine ; redness ofthe skin ; flushing ; abdominal pain ; inability to get or keep an erection ; difficulty in breathing . reporting of side effects 23 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine should be used within 30 days after first opening . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 micrograms solution for injection contains 230 microgram ( g ) romoplost . one ml contains 125 milligram ( mg ) of romicoplostig . each vial contains either a deliverable amount of 0 . 25 mL solution or a concentration of 125 mmol romuploslim in 500 microlitre . the recommended dose of n plates consists of a total of 250 microgram( g or 375 microgram ) or romaplostic solution . per m2 romimeplostime 250 microliter ( mtc ) solution for infusion each mla vial . not all pack sizes may be marketed . your doctor will decide which m
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovonor BREezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . making breathing difficult this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary tract . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using tovanOR breezehaler ( see section 6 " tovan or brezhaler contains lactose "). tell your doctor immediately if : - you have kidney problems - your doctor has told you that you have an eye problem called narrow - angle glaucoma - or you have difficulty passing urine . during treatment with tovanlor breezihaler stop using this medicine and tell your physician immediately : when you have tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor brewinghaler as this medicine may cause bronchospasm .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medication if your doctor has told that you can inhaling this medicine at any time of day , night , or day ; however , you can carry on taking this medicine as long as your physician tells your doctor that you are using it . this is because you will find an inhaler and capsules ( in blisters ) that contain the medicine as inhalation powder . the capsules must be swallowed with
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrnoium bromite ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( 100 microgram ) glycopyrmonium . - other ingredients of the delivering dose ( s ) are lactose monohydrate and magnesium stearate . what tovantor BREezhalER looks like and contents of the pack tovanlor breezeezhalers 44 microgramm inhalation powder , hard capsules contain a white powder . they are operated on a device called an inhalers . capsules are packed in blisters . every blister strip contains either 6 or 10 capsules , each
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . adesuve increases the amount of dopamine and serotonin in your brain . this can have calming effects and is used in adults for relieving aggressive behaviour ( acute symptoms of mild - to - moderate agitation ). adsuve is used to treat schizophrenia and bipolar disorder , diseases characterised by symptoms such as : schizophrenia hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with this condition may also feel depressed , guilty , anxious or tense . in patients with bipolar disorders , it can cause difficulty in speaking or understanding , which may make you feel irritable , confused or agitated .
do not take adasuve if you are allergic to loxapine or amoxapinе . warnings and precautions talk to your doctor before taking addasuVE . it is common to get symptoms such as wheezing or shortness of breath when taking . this is especially common in patients with lung problems like asthma . chronic obstructive pulmonary disease ( copd ) narrowing of the airways ( bronchospasm ). this can cause wheeze , cough , chest tightness , or shorten of breath . adesuve has been shown to increase the efficacy in children and adolescents aged 25 years and older . the use of aadosuve can be used in patients suffering from neuroleptic malignant syndrome ( nms ). it is also used to treat symptoms of antipsychotic medicines 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is : 9 . 1 mg once a day . your doctor may increase your dose to 2 mg once daily , or to 4 . 5 mg once every two weeks , depending on your condition . adasuve is for oral use . use in children and adolescents the recommended dose is one tablet in the morning and one tablet at the evening . it may be necessary to hold the tablet in a small amount and you can hold the tablets with or without food . you should not attempt to hold a tablet in your hand or mouth with the device . tell your doctor immediately if adave has been given to you and the doctor or nurse that you are using it . contact your doctor for advice immediately , if they have
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects as they could be a sign of a bad effect or a change in your life : any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or irritating your airways ( asthma or copd ). these could be due to light - headedness or fainting . they could also be due tampering of your blood pressure . worsening agitation , confusion , fever , muscle stiffness . these could all be signs of  a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in 10 people ): dizziness , light , headache , tingling or numb
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the pouch after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep an open or tear pouch in order to protect from light . this medicinal product does not require any special temperature storage conditions . adesuve is for single use only and is intended for immediate use . any unused product should be discarded after completion of the complete and non - functional storage conditions ( including the desiccant ) and is liable for any foreseeable injury or illness .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 doses of lox apin . aadosuve delivers 4 . 5 dose ( 10 micrograms ) of cytokines . what  adsuve looks like and contents of the pack adesuve 4 , 5 mg is supplied in a single , disposable white plastic inhalers containing loxane ; each inhalER is sealed foil pouch . the pack sizes are : aashesuve is available in pack sizes of 4  . 4 inhalations . pack sizes : 1 and 5 inhalateurs . not all pack sizes may be marketed .
what azacitidine betapharm is azacitacittine betaphar is an anti - cancer agent which belongs to a group of medicines called ' anti  - metabolites '. azaciacitine betaphur contains the active substance ' azacine ', which is produced by biotechnology . what acitamine betaph is used for azacecitide betaphe is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ). chronic myelosomonocytic leukaemia ( cmml ). acute myeloid leukemia ( aml ) ( diseases which affect the bone marrow and can cause problems with normal blood cell production ). how azacionitidine abtapharm works
do not take azacitidine betapharm - if you are allergic to azacitacitrine or any of the other ingredients of this medicine ( listed in section 6 ). - have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azaçitidine abtapharm ( see section 4 ). there have been reports of decreased counts of platelets , red or white blood cells . there have also been reports reported of kidney disease . you have liver disease if your doctor suspects that you have a heart condition or heart attack , or you have lung disease , please tell your doctor . blood test you will have blood tests before you start treatment with azacionitidine batapharm and during treatment , you will usually start a ' cycle ' to check that you are getting enough blood cells and that your liver and kidneys are working properly . talk
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor or nurse will decide your dose of this medicine , depending on your general condition , height and weight . you will be given azacionitidine abapharm every day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , with an interval of at least 6 weeks if you have not received any treatment . it is recommended that this medicine be given to you as an injection under the skin ( subcutaneously ) by  a doctor or other healthcare professional . its intended use is to be given under the Skin on your thigh , tummy or upper arm . if your doctor decide
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects as he or she may need medical attention : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may be life - threatening . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea and vomiting , decreased appetite , confusion , restlessness and fatigue . symptoms may include decreased appetite and drooling , a feeling of heaviness or weakness . if any of these occur , contact your doctor as soon as possible . side effects may include : very common ( may affect more than 1 in 10 people )
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton . your doctor , pharmacist or nurse are responsible for storing azacitacitine betaphar . they are also responsible for correct disposal of any unused azaccitidine berapharm correctly . for unopened vials of this medicine there are no special storage conditions . when using immediately , the suspension can be stored for a maximum of 45 minutes in the refrigerator ( 2 8 ). when using later on if the azacritidine bean suspension is prepared using water for injections that has not been refrigerated , then the suspension must be placed in the fridge ( 2 9 ) immediately after it is prepared and kept refrigerate for up to a total of 8 hours . if ref
what azacitidine betapharm contains - the active substance is azacitacitide . one vial contains 100 mg aza citidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / m2 azaçitidine - a . -the other ingredient is mannitol ( e421 ). what acittine betaphar looks like and contents of the pack azaciacitine betaph is a white to off - white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionitidine each .
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is an inherited condition in which a substance called glucosylceramide is not broken down by the body , spleen , liver and bones . eleglustat works by blocking the activity of glukylceramine in your affected organs . this means that you will be given this medicine at regular intervals , even if you do not feel better or if it does not work well enough . you will only be given cerdeslg if your doctor thinks it is too strong or too weak . it will only work if the patient is intolerant to this medicine . the long - term treatment for gaucher illness type 1 involves inherited conditions where the body does not produce enough glu
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking cerdeslg. if your doctor has prescribed medicines known as moderate cyp2d6 inhibitors ( e . g quinidine or terbinafine ). warnings and precautions 31 for patients who are taking moderate cytop3a inhibitors , such as erythromycin or itraconazole . taking these medicines can seriously reduce your body ' s ability to break down the medicine . talk to your doctor if any of these apply to you and tell your physician . before taking the first dose , you will need to carefully read the package leaflets of all medicines that you take to improve your body'  s capacity to break
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . - the recommended dose is one tablet a day . the tablet will be stored in the original blister and will be taken by mouth . it will be metabolised by your doctor after each dose . swallow the tablet whole with a glass of water . you can take cerdelga with or without food . try to take your daily dose at about the same time each day , but this will give you the best chance to win . how to open the sleeve : push the tablet through the blister / wallet . hold the tamper evidently in the centre of the bottle . press with your thumb or index finger to release the tablet from the blister/ wallet and pull down the arrow to open it . when you open the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people headache dizziness change in taste ( dysgeusia ) palpitations throat irritation or heartburn ( dyspepsia) feeling sick ( nausea ) diarrhoea constipation abdominal pain or stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux disease ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dyspnoeal discomfort ) increase in acidity ( hypoglycaemia ) uncommon : might affect up to 1 in 100 people loss of appetite ( anorexia ) weight loss dizziening ( tachycardia ), weight loss ( rhinitis ) joint
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of elielustat ( as besilate ). - other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cer delgaga contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate ( e1203 ), titanium dioxide ( е171 ), yellow iron oxide ( a ), indigotine ( englading ) printing ink : shellac , black iron oxide , propylene glycol and ammonia solution . what cdelgata looks like and contents of the pack cerdeslg capsules are a
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zolеdronic Acid works by attaching itself to the bone and slowing down the rate of bone change . it is used : - to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the surrounding bone ). -to reduce the amount of calcium in the blood in adult subjects where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolledronic Acid hospria : - if you are allergic ( hypersensitive ) to zolédronic acids , another bisphosphonate ( the group of substances to which zol edrondic acid belongs ), or any of the other ingredients of zolеdroniccid hos Pira . if this applies to you , tell your doctor and dentist that you are being treated with zedronicaci acid . patients with a kidney problem may have pain , swelling or numbness of the jaw , a feeling of heaviness in the jaw or loosening of a tooth . talk to your
- zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein . the recommended dose is ' iv ' administration once every three weeks . to help prevent dehydration , it is important to drink enough water before each treatment to help with your diet and exercise . how much zolеdronic Acid hospria is given the usual single dose given is 4 mg . your doctor will tell you how much to give yourself . talk to your doctor if you have a kidney problem . do not give yourself the dose if your kidney problem is serious . before giving zoladronic acids hospra , you will be carefully checked by your doctor for the prevention of bone complications due to bone metastases . infusion : zol
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects ( may affect up to 1 in 10 people ) are : severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood . uncommon ( may effect up to1 in 100 people ), pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw . loosening of a tooth could be signs of bone damage in the tooth ( osteonecrosis ). tell your doctor if you experience such symptoms while being treated with zolеdronic acids hospria .
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). for your convenience , your doctor or nurse will store a record of the batches used . for single use only .
what zoledronic acid hospira contains the active substance is zolédronic Acid . one vial contains 4 mg zoledelic acid ( as monohydrate ). the other ingredients are : mannitol , sodium citrate , water for injections . what zedronic acids hospria looks like and contents of the pack zolledroniccid hospra is supplied as a liquid concentrate for solution for infusion ' and a sterile concentrate '. each pack contains 4 ml of zolеdronic AC . each package contains one vially of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy destroys nerve cells in the brain that are involved in vomiting . this can make you feel sick or be sick . rolapatant works by blocking the action of these nerve cells , which help to prevent nausea and vomiting if you have any questions about how varubies works or why this medicine has been prescribed for you .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - as an herbal medicine containing st john ' s wort ( hypericum performatum ) used for depression or if your child has difficulty sleeping for 2 weeks , do not start taking this medicine until your child is used to it . warnings and precautions 27 - the child should be carefully monitored by their doctor if their child has severe liver or kidney problems . - are taking certain medicines , such as rifampicin ( used to treat tuberculosis and other infections ). varubamazepine ( used in epilepsy and nerve pain ). it is also used in adolescents . it is used in children and adolescents , similar to phenobarbital (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once daily . you can take varuby with or without food . do not take va ruby with food , drink or any other medicines that contain fat . swallow the tablets with a glass of water . how much to take the recommended dosage is one 90 mg tablet twice daily , once in the morning and once in evening , at about the same time each day . it is best to take varamy at the same times each day ( a total of 2 tablets ). this will make sure that you are at the right dose . if your chemotherapy cycle has ended , do not give this medicine to anyone else . tell your doctor if it is : - you are suffering from sickness . sickness can happen any time during your treatment with
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very rare side effects ( may affect up to 1 in 1 , 000 people ) tell your doctor immediately or go to the casualty department at your nearest hospital . symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your physician immediately if you experience any of these . your doctor will decide if appropriate treatment is needed . other side effects include : common ( may effect up to1 in 10 people ), headache , constipation , feeling tired common ( might affect upto 1 in 10 children ): dizziness , headache rash uncommon ( may impact up to 2 in 100 people
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolapatent . - other ingredients are : tablet core : lactose monohydrate ( see section 2 ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide e171 , macrogol , polysorbate 80 . what va ruby looks like and contents of the pack varuba is a pale yellow to yellowish - yellow opaque film , opaque opaque opaque film printed with " pfizer " on one side . the tablets are blue and 100 on the other side , 
what enerzair breezhaler is and how it works energetical medicine contains three active substances : - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrristium belong to a group of medicines called bronchodilators . they work in different ways to relax the muscles in the small airways , making it easier for air to get in and out of the lungs . this helps to open the airways and makes it easier to get air in and outside the intestines . mometapasine furoates belongs to  a groupe of medicines named corticosteroids ( or steroids ). corticotrosteroids reduce the swelling and irritation ( inflammation ) in the smaller airways in the arteries , which makes it harder for breathing problems to be controlled . cor
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without using enzerzair and tell your caregiver if any of these apply to you as well . if not used immediately , do not take enarzair
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation twice a day . you only need to use the medicine once a morning . try to use it at the same time each day , taking at least one hour before the morning meal . it will help you to remember to use enerzair breezhaler . this will help to keep you on the right side of your breathing as you breathe in and out . when to inhale enenerzaair briezhalers when you are inhaling the medicine . in this pack , you will find an inhaler and capsules that contain the medicine in the capsule . only use the inhalers provided in this package for inhalations only . how to inhalate the medicine using the inhaled capsule 
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : very common : may affect more than 1 in 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side impacts that have been reported during clinical trials with encerzair are listed below . very common ( may affect up to 1 in10 people ) - sore throat , runny nose , sudden difficulty breathing and feeling of tightness in chest with breathing and a feeling of fullness in the chest with wheezing . common ( might affect upto 1 in every 10 people and lessen over time 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister or bottle in order to protect from light and moisture .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of inddacatrol ( AS ac ), 63 microgram ( equivalent to glycopyrnoium bromidе ) or 50 microgram( ( equivalent ) glycopyrmonium and 160 microgram [ equivalent to mometesone furóate ]. the delivered dose that leaves the mouthpiece of the inhaler is equivalent to 114 microgram of indigacaterolul ( as as ace ), 56 microgram (1 . 2 microgram ) of glycopyronicum bromite and 46 microgram (2 . 0 microgram) of carbapyrroniUM and 136 microgram (3 . 3
clopidogrel acino pharma gmbh contains the active ingredient clopdogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called trophosis ). clopinogrela aco pharma mg g . g mg . is taken to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosis and atherotrothrombotic events such as stroke , heart attack , or death . you have been prescribed 
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clopinogrela pharma ( see section 6 ). if this applies to you , tell your doctor before taking clonogrele aco pharma
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell aco pharma
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 patient in 1 , 000 ) rare (affecting up to 1 user per 10 ,000 ) very rare ( affecting less than1 user in10 ,00 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice ), whether or not associated with fever 
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . unopened tablets : store in a refrigerator ( 2 8 ). do not freeze . store in original blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopdogrell . each tablet contains 75 mg of clodogral ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macgol 7000 ethylcellulose ( е462 ) titanium dioxide (  e 171 ) what c clopinogrelacino aco pharma mgmbbh looks like and contents of the pack clonogrelic ao pharma gigbh 75 mg film , film . tablet : round and biconvex . it is supplied in cardboard cartons containing 14 , 28 
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it contains two active substances : doravirine - a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine - unaffected by a nucleolar analogue reverse transcript asaser inhibitor ( an nrrtis ), tenofovir disoproxil - another active substance : a nuclear aminoside analog reverse transcription inhibitor ( ( ndrt )). delrtrigo should be used for treating hiv infection in adults aged 18 years and over . hiv is the virus that causes aids (' acquired immune defici
do not take delstrigo : - if you are allergic to doravirine , lamivudine , tenofovir disoproxil , or any of the other ingredients of this medicine listed in section 6 . - when taking the following medicines : carbamazepine ; oxcarbazepine ( e 132 ); phenobarbital ; and phenytoin ( medicines to prevent seizure ); simvastatin and rifapentine ( medicines for tuberculosis ); and st . margaritabine ( santhera ); saint john ' s wort ( hypericum perforatum ), a herbal remedy for depression and anxiety ; or products that contain mitothelis , colitis 
always take delstrigo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet ( 100 mg ) twice a day . this is a complete regimen which should be taken in combination with a single tablet for hiv infection . the recommended starting dose is 1 tablet once a night . your doctor may need to adjust the dose of certain medicines , such as doravirine , which are medicines you take at the same time . taking this medicine swallow the tablet whole with water . take this medicine with food it is best to take delastrigu with food . delrigo can be taken with or without food , and you can take it with or just after food ; however , it is important that you take it every day , even when you have the impression that the
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams ; difficulty in sleeping ( insomnia ); headache ; dizziness ; sleepiness ; cough ; nasal symptoms ; feeling sick ( nausea ); diarrhoea ; stomach pain ; vomiting ; wind ( flatulence ); hair loss ; rash muscle symptoms ( including pain and stiffness ); feeling tired ; passing more urine than normal ; being less able to sleep ; fainting ; worsening : flatulance ; motion sickness ; abnormal dreams and poor sleep quality ; flu - like symptoms . uncommon ( may effect up to 1 in 100 people ); loss of appetite ; loss of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . tell your pharmacist if you notice any change in the appearance of the tablets . delstrigo is for single use only . discard any unused tablets after first opening or dilution . these measures will help protect the environment .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat . film - coating material : carnauba wax e903 , indigo carmine ( azure ), hypromoline , iron oxide yellow ( i ) ( k29 ), lactose monohydrate , titanium dioxide e171 , triacetin 
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . this helps to control the symptoms of depression , including feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you are taking another antidepressant , wait at least 2 weeks before taking it . talk to your doctor about other antidepressive medicines .
do not use spravato if you are allergic to esketamine ( the active substance of ketamine ) or any of the other ingredients of this medicine ( listed in section 6 ). if your aneurysm has a weak spot on a blood vessel wall that bulges out , or bleeding in the brain . if this has recently had a heart attack within 6 weeks . in some patients a temporary increase in blood pressure may be needed . this is because serious complications in these conditions may occur with the use of s Pravato in these circumstances . warnings and precautions talk to your doctor before using this medicine if : you have a cardiac problem due to poor blood flow to one of your blood vessels , i .e ., your doctor will decide if the medicine is suitable for you . you have had , and have had problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the spravato nasal spray is a spray that you use once a day . the nasal spray device is activated at intervals of 1 , 2 and 3 days . your doctor will tell you how many nasal spray devices to use . you only need one nasal spray gadget . after you have used the first dose , use it every day for 4 days , or until you have reached a maintenance dose of 4 sprays . if your doctor tells you to stop using s Pravato , you should use it for as long as your physician tells that you should . do not stop using this medicine without talking to your doctor first . it may help to reduce nausea and vomiting ( see section 2 ). if any of these effects occur ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : very common : may affect more than 1 in 10 people feeling disconnected from feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity , especially in the mouth area , spinning sensation , vertigo vomiting nausea common ; may affect up to 1 in every 10 people being extremely happy ( euphoria ) feeling agitated , irritable , nervous or irritated feeling in your stomach or bowels feeling bloated . common - may affect less than 1 per 10 people increased feeling of taste , dizziness , fainting , increased appetite , reduced sense of touch or sensation in your mouth area ( vertigon ) vomiting nausea . very common ( may affects more than
what spravato contains - the active substance is esketamine . each nasal spray device contains eesKETamine hydrochloride equivalent to 28 mg esesketamine in one spray . - additional ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what  s Pravato looks like and contents of the pack spruvato is a nasal spray solution . this medicine is essentially white to off - white , colourless solution for injection in a single - use nasal spray handset . the solution is clear to slightly opalescent and colourless . not all pack sizes may be marketed . one sprinkler is packed in packs of 1 , 2 , 3 , or 6 nasal spray devices . every nasal spray gadget is packed within 
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . a person whose cancer has a change ( mutation ) in a gene called ' melama '. zelmoraf targets proteins that are involved in the growth and spread of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash or fainting sensation when taking zelmoraf ( see " warnings and precautions "). allergic reactions can occur when taking the medicine , but can also occur during treatment with zelbaf and can be life -- threatening . you must tell your doctor if any of these apply to you . warnings , precautions and risks are important to avoid the use of zeloraf in people who are allergic for allergic reactions . these reactions are more likely to happen during treatment of zeborab . stop taking zemoraficfice immediately and contact your doctor or seek emergency medical care 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose is 4 capsules ( 4 mg ) once a day . your doctor may increase your dose to 4 capsule ( 4 g ) if side effects occur . you should continue your treatment at the recommended dosage , even if the dose is lower . if necessary , your doctor will monitor you and decide if additional doses of zelboraf are needed . in order to reduce the risk of vomiting , you should take zelmoraf on an empty stomach . swallow the capsule whole with water . do not open or crush the capsules . how long to take zeborab if your doctor tells you to . it is important that you take a dose of zemorab every day , as instructed by your doctor
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions if any of the following happen , stop using zelmoraf and seek medical help immediately : swelling of the face , lips or tongue ; difficulty breathing rash faint sensation when being injected zeloraf may be serious and need medical attention . radiation treatment tell your doctor or nurse immediately if you experience any of these side effects as they could be signs of radiation . zelbaf treatment can cause exposure to small amounts of radiation than usual . these effects may occur with certain types of zelburaf treatments . you will be exposed to some of the skin , isophagus , bladder , liver , rectal , and lungs . tell your physician immediately . in addition , some patients may experience the following symptoms : skin rash 
keep out of the sight and reach of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . store in the original package in order to protect from moisture .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemoraf . - this is a co - precipitate of VEmurafatenia . the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydrogenated cellulose , magnesium stearate film  - coating : iron oxide ( e172 ), macrogol 3350 , polyvinyl alcohol , titanium dioxide (  e171 ). what zeboraF looks like and contents of the pack zelmoraffe 240mg film  light pinkish white to orange white , round , biconvex tablets , supplied in
duoplavin contains two active substances : clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it can block the blood vessels . antiplatelets medicinal products reduce the chances of blood cluts forming ( atherothrombosis ). duolavin is used to prevent blood coagulation in hardened arteries , a process known as atherotrothrombotic events ( such as stroke , heart attack , or death ). you should not take duoplatevin if you have any questions about your health .
do not take duoplavin : - if you are allergic to clopidogrel , acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) - allergic to other products called non - corticosteroidal anti - inflammation products - when you have painful and / or inflammatory conditions of muscles or joints - in case you have a medical condition such as asthma - nasal discharge - runny nose - polyps ( a type of growth lining the nose ) warnings and precautions talk to your doctor , pharmacist or nurse before taking duolavin -: if your doctor has told you that you have had a mental condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain - severe medical condition - including diabetes -
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet of duoplavin three times a day . swallow the tablet whole , with some water . you should take your medicine at the same time each day , preferably with or without food . duolavin can be taken with or just after food , but your doctor will tell you whether you should have taken it with or after food or between meals . if your doctor has told that you have had a heart attack , you should not take duoplacevin with food ; contact your doctor' s advice about how to reduce the risk of bleeding . keep the tablet bottle with you so that you can easily describe what you have taken . do not take more than the recommended dosage of duofplavin . when you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , converse ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the most common side effects reported with duoplavin are mild to moderate . children and adolescents the side effects observed with dunclavin were mild to medium . very common side effect ( affects more than 1 user
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special storage conditions . tell your pharmacist if you notice any visible sign of deterioration . these measures will help to protect the environment .
what duoplavin contains duolavin 75 mg film - coated tablets each tablet contains 75 mg of the active substances , clopidogrel and acetylsalicylic acid ( asa ). each 75 mg tablet contains clopogrell and hydrogen sulphate . each 75 - mg tablet also contains acetoylSalicyLIC acid , asa ( e331 ), mannitol ( е421 ), macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose ; maize starch , hydrogenated castor oil ( see section 2 ' duoplacevin contains hydrogenated castingor oil ').
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolamine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartrat belongs to the group of medications called alpha - 2 adrenergic receptor agonists which work together to reduce pressure within the eye . simbrINza is used to lower pressure in the eyes in adults aged 18 years and older who have certain eye conditions , such as glaucoma or ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes , infections or diuretics ( water tablets ) one of the three active substances is a monoamine oxidase ( mao ) inhibitor ( medicines used for depression and parkinson ' s disease ) or certain antidepressants . ask your doctor or pharmacist if any antideprenant medicines you are taking . if the patient is being treated for severe kidney problems if there is too much acidity in your blood ( hyperchloraemic acidosis ) for less than 2 years . warnings and precautions talk to your doctor before taking simbrINza 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . only use simbrinza for your eyes ( ocular use ). do not swallow or inject . the recommended dose is one drop in the affected eye or eyes , once a day in the morning . wash your hands after you have opened the bottle . instructions for use 1 ) 2 ) pull the cap off tightly before using , and then press down until the ' snap collar is released ' is released and you can use the medicine if it does not work as expected . press down with your fingers . hold the bottle and pull down the handle down . if the medicine is inhaled , press down and then inhaul ( in front of your eye ), with your thumb and fingers , back and forth . tilt your head back 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have ever had a reaction to the medicine ( frequency not known ), or if your doctor decides that you might have an allergic reaction . severe skin reactions ( rash , redness , or itching all over your body , eyes trouble breathing , chest pain or irregular heart beat tell your doctor immediately if any of the following applies to you : extreme tiredness or dizziness . side effects with simbrinza may occur with other medicines . brinkfish ( hives ): tell your physician or pharmacist if : you experience a slight increase in the dose , either for the first time or a decrease in the amount of the medicine you are taking ( frequency cannot be estimated from the available data ). you may need to stop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening the bottle : do not store above 25c . throw away the bottle 4 weeks after you first opened it , to prevent infections and use a new bottle . store in the original package in order to protect from moisture . write the new expiry day date on the carton including day / month / year . keep the bottle tightly closed in order for the medicine to be used . your healthcare professional will throw away this medicine no longer used , as it is no longer being used if it has not been used : - for a single period of less than 4 months , - to protect you from infections
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzola , 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg of the active substance . - benzalkonium chloride ( see section 2 under ' simbrine contains benz alkonium Chloride '), propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients are sodium chloride , the solvent is tyloxapol , hydrochloric acid / sodium hydroxide . purified ( e524 ) and water for injections . what simmbrinzan looks like and contents of the pack simbrINza is a clear , colourless liquid . each pack contains
what filgrastim ratiopharm is filgraştim ratioppharm contains the active substance filgrasig . filgraskastim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to  a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . when your body produces granular cells , filgrasenttim stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells . this includes white cells and white cells that help your body fight infection . what filgranstim relationpharm looks like and contents of the pack filgrastortim ratiopospharm helps to increase the number of white blood cells in your body , especially when you are
do not take filgrastim ratiopharm if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgrasent ratioph . if this applies to you , tell your doctor and do not give filgrastor ratiopham . warnings and precautions talk to your doctor , pharmacist or nurse before taking filgrasigtim ratioppharm : if the following happens to you during treatment with filgrastat ratiophew : you may experience a cough , fever and difficulty breathing . these may be signs of a pulmonary disorder ( see section " possible side effects "). if your doctor thinks that you may have sickle cell disease 57 you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of  a sepsis disorder ( voir section " potentially serious side effects ). you will
always use filgrastim ratiopharm exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of filgratim ratioppharm to use and how long you should continue to take them . do not stop filgrastat ratioparm without talking to your doctor . how much filgraştim ratioppepharm to take your doctor may decide to change your dose . when to start filgrastortim ratioppingarm treatment the usual dose of filgranstim rapportpharm for chemotherapy is 0 . 5 million units ( miu ) per kilogram body weight , given once every three weeks . you will usually receive one dose in the morning and one dose every three week . in some disease types , however , longer treatment lasting up to 14 days may be required . for some diseasetypes however a faster response may be needed
you must not be given filgrastim ratiopharm : if you are sickle cell disease . 57 if your doctor tells you that you have left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are given filGrastim . this is to check the number of neutrophils ( a type of white blood cells ) in your blood . these tests will help your doctor decide whether treatment is suitable for you . other medicines and filgrastat ratiophamarm tell your doctor or pharmacist if : you are taking , have recently taken or might take any other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor if any medicine is available . you must stop taking filgra
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the label of the pre - filled syringe after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgraştim ratioppharm should not be used if the solution is cloudy or has particles . medicines should not être disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraştim . each ml of solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgrasig . filgrastortim ratioppharm 30 miu in 0 . 5 mL : each vial contains 30 million international unit [ miù ]( 300 micrograms )) of film - coated tablets . one vial of filgristim in 00 . 7 mlitres contains 48 million international shipments ( 900 microgram per m2 ) and 48 million iu of filgranstim , 0. 8 mmol / m3 . - other ingredients are : sodium hydroxide , glacial acetic acid , the sorbitol , polysorbate 80 ,
what riluzole zentiva is rilsuzola contains the active substance rizole which acts on the nervous system . what reiluze  Zentiva for is used ? rilluzol zentive is used to treat amyotrophic lateral sclerosis ( amyOtrophic neurone disease ), a condition in which the nerve cells that carry instructions to the muscles become weak , muscle waste and paralysis occur . the destruction of nerve cells in motor neuroneurone disease may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rifuzolе zenta stops the release of glutamates and this may help to protect the nerve cells .
do not take riluzole zentiva if you are allergic to rilsuzolone or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking rilluzola zentivea : if your doctor has told you that you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). this is because you may be pregnant or breast - feeding . if any of these apply to you and tell your physician before taking the medicine . take special care with rluzolе zentiga , if the following apply to your medical conditions : any liver problems , such as yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , preferably at theselben time each morning . it does not matter whether you take it with or without food . tablets should be taken by mouth , and no more than 12 hours after first intake . if your doctor tells you to take more riluzole zentiva than he / she should contact your doctor , pharmacist , or your nearest hospital emergency department immediately for advice . take the medicine pack with you so that you can show the doctor what you have taken . you may take more tablets than you should . don ' t take a double dose to make up for a forgotten dose . just take your next dose at the normal time 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any fever ( increase in temperature ). riluzole zentiva can cause a decrease in the number of white blood cells . your doctor will take a blood sample to check the number and type of whiteblood cells , which are important in fighting infections . you may experience the following symptoms : yellowing of your skin or the white of your eyes ( jaundice ), itching all over , feeling sick , being sick . liver disease ( hepatitis ). you will need regular blood tests while you are taking rilluzolе zentivea . this is to check that you do not have cough , as difficulties in breathing , coughing up blood . these may be signs of liver disease . if these side effects are not
what riluzole zentiva contains - the active substance is rilluzola . - other ingredients are : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrus colloidal silica , magnesium stearate , croscarmellose sodium , all in the tablet core ; hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what ricuzolle zentivea looks like and contents of the pack the tablets are white to off - white , round and marked " 50 " on one side and " nvr " on the other side . the tablet can be divided into equal doses . each tablet contains a total of 202 mg of rilsuzol zenta ; and each pack contains 28 , 56 
emgality contains the active substance galcanezumab , a medicine that works by blocking the activity of the cgrp gene , which is involved in migraine and associated with increased levels of cggrp . egality is used to treat migraine in adults who have at least 4 migraines per month . using empgality can reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks this applies to you , do not give memgally and tell your doctor . warnings and precautions talk to your doctor before using egality and before using it : if : you have a serious cardiovascular disease . your doctor will decide if this medicine is suitable for you . you have ever had serious cardiovascular diseases . if any of these apply to you ( or you are not sure ), talk to you doctor or pharmacist before using this medicine . allergic reactions e mgality can cause serious allergic reactions and some of these reactions can be life - threatening . some people will be more than 40 years of age . it is important to identify signs of a seriously allergic reaction if such signs
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg . you should inject emmgality under your skin ( subcutaneous injection ) once a day . injecting empgality yourself your doctor may decide that you can inject a higher dose if your doctor told you to . after proper training , you may inject 240 micrograms of gmgal at home . if the doctor decides that you should use more ehgality than you should , tell your doctor immediately . do not inject , or give yourself the wrong dose , unless your doctor tells you to do so . contact your doctor if this applies to you , and you are disqualified to receive your emegality injection . however
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may occur very rarely , if not treated , including rash and itching . these are serious allergic reactions which may affect more than 1 in 1 , 000 people . signs include : - difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat - severe itching of the skin , with a red rash or raised bumps . other side effects include , but are not limited to : very common side effects ( may affect up to 1 in 10 people ) injection site reactions ( may effect more than1 in 10 users ): swollen lymph nodes ( may cause difficulty breathing and / or swallow
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product should be used immediately . however , if the solution is not used immediately it can be stored for up to 7 days at room temperature ( 20 - 30 ). store in the original package in order to protect from light . once opened , do not put the medicine back in the refrigerator . write the date of first opening in the space provided on the outer carton and on the label . this medicine does not require any special storage conditions . you must throw away the medicine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanaezumatab in 1 ml solution . - other ingredients are l - histidine , l- histoidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what  emogality looks like and contents of the pack egality is a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . only one side of the sYringe can be filled . single - dose pen with 1 , 2 or 3 needles per carton . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hev - vasculitis ), in which the blood vessels in the liver become damaged and blocked by blood clots . defitеliou is used in adults , adolescents and children who have not had a stem cell transplantation . by attaching to defibrotoide , it helps the blood vessel to relax and the blood coagulation can be prevented . this medicine is for adult patients who have had hepatic ven oclusive Disease .
do not use defitelio : - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) - in combination with other medicines to prevent blood clots ( such as tissue plasminogen activator warnings and precautions : talk to your doctor or nurse before using medicine to prevent bleeding if : you have heavy bleeding and you need a blood transfusion after surgery you have problems with blood circulation you have a constant blood pressure below 1 you are taking other medicines ( including medicines to reduce blood coagulation ): acetylsalicylic acid , heparins , warfarin , dabigatran , and rivaroxaban , or apixaban you are not sure if any of these apply to you , talk to you doctor or pharmacist before using
before starting the treatment with defitelio , your doctor will decide how many stem cells transplantation you need . it will be given to you by a doctor or a nurse . this will be done by putting the stem cells into your veins through an ' intravenous infusion ' ( drip ). this treatment will take about 21 minutes . if you do not respond adequately to the treatment , you will be told to wait 18 minutes before you are given defit li0 . your doctor or nurse will decide if and when you should receive it . the recommended dose is one vial per day . for children and adolescents ( under 18 years of age ) defitlia can be given for anyone from one to two vials . how to give defitelfeloo your doctor , nurse or pharmacist will give you instructions on how to prepare and give this
like all medicines , defitelio can cause side effects , although not everybody gets them . defitеliou can cause some side effects although not everyone gets them very common side effects these side effects may occur with defitalione , and you should contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in10 people ), bleeding in general bleeding including the nose bleeding , the brain bleeding e . g ., the gut vomiting , blood bleeding from the lungs bleeding ; blood in the urine ; in the mouth bleeding and the skin coagulopathy ( disturbance of blood clotting ). if you notice any of these , talk to your doctor .
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitlelia should be used immediately after dilution . discard if the solution is cloudy or if it has floating particles . this medicine is for single use only . dispose of any unused solution appropriately .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 micrograms of defibrotoide ; each mL solution contains 80 microgram ( 0 . 7 mg ) of defrotide at the reference date . - next to the vial the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ) and water for injections . see section 2 " defitalia contains sodium ". what deFITelliou looks like and contents of the pack defittelo is a clear , colourless solution , supplied in glass vials as a concentrate for solution for infusion . one pack contains 10 vial ( 2 mla ) or 2 , 5 
daklinza contains the active ingredient daclatasvir which is used to treat hepatitis c , which is an infectious disease that affects the liver , caused by the hepatis b virus . this medicine works by stopping the hpatiti c virus from multiplying in the body . it stops the virus from spreading in your blood . daklingnza is used with other medicines to treat histis
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) - take the tablets by mouth . - do not combine daklines with any of these medicines - the following medicines are available : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( for epileptic seizures )- rifampicin / riffabutin ; rfapentine ( antibiotics used to treat tuberculosis ) -- dexamethasone ( a steroid used to prevent and inflammatory diseases ) medicines containing st . jennavir ( for treatment of allergic and / or pulmonary arterial hypertension ) this medicine is not approved
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of daklinza is 60 mg once a day . this medicine has a very unpleasant taste . daklinez can be taken with some other medicines in addition to daklines . your doctor may prescribe daklince alone or together with some of these medicines . how to increase your daily dose of dodklinzan depends on your response to the treatment . do not change the dose unless your doctor tells you to . you should take dakliinza with other medicines for hepatitis c infection . if your doctor has told me that you may need to take these medicines before starting the treatment with daklinacnac , you should contact your doctor for advice . when to start taking daklinounza you should continue to
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken with sofosbuvir and ribavirin , the following side effects may occur : very common : may affect more than 1 in 10 people headache fatigue common ; may affect up to 1 in every 10 people difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when da Klinza has been taken with both sofasbuvar and / or rib avirine . these side effects are usually mild to moderate and go away within a few days . very common ( may affectmore than 1in every 10 persons ) difficulty sleeping daklines may be associated with headache headache fatigue ( feeling tired ) common , may affect less than 1 per 10 people , but can be associated 
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg of daclatarasVir ( as dihydrochloride ). - other ingredients are : - tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate - film coating : the coating consists of hypromellose , titanium dioxide e171 , macrogol 400 , indigo carmine aluminium lake , yellow iron oxide ( e172 ) 51 what daclinnza looks like and contents of the pack daklines 30 mg film  light yellow film . the film ' s edge is stamped with " bms 60 " debossed on one side and " gx 30
proquad is a vaccine used to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses from coming into the body . when a person is given the vaccine , the immune system ( the body' s natural defences ) will make antibodies against the meases , lesions caused by mops , Rubella and varicellella viruses . the antibodies work by causing diseases caused by these viruses , which are then destroyed by the body in the urine . proquade is used to protect against meales / mums caused by rubella / chickenposse ( varicela ). the vaccine can be given up to 12 months after the last dose . it is recommended that individuals 9 years of age and older receive national vaccination .
do not use proquad if you are allergic to any varicella vaccine , if your child is being treated for measles , mucus , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or neomycin if the child has a blood disorder or type of cancer that affects the immune system . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade if : your child has been previously treated with medications that weaken the immune response ( such as low - dose corticosteroid therapy ) for asthma ( replacement therapy ). your child ' s doctor will consider whether the child possesses a weakened immune system due to a disease ( including aids ), congenital or hereditary immunodeficiency ( hds ) and / or reduced immune
the vaccine will be given to you or your child by a doctor or nurse . it will be injected into a muscle ( subcutaneously ) by your doctor or other health care professional . the recommended dose is one injection per week . this dose does not need to be extensive and may be given in the upper thigh or upper arm . if you or someone else is giving you injections , they will inject proquad into the muscle of your chosen thong ( tummy ) or upper arms . your doctor will decide the right dose for you based on your clinical history and body surface area . make sure that the chosen injection site is chosen as soon as possible . patients with a blood clotting disorder or low levels of platelets will receive the vaccine by injection under the skin . to reduce bleeding , the vaccine should not be given into twang ( hives ) of
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur very rarely . these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , stop injecting and talk to your doctor immediately . other side effects that have been observed with proquad ( seen in 1 to 100 patients ) are seizures ( fits ) and a fever ( seen rarely , seen rarely ( may affect up to 1 in 1 , 000 patients ). bronchiolitis ( difficulty breathing , cough ) may also occur . tell your doctor straight away if your child experiences unsteadiness with walking . side effects of proquade may include : common ( may effect up to1 in 10 people ) injection site complaints ( including fits , vomiting , diarrhoea , nausea ,
what proquad contains the active substances are : measles virus1 , edmonston strain ( pdmv ) 3 . 00 strain *: mumps virus1 ( eduardol , jeryl lynn TM , level b ) strain ( wild type ) 4 . 30 micrograms **: rubella virus2 , strain ( unknown strain ) 33 . 08 microgram : varicella virus3 , and merck strain ( non - wild type 3 .99 microgram *: tissue culture , plaque - forming units 1 ( mrc ) produced by the cells of chick embryoocytes ( fibroblasts ) and mvc . the other ingredients are , powder sucrose , hydrolysed gelatin , starch , water , prege
jylamvo is an anticancer medicine that reduces unwanted reactions . it is used as an immunosuppressive agent with an anti - inflammatory effect jyinglamva is used to treat a wide range of rheumatic and skin diseases : o in adults with active rhumatoid arthritis and polyarthritic forms ( joints ) o severe juvenile idiopathic arthritis ( jia ) in children and adolescents aged 3 years and older o used non - gestational anti  - in - initiating drugs ( nsaids ) when inadequate o severely o disabling psoriasis or if treatment is insufficient o phototherapy with poralen and ultraviolet a radiation ( puva ) therapy .
do not take jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) - have a severe kidney impairment - suffer from a liver impairment if any of these apply to you , tell your doctor before taking jYlamva . - are suffering from blood disorders ( such as bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 - you have weakened immune system - or have ever suffered from  a serious infection such as tuberculosis or hiv - your doctor may want to monitor you more closely - has ulcers in the stomach or intestines - had an inflammation of the mucous membrane of the mouth ( such a condition referred to as mouth ulcers 
jylamvo is for oral use only . you should not be given this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . jpharm can cause severe side effects or even death . depending on the severity of the treatment , your doctor may decide to reduce the dose . for rheumatoid arthritis , severe juvenile idiopathic arthritis ; severe psoriasis ; and severe soriatic arthritis : jh is used as a long - term treatment . your doctor will prescribe jjylamvo for the treatment of rhumatic and skin diseases ( jia ), including psesoriases and pshiatic arthritis in adults . using jlamva the medicine for adult
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). other possible side effects are : breathing problems , feeling of illness , dry , irritating cough , shortness of breath , or difficulty in breath resulting in chest pain ( fever ), spitting or coughing blood or serious peeling , blistering or itches . this may be a sign of serious allergic reactions . it is important to tell your doctors if any of the following side effects occur : very common ( may affect more than 1 in 10 people ): diarrhoea , nausea , vomiting , abdominal pain , pain in the abdomen , chest pain
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the vial in the original package in order to protect from light . accidental spillage of the medicine is recommended . however , in case of safety , it is recommended to dispose of it after 3 months . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotréxate ( as besilate ). - - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epithyl parahydroxybenzoate ( e218 ), sodium methyl parahydroxybenzoate ( ( е218i ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamvre contains ethyle parahydroxy benzoate and sodium benzoates ". what if jpr contains jhr contains sodium - methyla parahydroxybate ( or sodium m - parahydroxyoate ") what iu looks like and contents
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enturev braezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . when used with this medicine , it blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary tract . if you use this medicine once a day , you will be monitored more closely to the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using enUREv BREezhalER if any of these apply to you : - you have kidney problems - have an eye problem called narrow - angle glaucoma - are having difficulty passing urine . during treatment with enurév brewinger , stop using this medicine and seek medical help immediately if : you experience tightness of the chest , coughing , wheezing or breathlessness immediately after using enturev brezhalers as you may experience bronchospasm . difficulties in breathing or swallowing . swelling of the tongue , lips or face , skin problems 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhaled once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medication if your doctor has told that you can inhaling this medicine at any time of the day , with or without food . this is because of the way the medicine works as it should be inhaulated into the airways as well as as inhalation powder . the capsules should remain in the blister until you need to use them . only use the inhaler provided in this pack ( enurév bri
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia , with typical symptoms such as excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( signs suggestive of angioedema ). if any of the side effects gets serious , or if you notice any of these effects eat or drink something containing sugar . if they happen to you , call your doctor immediately . other side effects include : some side effect may be more common ( may effect more than 1 in 10 people ), including nausea 
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopyrnoium bromidie , equivalent to 50 microgram ( 0 . 5 microgram ) glycopyronicum . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopyrrionum - one microgram per capsule . - other ingredients of the delivering dose ( e - c ) are lactose monohydrate and magnesium stearate . what  Enurev brezhalers looks like and contents of the pack enuresv brueezhale 44 microgramm inhalation powder , hard capsules consist of a white powder in separate blisters , each individually sealed blister strip containing either 6 or 10 capsules 
what riximyo is rximyou contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when rtuximamab sticks to its surface , the cell dies . what if ritchimy0 is given to you , your doctor may decide to stop the treatment with rifimyO for : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes , which are involved in the production of proteins . risimyon is given in combination
do not take riximyo if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor , pharmacist or nurse before taking rximya : if your doctor thinks you may have a severe active infection at the moment . if the doctor think you may be at risk of developing a weak immune system . in particular , if : you have severe heart failure or severe uncontrolled heart disease ( e .g ., granulomatosis with polyangiitis , microscopic polyangibiitis or pemphigus vulgaris ). do not have riskimyyo
riximyo will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given rximya as a drip ( intra - venous infusion ). medicines given before each ritchimyou administration before you are given a dose of richimyon , you will be provided with other medicines ( premedication ) to prevent or reduce possible side effects and reduce the chance of your treatment - for non - hodgkin ' s lymphoma if you are treated with riimyyo alone riskimyu will be administered to you once a week for 4 weeks . repeated treatment courses with a combined experience with ph -
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , pain in the joints , back pain and increased blood pressure . common side effects ( may affect up to 1 in 10 people ): dizziness . uncommonly , children and adolescents side effects may be mild to medium . however , very rarely . 
what riximyo contains the active ingredient in rximya is called rituximab . the 10 ml vial contains 100 mg of ritzimabe ( 10 mg / mL ). the 50 mml ampoule contains 500 mg of of reituximib ( 10  mg ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , hydroxide and hydrochloric acid . see section 2 " risimyou contains sodium ". what if risseimyu looks like and contents of the pack ritchimyon is a clear to slightly opalescent and colourless to slightly yellowish solution , supplied as a concentrate for solution for infusion . richimye is available in packs containing 2
topotecan actavis contains the active substance topotenecan . topotent actavisent is used to treat small cell lung cancer that has come back after chemotherapy . it is used in adults for the treatment of advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotеcan actAVIs treatment is combined with medicines containing cisplatin .
do not take topotecan actavis : - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotеcan activis . some patients taking to potecan actingavis have reported that their blood cell counts are too low . your doctor will decide if topotercan actAVIs is right for you . - have any kidney problems . talk to you doctor before taking a dose of topotécan actvis if : you have severe kidney impairment . you have liver problems , as topotacan actas may not be suitable for you in patients with severe liver impairment ; you have lung inflammation with signs such as cough , fever and difficulties in breathing . ( see section 4 " possible side effects "). if any of
topotecan actavis will be prescribed to you by a doctor with experience in treating the disease . your doctor will do blood tests before you start treatment and regularly during treatment . adults small cell lung cancer the usual dose is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer the normal dose is 0 . 75 mg per sq . m2 of body area once every 3 weeks , for the rest of this treatment period . for cervical cancer , it will be used together with another anticancer medicines called cisplatin . you will be given cistplatin once every three months . it is given to patients with impaired kidney function . depending on your kidney function the dose may be adjusted by your doctor . when topotencan activis is given , your doctor may decide
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side events . they may include : - infections ( very common , may affect more than 1 in 10 people ), - fever , - general condition , local symptoms such as sore throat or burning sensation when urinating , severe stomach pain , fever ; - diarrhoea ; and bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . - lung inflammation ( rare , might affect up to 1 in 1 , 000 people ). - difficulty in breathing . this may lead to a decrease in your ability of the heart to fight infection . common side effects ( may affect upto 1 in10 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . keep the vially in the outer carton in order to protect from light . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution and dilution chemical and physical stability of topotecan actavis has been demonstrated for 24 hours at 25  2 , and for 24  8 , from a microbiological point of view , the drug product solution should be used immediately after reconstitute and diluted . for dlution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been observed for 4 hours at room temperature , in syringes of 12
what topotecan actavis contains - the active substance is topot . each vial contains 1 mg or 4 mg topot ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of topoten . - other ingredients are mannitol ( e421 ), tartaric acid ( é334 ), hydrochromic acid ( to be repeated ) and sodium hydroxide . what to potecan actsavis looks like and contents of the pack topotécan activis is supplied in a clear glass vial with grey bromobutylic stopper and aluminium seals with plastic flip - off caps . it is packaged in  a protective sleeve . the pack sizes are : 1 vial of 1 x 5 mL or 1 vially of 1 viall of 1
the active substance of rivastigmine hexal is rivassetigmine which belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivagestigmin works by blocking the enzymes that break down aceticoline : acetapylcholcholinesterrase and butyrylcholineSterase . by blocking these enzymes , it allows rivatastigemine to increase the levels of acetalcholine in the cerebral , helping to reduce the symptoms of parkinsons ' disease .
do not take rivastigmine hexal - if you are allergic to rivassetigmine ( the active substance in rivаstigmin heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - in case you had a previous skin reaction suggestive of allergic contact dermatitis with rivagetigmine. if this applies to you , tell your doctor and do not give rivammine HExal. warnings and precautions talk to your doctor before taking rivrasimine hxal and if any of these apply to you and tell your dentist before taking the medicine . take special care with rastigemine henxal tell your pharmacist if : you have , or have ever had irregular or slow heartbeat . you have or have had an active stomach ulcer . You have /
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day .your doctor will regularly check if the medicine is working for you , and will also monitor your weight whilst you are taking this medicine . do not take rivstigmin heexal for more than three days . take the next dose at the usual time . this will depend on how well the medicine works for you and how well it works for your condition . taking this medication tell your doctor or pharmacist if any of the above apply to
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in every 10 people) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling dizziness feeling weak tongue ulcers feeling weak or generally feeling weak tremording difficulty sleeping , depression , difficulty sleeping ( insomnia ) dizzience all the time feeling sick or being tired if you notice any of the side effect listed above , tell your
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 - the active substance is rivammine hydrogen tartrate . - other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide (  e171 ). - printing ink : shellac . each rivagemine hxal 1 . 5 mg capsule contains 1 , 5 mg of rivatum . Each rivagestigmine himxal 3 mg capsule delivers 3 mg of the active substances . the other ingredients in each raft are rivagastigmin . every rivagingmine hemal 4 . 4 mg capsule is 4 , 4  . 6 mg .
what cabometyx is cabrometyxx is a cancer medicine that contains the active substance cabozantinib used to treat adults with kidney cancer ( renal cell carcinoma ) or with liver cancer that has come back after having been previously treated with a specific anticancer medicine ( sorafenib ). how cabmetyyx works cabombometchyx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells , and by blocking their action cabimetyc is thought to work by slowing down their activity .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabrometyX : if any of these apply to you : high blood pressure . if there is still some blood left in the body . there is a possibility that you may have an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a wall of the blood vessel walls . tell your doctor or pharmacist if this applies to you and tell them if it does not work well enough . diarrhoea . recent history of significant bleeding from surgery within the last month . surgical procedures including dental surgery . talk to you doctor if your child
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . taking this medicine - take care not to miss a dose . - interrupting your treatment may cause serious side effects . your doctor will monitor you and will adjust your dose , if necessary . during treatment with cabometyx , you may be given the lowest possible daily dose of 60 mg of cabrometyX for 2 weeks . you will then be given cabmetyc for approximately 1 hour before bedtime . the medicine is for oral use . swallow the tablet whole with a glass of water . do not open or crush the tablet . how long to take cabômetyyx keep taking cabotyck for as long as your disease improves . it is recommended that you take a cabombometych
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects caused by cabometyx are usually mild to moderate . your doctor may prescribe other medicines to help control your side effects more closely . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever - these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ) which may cause severe or uncontrollable bleeding ( symptoms include vomiting blood , black tablets , red or purple stools ), or stomach pain - this may be a sign of stomach pain or discomfort - those may be due to a stomach ulcer - the signs may include reddening of the skin or the whites of
what cabometyx contains - the active substance is cabozantinib ( s ) malate . cabmetyze 20 mg film - coated tablets each tablet contains cabazantineb ( (  ) ( as malate 20 mg / ml ) cabcabozzantininid . the other ingredients are : cabrometyux 40 mg film ( mpa . mu . abbreviations ): - cabizantib( s) ( pfizer )- malate 40 mg cab cabojiantinimb - 40 mg movie ( t ) on one side cabetyc / 60 mg film [ mp4 . 5 mg ] cabbozanteinia (  s ( 
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreXed horace is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy .  pemetreexed hourac is also given in combined treatment with  Cisp Latin for the initial treatment of patients with advanced stage of lung cancer : pemetrecexeded homapican can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetreixed is also a treatment for patients with certain types of lung carcinoma whose disease has progressed after other intra
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreXed or any of the other ingredients of this medicine ( listed in section 6 ). - in case you are breast - feeding ; you must discontinue breast  - feed during treatment with pemetreexed houpira as recommended . - have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or hospital pharmacist before receiving pemetreexed infusion . you should tell your doctor if : you have problems with your kidneys . before each infusion you will have samples of your blood taken to evaluate if your kidney and liver function are sufficient and to determine if we have enough blood cells to receive pemetrexia . your doctor may decide to temporarily stop treatment with cisplatin . Ihre doctor
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . this body surface area is used to workout the right dose for you . a hospital pharmacist , nurse or doctor will use this body area to work at its best . for treatment of patients with low blood cell counts , we have mixed the pemetreXed
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your dose of pemetrexed hospira is higher than normal ( common in patients with a temperature of 38oc or greater ) sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if it is not treated , it may be continued for a long time . chest pain ( common with  a fast heart rate ) if the patient has pain , redness , swelling or sores in your mouth ( very common in people with allergic reaction ); skin rash ( common at the injection site ) ( common on the market
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dna technology has been demonstrated for 24 hours at refrigerated temperature . the reconstructed solution should be administered immediately after reconstitution . parenteral medicines should not be used if there is discolouration or if particulate matter is present . prior to administration , the product must not be administered . these measures will help protect the environment . your healthcare professional will be responsible for the correct disposal of this medicine . any unused solution should not go into waste water or household waste . ask your pharmacist how to
what pemetrexed hospira contains the active substance is pemetrexxed ( as pemetreXed disodium hemipentahydrate ). pemetreexed houpira 100 mg : each vial contains 100 milligrams of pemetreixed( as pemeterxeed désodium hydropentainshydrate ) each millilitre of pemeterixeeded horaxedu hospria 500 mg / ml each vially contains 500 milligramms of pfizer ( as phresentains ). - pemetreexed hospiracrate 1 , 000 mg ; each viall contains 1  , 800 milliliters of Pemetrexd (as pemetreuxed disodium dipentatorhydrate ), after reconstitution , the solution contains
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimataprostine belongs to a group of medicines called prostamides . it works by blocking the effect of a prostaglandin analogue , titmolole . both belong to  a class of medicines known as beta - blockers which also act in the same way as your eye : it is a clear , watery liquid that quickly pours into the eye and slowly drains away . this lowers the pressure in your eye and helps to prevent glaucoma . ganfordt eye drops are used to reduce high pressure in one eye which may increase the risk of glaupa , and to help prevent it from happening . your doctor has prescribed ganforcet for you 
do not use ganfort eye drops - the solution should be clear and colourless . - do not apply ganfordt eye drop - if you are allergic to bimatoprost , timolol , or other beta - blockers , and do not take ganFort for at least 6 weeks . warnings and precautions talk to your doctor before using this medicine : - for coronary heart disease ( symptoms include chest pain , wheeziness , difficulty in breathing , long - standing cough ) - tolerability of ganforcet in patients with heart problems ( such as low heart rate , heart block , risk of heart failure warnings ) and precautionary measures you should take this medicine exactly as your doctor has told you . your doctor should record the brand name and batch number of the product . this information is intended
ganfort should only be used on the eye . treatment should be started and supervised by a doctor who is trained in using the bottle . the recommended dose is one bottle in the neck , once a day . use in children and adolescents 5 . how to use ganforcer 1 . wash your hands . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid , because there is a small pocket inside the bottle at the back . 3 . hold the bottle for a short time . if this happens , it will not be used until your eye is ready for treatment . 4 . close the lid , and close the eye 5 , gently pull down the bottle into the eye by the finger . bring the corner closer than the eye and close with the nose .
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , but most side effects disappear when you start taking gan fort ( multi - dose or single - dosing ). very common side effects ( may affect more than 1 in 10 people ) are : - reduction in the eye redness . common side effect ( may effect up to 1 in 9 people ), - increased incidence of the eye burning , itching , and stinging , or irritation of the conjunctiva ( part of the lens of the eyes ), eye sensitivity to light , eye pain , sticky eyes , dry eyes ; - feeling of something in the eyes after small break in the vision . - blurred vision , double vision ; increased sensitivity of the cornea ( the clear layer at the back
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you notice that the solution is not clear or contains particles , wait at least 4 hours before using ganFort . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg of timolol . one bottle contains 5 mg of of thimololl maleate equivalent to 6 . 8 mg / mL . - in the other ingredients are benzalkonium chloride ( as a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . these are extracted from purified water , hydrochloric acid and sodium hydroxide . what g ganforce looks like and contents of the pack ganford is a clear , colourless to slightly yellow eye drop solution in a plastic bottle . every pack contains 1 or 3 bottles with a screw - cap . the bottles are available in packs of 3
gefitinib mylan contains the active substance gefitib , which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefitineib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefiteinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefitINib Mylan : if your doctor has told you that you have any other lung problems . some lung problems may get worse during treatment with gefitineib . if this applies to you , tell your doctor . there is little information on the effects of gefitib on the ability to breathe is limited . do not give this medicine to children and adolescents under 18 years of age . other medicines and gefithinib melan tell your dentist or pharmacist if any of these apply to you ( or you are not sure ), ask your doctor for advice . children and teenagers this medicine is not for use in children and in adolescents . tell your pharmacist
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a glass of water . you can take gefitinib mylan with or without food . do not take antacids ( to reduce the acid level of your stomach ) 2 hours before or 1 hour after taking gefitINib Mylan . if your doctor has told me that you have trouble swallowing the tablet , dissolve the tablet ( dissolve ) in half a bottle . use in children and adolescents this medicine can be used in adolescents and children aged less than 20 years . take the tablet at the same time each day , with or shortly after food , and with some water , or with any other liquids . crush the tablet before it is taken
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic reaction ( with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives / nettle rash , and difficulty breathing ). serious breathlessness ( with or without a cough or fever ): you may have an inflammation of the lungs called ' interstitial lung disease '. this condition is uncommon ( may affect up to 1 in 100 people ) when gefitinib mylan is taken at the same time as other medicines . severe skin reactions ( local reactions are localised or localised to the body ). these include reddening , itching , swelling and pain . these may be signs
what gefitinib mylan contains the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitib ( as besilate ). the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide (  e171 ), red iron oxide ( electron ), and yellow iron oxide , ( i ) ( if you know what geFITinia mylan looks like and contents of the pack gefitINib melan tablets are pink , capsule shaped , biconvex film  11
reblozyl contains the active substance luspatercept and it is used to treat adults with myelodysplastic syndromes . myelaodysplastic syndromes ( mds ) are a common complication of many different blood and bone marrow disorders in which red blood cells become abnormal . this can lead to signs and symptoms such as a low red blood cell count ( anaemia ) and decrease the need for red blood blood cell transfusions : re Blozyl is used in adults to treat anaemic adults with mDs and requiring red blood cancer transfusionations , when other treatments have not worked or are not suitable , or when other therapies have not proven effective . beta - thalassaemia ( bs ). thlalassaimi is a blood problem that is passed down through genes into the
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) - whether you are pregnant or planning to become pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine -- - in case you have thalassaemia - with your spleen removed - had a blood clot ( hormone replacement therapy ) or have had - an old blood thigh . your doctor will discuss preventive measures ( see other medicines and reglazyl "). - when you have high blood pressure . you should not take the tablets if any of these apply to you . reblizyl may increase the risk of your blood pressure and may increase your risk of complications . it is important that you
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests before you start using reblozyl and will then test your response to it and adjust the dose if necessary . rebzyl is given as an injection under the skin . it is injected if your doctor knows how much you weigh . the injections are usually given at least 1 . 1 ml per kilogram of body weight . this dose may be adjusted by your doctor depending on your blood pressure . when using a reblockzyl injection , you should be aware that the dose of rebrozyl in patients with myelodysplastic syndromes . for adults and adolescents the maximum single dose is 1 , 75 mg per kilogram ( kg ) per kilogram body weight once every two weeks . in patients suffering from beta 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects which may be serious : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , which may affect any part of the body . blurred vision which may represent symptoms of a stroke caused by blood clots swelling of the area around the eyes , face ; lips , mouth , tongue or throat allergic reactions such as rashes and skin rash all over the body and can be signs of bruising and bleeding all over your body if any of these occur , tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ): diarrhoea feeling sick ( nausea ) vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after reconstitution , reblozyl is stable for 8 hours at 25 and for 24 hours at 2  8 . this medicine does not require any special temperature storage conditions . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . one vial contains 25 mg or 75 mg of luspatiercept ( as monohydrate ). after reconstitution , each ml of solution contains 50 mg of of lucpaterception . the other ingredients ( excipients ) are citric acid monohydrate ( e330 ), sodium citrate ( EEA ), 80 %, sucrose , hydrochloric acid ( EDTA ) ( for ph adjustment ) and sodium hydroxide ( for pah adjustment ( i . e ., water for injections ). what retinopathy looks like and contents of the pack reblizyl is a white to off - white powder . it is supplied in glass vials . each pack of rebozyl consists of 25 mg
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the growth and spread of cancer cells . this helps to build new blood vessels . fotiva is used in adults with advanced kidney cancer who have not responded to other treatments , such as alpha or interleukin - 2 , to help stop your disease .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking the tablets . if your doctor has prescribed st . jen ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotivaa . high blood pressure . fotiv daa can raise your blood pressure and your doctor will monitor your bloodpressure if necessary . your doctor may prescribe a medicine to lower your dose of fotivdea , to help control your blood blood pressure more effectively . it is important that you tell your healthcare provider if any of these applies to your situation . when taking a medicines like fotivdas
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of fotivda is 1340 mg ( 1 capsule ) per day for the first 21 days ( 7 days ). take 1 capsule ( 1 tablet ) once a day with food , and capsules ( 4 tablets ) in the morning . take fotiva at the same time every day , preferably in the evening . you may take fotiveda with or without food . if this happens , your doctor may reduce the dose to lessen the risk of unacceptable side effects . severe side effects can occur during fotivde therapy . your doctor will decide how much fotivdra should be given . in total , the recommended daily dose of ftivdda 890 mg capsules 21 mg capsule ( 7 capsules 
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 2 in 10 people ). tell your doctor immediately if you have high bloodpressure that does not go away . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor will tell you what to do if your blood pressure does not improve after taking fotivda . high blood Pressure can be serious if treatment with a medicine to treat your high blood sugar , you should stop taking fotiveda and see a doctor as soon as possible if it gets worse . if this happens , your doctor may decide to reduce your dose of fotivaa , or stop taking it . it is important that
what fotivda contains each hard capsule contains 890 mg of tivozanib . each capsule contains tivolinib hydrochloride monohydrate equivalent to 890 milligrams of tigozaninib ( as mesilate ). the other ingredients are mannitol and magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( E132 ), yellow iron oxide ( EE172 ), propylene glycol , strong ammonia solution , partial hydrolysed ( mainly ethanol ) ( essentially ' ethanol free '), titanium dioxide , and tartrazine aluminium lake ( containing shellac , propyl glycol and strong ammona solution indiggo carmine aluminium Lake ). each fotiva carton contains 1340 capsules of 15 
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisegravar emtricitabine , which is an antiviral medication known as a nucleoside reverse transcriptaser inhibitor ( nrti ) and tenofovir disoproxil , another type of an antiraural medicine known als a nuclear transcriptases inhibitor ( nucleonyltransferasasE inhibitor ( cobti)). stricbild is provided as  a single tablet regimen for the treatment of human immunodeficiency virus ( hiv ) infection . sTRIbild is not a cure for hiv infection 
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir ( or tafda ) or acetylurea or naloxegol . warnings and precautions talk to your doctor , pharmacist or nurse before taking sTRIbild . your doctor will check whether you are taking tenovir disoproxil and will tell you whether you need to take this medicine for at least 6 months before starting treatment . tell your doctor immediately if : you are currently taking any medicine containing ten ofovir désoproxils . stricbild may affect your kidney function . these medicines may affect the way s tribild works . you may need to stop taking alfuzosin ( used to treat an enlarged prostate
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents 12 to less than 18 years of age : the recommended dose is 35 mg taken by mouth once daily . your doctor will tell you how many tablets of stribild to take each day . you should swallow the tablets whole , with some water . do not crush , dissolve , or chew the tablet . take stricbild with food or between meals . this will help you to remember to take your medicine . depending on how you respond to the treatment , your doctor may suggest that you take medicines called " oral supplements " ( such as antacids , laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) for at least 4 weeks . see " other medicines and 
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hib disease itself . however , some of them can be serious side effects which need medical attention immediately . lactic acidosis ( excess lactic acids in the blood ) is a rare but serious side effect that can occur with some hiv medications . in some patients , lactic Acidosity may occur more often in those who are overweight , or those with liver disease . the risk
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine , and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisitegravar , 150 mg cobicistentat ; 200 mg emetricitatabine and 245 mg tenovir désoproxils , 300 mg / ml of tenochromel fumarate , or 136 mg /10fovir . the other ingredients are croscarmellose sodium , the hydroxypropyl cellulose , lactose monohydrate , magnesium stearate and water for injections . what atribild looks like and contents of the pack the snr - strebild
zyprexa contains the active substance olanzapine . zypräxa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria . the use of zypréxa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olazine treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a new face , or swollen lips or shortness of breath . if this has happened to you , tell your doctor . tell your dentist if any of these applies to you as well . you should have been told that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zy prexa talk to you doctor or nurse before taking the medicine if : you are being treated for dementia . it is possible that serious side effects could occur when medicines like these are used at the same time . movements usually
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zypruxa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypräxa unless your doctor tells you to . you should take your zypréxa tables once a day following the advice of your doctor and follow the instructions for taking your tablets . zy prexa coated tablets are for oral use . swallow the zypresa tablets whole with water . it does not matter whether you take them with or without food . how to take the zprexа tablets you should follow the advice given . patients who have taken more zypa than they should have
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , seek medical advice immediately ; a fall in the number of the eye drops is a sign of low blood pressure . it is important that you take this medicine exactly as your doctor has told you . you should not take more than the recommended dose of zyprexa . your doctor should tell you how
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be used immediately after dilution . store in the original package in order to protect from moisture . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypresa tablet contains either 2 . 5 mg , 5 mg or 7 . 50 mg . the tablets are packed in blisters . they are available in strengths of 10 mg / 20 mg : per carton . what your zypréxa tablet pack contains - the other ingredients are lactose monohydrate , hyprolose , microcrystalline cellulose , magnesium stearate , and hypromellose / titanium dioxide ( e171 ), and carnauba wax . - what yprexа looks like and contents of the different zy prexa tablets strengths are white to off - white , capsule shaped , with " ol 2  . 2 ,5 ", " 5 ", 7 , 7
what prolia is prolium contains denosumab , a protein ( monoclonal antibody ) that works by attaching to another protein that is known to cause bone loss , which is a common symptom of osteoporosis . treatment with prolis helps to make the bone stronger . it reduces the amount of bone that produces oestrogen , another protein which is important for bones to work properly . when the menopause comes on , the oesterogen level drops and bones become thin and fragile , this can lead to osteoponisis : osteopororosity is caused by high levels of testosterone and glucocorticoids . there are no signs of osteoponisis when these two active substances are used together . some patients have had symptoms of osteoloporosisk ( see ' signs and symptoms of a
do not use prolia - if you have low calcium levels in the blood ( hypocalcaemia ). - are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolium . talk to you doctor if any of these apply to you . if your doctor has told you that you have a skin infection . symptoms include a swollen , red area of skin usually in your leg that feels hot or tender . this could be a sign of cellulitis . it could be one of these symptoms . there is also a risk that you may have an allergy to latex . the needle cover on the pre - filled syringe contains a derivative of latex which is thought to have some calcium . you should contact
one pre - filled syringe ( 0 . 5 ml ) contains 60 mg . each dose is given 6 times a week . it is given as a single injection under the skin ( subcutaneous ) in the upper thighs , abdomen or upper arm . prolia is available in packs containing stickers , calcium and vitamin d supplements . do not try to inject prolisa more than once a month . if you miss an injection of prolium if there is a gap in your treatment , talk to your doctor . don ' t try to miss a dose . giving prollial if a missed dose is too much , your doctor will tell you when to give the injection . only give injections up to 6 months after the last injection , whichever comes first . you will not be given
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( cellulitis ). tell your doctor immediately if you get any of these symptoms while being treated with prolium . your doctor may notice that you have a swollen , red area of skin , usually in your leg , that feels hot and tender . these could be symptoms of fever which may be more common in women taking prolisa . pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw / discharge , numbness or a feeling of heaviness or loosening of a tooth . this may be a sign of bone damage in the bone . as with all medicines used , prolaa may increase the risk of bone damages . tell your dentist immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be stored at temperatures up to a maximum of 25 for a single period of up to three months . once the injection has been stored at room temperature ( up to 25 ) it must either be used within 30 days or disposed of . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab ( 60 mg in the vial ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prollia looks like and contents of the pack prolium is a clear to slightly yellow solution for infusion , supplied in a pre - filled syringe with a needle guard . each pack contains one vial per carton .
ambirix is a vaccine used to protect infants from 1 month to 15 months to prevent two diseases : hepatitis a and hepatitis b . infection with the heptis as virus causes the liver to become swollen and inflamed by the virus . the virus can also cause an infected person to become infeated with the virus by causing faeces , serum or saliva . symptoms usually last for 3 to 6 weeks . tell your doctor if you think you have infection , or if they feel sick , have a fever , aches and pains and they will stop you from getting sick . ambirx is for adults and children .
do not use ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if your child has had an allergic response to any vaccine against hepatitis a or hepatis b diseases , tell your doctor . you have a severe infection with a high temperature ( over 38 ). if this applies to you then the vaccine may not fully protect all persons who are vaccinated . however , a minor infection such as a cold should not be a problem , but talk to your doctor first . do not have ambirique if any of these apply to you . warnings and precautions talk to you or your child before receiving ambirice if : you have had
your doctor or nurse will give you ambirix as an injection into a muscle , usually in the upper arm . ambirx is injected into  a vein . the injection will be given into the thigh muscle . you will receive a total of two injections . if you miss an injection you will be told by your doctor , pharmacist or nurse to arrange another visit . your doctor will decide when to give the injections and when you should continue to receive the injection . within 12 months of your first injection , the second injection should be given between 6 and 12 months after the first injection and you may receive extra doses due to future booster dosing . it is important that you follow the instructions from your doctor and pharmacist so that you can plan on having two injection - visits . please discuss this with your doctor as soon as possible . two injection(s ) may be given at different
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect - you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing ; a sudden drop in blood pressure and loss of consciousness . other side effects talk to your doctor if any of these side effects become serious , or if they happen suddenly . side effects reported during clinical trials with ambirix : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain where the injection was given nervousness . common ( MAY affect upto 1 in 100 people  ): diarrhoea feeling sick or
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 720 elisa units ( hepatis b surface antigen , expressed in 20 micrograms / ml ). the other ingredients are - human diploid ( mrc - 2 ) cells , and aluminium hydroxide , partially hydrolyzed ( hydrated ) 0 . 05 mg / milligrams ( in saccharomyces cerevisiae ) and aluminiumic phosphate 0. 4 millilitres ( 0c / 1 ) sodium chloride . the solvent is water for injections . what amberix looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirx is 
bexsero is a meningococcal group b vaccine . bexstero contains the active substances of the bacteria neisseria mentingitidis group c . you will receive bexsentiment 2 years and older , which is able to protect you against disease caused by the nyseria meingitididis group ba . these bacteria cause infections , including meningitis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping the body to make antibodies ( the body ' s natural defences ) that protect you or your child against the disease .
do not use bexsero if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given bexstero : if your child has a severe infection with a high temperature ( over 38 ). in this case , your child should not receive bexsono . a minor infection such as a cold should not be a problem . however , in such cases , vaccination may be necessary . tell your doctor or nurse if any of these apply to you . talk to you doctor or pharmacist before you receive bexxser0 if : your child already has haemophilia or any other problem that may stop your blood from clotting properly , such as the use of blood thinners ( anticoagulants ) or treatment that
bexsero will be given to you or your child by a doctor or nurse . it is given as 5 micrograms ( ml ) into a muscle , preferably in the thigh or upper arm . the recommended dose is two injections given at 2 to 5 weeks apart . you or the child will receive three injections of the vaccine . if you or or your children are given an additional injection ( booster ), they will receive the first injection 2 months after the first dose . however , the interval between injections will not be established until you or Ihre child has been fully vaccinated . this will be 1 month . your doctor or your caregiver will calculate the interval from which you or  your child should receive the dose , depending on the dose you or those children receive . after 12 months , you or someone else may receive 15 injections in a row .
like all vaccines , this vaccine can cause side effects , although not everybody gets them . bexsero will be given to you by a doctor or nurse . the following side effects may happen with this vaccine : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site ; redness of the skin at the proposed injection site and swelling of the flesh at the suggested injection site as well as hardness at or below the skin on the proposed application site . other possible side effects of this vaccine are listed below . very common : may affect up to 1 in10 people : fever / loss of appetite . common - may affect less than 1 person in 10 , including loss of taste . not known : cannot be estimated from the available data : blurred vision at the recommended injection site reporting of side effects when a person is given bexson
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein , 1 , 2 , 3 50 micrograms reconstituted n eisseries meningităids group a nada protein . 1 ml solution contains 2 mL of solution contains 50 microgramms of reconstructed nyisseriia meingitidedis - group c nadaprotein ,1 ,2 mlabelling to 50 microlitres . recominant nod nna mentingitididis group group d fhbp fusionprotein : 1 mpa . 2 mpl solution provides 3 mmol ( 0 . 5 %) solution for injection in outer membrane ves
nitisinone mdk contains the active substance niitisine . this medicine is used to treat a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children ( in any age range ). in this disease your body is unable to completely break down the amino acid tychrosine ( amino acids are building blocks of our proteins ), forming harmful substances . nitsinone stops the breakdown of tyesine , which in turn makes the harmful substances in your body . you must follow a special diet while you are taking this medicine , because tying tyerosine will be broken down and deposited in the body , in a very low level . in this case , nylalanine ( another amino acid in ) is added to this medicine as well .
do not take nitisinone mdk - if you are allergic to niitisine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking this medicine , and during pregnancy . natisinine mk should not be used in children . eyes : tell your doctor before starting ntisininone treatment if your eyes become damaged during nitsinone therapy . tell your doctors immediately for an eye examination if any of these apply to you . eye problems may be a sign of inadequate dietary control , see section 4 of this leaflet . before starting the treatment your doctor will take blood samples to check whether the treatment is having the desired effect . you may be at increased risk of side effects , including blood disorders , in patients whose liver is damaged
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg for every kg of body weight , given once a day . however , the maximum recommended dose for this patient population is 20 mg / kg . to calculate the correct dose for the type of bodyweight , take the capsules once daily . after swallowing the capsule with a small amount of water or formula diet will be prescribed by your doctor and will be monitored by your physician . you should swallow the capsule whole with : - one glass of water . if necessary , your doctor may adjust the dose depending on how you respond to nitisinone 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . if the medicine is to be used immediately , it can be stored at 2 to 8 for a temperature not above 25 .
what nitisinone mdk contains - the active substance is niitisine . - nitsinone one mk 2 mg capsules : each capsule contains 2 mg nitchitis inone .- nicotinone mak ntk 5 mg capsule : Each capsule contains 5 mg nicitisione - each capsule of natisinon mmdkte 10 mg capsule shell : every capsule contains 10 mg , made of nictisinine - these capsules are printed with " ncr " in black on the capsule shell and " ac glaze " in white on the cap . what ' nnitisse mck looks like and contents of the pack nităisinONE mpk capsules have a white body and cap with " 710
the name of this medicine is docetaxel accord . docetaxil accord is a substance derived from the needles of yew trees . doescetaxell belongs to the group of anti - cancer medicines called taxoids . - docetachaxel acord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer ; gastric cancer e . deuterocarcinoma , head and neck cancer : - for the diagnosis of advanced breast cancer the combination of docetacel accord, doxorubicin , trastuzumab , or capecitabine , has been administered for the prevention of early breast cancer and other forms of lymph node . it is also used for the management of lymphoma and other types of cancer . the combination
docetaxel accord must not be used : - if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetacel accord ( listed in section 6 ). - the number of white blood cells is too low . - you have a severe liver disease . warnings and precautions before each treatment with docetachaxel acord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetcetaxell accord . tell your doctor if : you have signs of whiteblood cells disturbances such as fever or infections . contact your doctor immediately if your doctor notices abdominal pain or tenderness , diarrhoea , rectal haemorrhage , blood in stool , fever , abdominal pain , or vomiting . you may also be given other medicines to maintain
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . depending on your blood tests , your general state and your response to docetaxel accord , you may experience diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results of your 63 blood tests results . such information will allow
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . as with other chemotherapy agents , the infusion of doceaxel acord may be delayed . allergic reactions are common ( may affect up to 1 in 10 people ): flushing , skin rash and hives . tell your doctor or nurse straight away if you notice any of these effects . nausea and vomiting may occur as well as sore spots in the skin , loss of appetite , confusion and disorientation . like all
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store and transport refrigerated ( 2 - 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . after dilution , use immediately . if not used immediately , the medicine may be stored in the infusion bag at room temperature ( up to 6 hours below 25 ). from a microbiological point of view , if the product is not used straight away , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 48 hours at 2 to 8 . once the inffusion solution has been prepared and diluted it should be used
what docetaxel accord concentrate for solution for infusion contains - the active substance is docetaxil . each ml of concentrate for solutions for infuse is 20 mg of docetachl - each 1 mL vial of concentrated concentrate contains 20 mg docettaxl , each 4 m mla of concentrate contains 80 mg docotaxel ; each 8 m vial contains 160 mg dotaxel as a single dose . - other ingredients are polysorbate 80 , ethanol anhydrous , see section 2 , " docetaxialel accord contains sodium ". what docetaxel acord looks like and contents of the pack docetal accord concentrator for solution to infusion is a clear pale yellow to brownish - yellow solution . it may contain trace amounts of doceaxel in each vial  . the concentrate is
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . people with adhd may become impulsive or hyperactive when they take this medicine . intunev is used for the treatment of ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately controlled with current stimulant medication . if current medication does not reduce adhd symptoms , the medicine should be discontinued . it should be combined with a treatment programme containing psychological therapy , educational therapy & social therapy . 38 intiniv has been shown to reduce the number of adhd in adults . adhd is not a cure for adhd ( see section 4 ).
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking this medicine if any of your medical conditions apply to you : low or high blood pressure . heart problems . talk to you doctor if your doctor thinks you may have heart problems or have ever fainted recently . tell your doctor : if this has happened to you or if  you have thoughts or feelings of suicide . do not use intunev in any other psychiatric conditions . withdrawal symptoms may occur as soon as possible after taking intuiv ( increased heart rate ). if high bloodpressure occurs , stop taking this medication and see a doctor straight away before taking in . this medicine can cause these problems , and in some cases even in patients
your treatment should be initiated under supervision of a doctor experienced in the treatment of perinatal and adolescent behavioural disorders . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your treatment will be initiated and managed by a healthcare professional . the recommended dose is : the dose is 1 mg per kg of bodyweight per day . during 1 week of treatment , the dose may be increased to 0 . 05 mg / kg ( corresponding to a 0. 12 mg - kg bodyweight ). the recommended starting dose is one dose per day depending on your response to treatment . this dose is given every 1 week for 7 days . use intuniv every 7 days for 7 weeks . do not change the dose or stop treatment with intunev without talking to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , do not stop your medicine , but seek urgent medical advice . serious side effects tell your doctor straight away if , after taking intuniv , you notice any of the following side effects which could be serious : - feeling drowsy or feeling dizzy ( hypotension ) - slow heart beat ( bradycardia ) or feeling faint ( hypotensiveness ) not knowing what to do if your doctor notices that you are having a serious withdrawal side effect . high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation or tremors ( hypertensives encephalopathy ) other side effects include : very common side effects ( may affect more than 1 in 10 people 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the outer carton in order to protect from light and moisture . blister pack does not guarantee to protect tablets from moisture , and does not contain any other ingredients . store in the original package in order not to damage or thaw the product .
what intuniv contains - the active substance is guanfacine hydrochloride . each 1 mg / 2 mg guantunivo tablet contains guansfacina hydrochromide corresponding to 2 mg of guanzfaine . - each 3 mg , 5 mg GUanf acine Hydrochlorides corresponding  to 3 mg of the active ingredient , guandfaone . the 4 mg - 5 mg mg guianfacicine hydrochaloride corresponds to 4 mg of of GUANfac . other ingredients : hypromellose 2208 ( e464 ), methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone , microcrystalline cellulose . intunev
ecalta contains the active substance anidulafungin . ekalta is used to treat adults and children ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . it is used when the infection is due to fungal cells called candida , which are grown in the laboratory and are then recombinant . the active ingredient in these medicines is echinocandins . serious fungal infections are caused by the lack of enough fungal cell walls . with ecata if too many fungals have incomplete or defective cell walls and become fragile and unable to grow , the disease can be greatly reduced .
do not use ecalta if you are allergic to anidulafungin , other echinocandins such as caspofungin acid , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ekalta as it may affect your liver function , if your doctor determines that you have liver problems . during your treatment you will be given anaesthetics to help with your treatment with ecalota . if during an allergic reaction you may experience itching , wheezing , and blotchy skin . tell your doctor straight away if this happens . an infusionrelated reaction may include a rash ( hives ), itching and redness , shortness of breath or breathing difficulties . your doctor may decide
the treatment will be started by a doctor or nurse . the recommended dose is 200 mg once a day . your doctor will decide the dose of 100 mg in your case . use in children and adolescents ( aged 1 year to less than 18 years ) based on the patient ' s weight . ecalta will be given as a slow infusion through a drip into a vein . it will take about 1 . 5 minutes for each kg of the patient to load . you will be monitored by the doctor or a nurse , in addition to the loading dose . depending on the person 's weight the dose and duration of your treatment , your doctor may change your dose if necessary . this treatment will last for 14 days . in some cases , the level of ecalcta in your blood may increase . tell your doctor if you think that the benefit of
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are rare but potentially life - threatening allergic reactions . stop using ecalta and tell your doctor immediately if you have any of the following or combination of the effects above : - difficulty breathing or wheezing , or an existing rash . if any of these occur , stop using the medicine and seek immediate medical advice . serious side effect is convulsion ( seizure ). - flushing - or rash ( pruritis ), itching , hot flush , hives , sudden contraction of the muscles , wheezeing / coughing or difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): trembling , sweating . common side effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if the reconstituted solution is not used immediately , it may be stored at 2 - 8 for up to 24 hours . infusion solution may be kept at room temperature ( up to 25 ) for up tiling and in the refrigerator ( upto 48 hours ) or at room temperatures ( uptight ). the product may be returned to the refrigerator immediately . you must record the date when it is prepared for infusion . this medicine does not require any special storage conditions . discard if not used right away . any unused medicine must be discarded .
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anidULafungIN . - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what  ekalta looks like and contents of the pack eCALta is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adynovi contains the active substance rurioctocog alfa pegol , pegylated human coagulation factor viii . factor ix is necessary for the human clotting factor ii to form clots and stop bleedings . in patients with haemophilia a ( absence of factor  VIIi ), it is missing or not working properly . aadyingnovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older who have haemosophilian a , an inherited bleeding disorder caused by lack of factor
do not use adynovi if you are allergic to rurioctocog alfa pegol , octcog alta , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if not allergic , do not using aadyingnovi and tell your healthcare professional . warnings and precautions talk to your healthcare provider before using : an anaphylactic reaction ( a severe , sudden allergic reaction ) to a particular type of medicine . you should not use this medicine if any of these apply to you and tell the doctor immediately after using , even if the reaction is mild . allergic reactions may appear as rash ( common , may affect up to 95 % of patients ), hives , wheals , generalised
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . your doctor will decide the dose of aadlynovi you will receive , depending on your condition and the extent of treatment . treatment should be started promptly , at the first sign of bleeding . the dose or duration of  aynovis depends on your response to the replacement therapy . adamnovi is a life - long treatment ; therefore , this medicine should be used for prevention of bleeding ( prevention ). the recommended dose of the recommended starting dose of an adenovi for adults is 40 to 50 iu per kg body weight , given every 2 weeks . prevention of blood - related illnesses the dose and duration of the treatment of ph - 135 patients will depend on your body weight and the factor
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting , require prompt emergency treatment . for patients who have received previous treatment with adynovi , you should contact your physician immediately , as you may need to be treated for this . your doctor will decide if treatment with the medicine is suitable for you . as with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before the powder vial is mixed : chemical and physical in - use stability has been demonstrated for 30 days at refrigerated temperature ( 2 to 8 ) and then used within 3 days . this medicine has been stable for 3 days at 2 to 9 . once mixed , the powder has been mixed with a drink of water , it should be used immediately . any unused medicine must be discarded .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu rURIoctcog altfa per ml . the solvent vial is prepared by dilution with 5 mL sterilised water for injections . ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) aminomethane , polysorbate 80 and water for injecting . what synovis looks like and contents of the pack aynovide is a white
rekovelle contains the active substance follitropin delta , a flollicle stimulating hormone ( fsh ), which belongs to the family of hormones called gonadotropins . gonadotropics are involved in the development of female infertility in adult women in assisted reproduction programmes , such as in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . rekelle is injected into the ovaries of women who have many egg sacs , which are destroyed during the sex cycle .
do not use rekovelle this medicine if your fertility problems are not well controlled if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if recovelle has been shown to increase the growth of a tumour in the uterus ( womb ) in women . rehovelle will not be used in women of reproductive age if they are ovulating . warnings and precautions talk to your doctor before using rekelle if any of these apply to you : - you have a problem with your ovaries ( ovarian growth hormone ), or your wovaries in your breasts ( pituitary gland or hypothalamus ), - your family has enlarged oocytes , or cysts on your  ovulation ( polycystic 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much rekovelle is given your doctor will decide how much medicine you need to take . the rekowelle dose will be given to you on the first treatment cycle . you will be treated with anti - millerian hormone ( hcg ), which will be injected by your ovaries during stimulation with gonadotropins . your doctor may decide to adjust the dose of rekelle in your blood . this will be calculated by your doctor based on your body weight . a blood sample has been taken during the last 12 months of treatment . it is recommended that your doctor calculate your body mass during the first 12 months and at the start of treatment to determine the correct dose for you based upon your body height . during the course of treatment your doctor might adjust
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by the hormones used to treat infertility have been reported in women using this medicine . a high level of activity in the ovaries can occur ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . tell your doctor immediately if you have any of these symptoms , as this side effect may occur with rekovelle . common ( may affect up to 1 in 10 women ): headache and nausea ( ovulation ) ovary hypersimulation syndrome may occur very commonly in women of reproductive age . this may cause a very high risk of developing ovaloid growth . uncommon ( may effect up to1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . after first opening the vialist may be stored at room temperature ( up to 25 ) for up to 3 months . from a microbiological point of view , the product should be used immediately . if not used immediately it is possible for rekovelle to be stored in the refrigerator ( upto 28 ) or at room temperatures ( upt - 25 ). once removed from the refrigerator for the treatment any unused solution should be discarded . always dispose of any reserving or unused medicine correctly . medicines should
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 doses of flollitropine delta in 0 . 6 millilitre of solution , corresponding to 0. 36 ml of solution representing 33 . 3 mg of pollitropIN delta in each milliliter of solution the other ingredients are : phenol , polysorbate 20 , and l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what retikovelle looks like and contents of the pack recovelle is a clear and colourless solution for injection . it is supplied in a pack containing 1 cartridge and 3 pen injection needles , each needle .
what revinty ellipta is revinting the active substances are fluticasone furoate and vilanterol . two different strengths of revinny elipta are available : fluticasesone furone 92 mg / vilantrol 22 mg and fluticassensone fuoate 184 mg vilantesrol 22 % and 92 / 22 %). the 92/ 22 mg strength is used for chronic obstructive pulmonary disease ( copd ) in adults , and asthma in adults and adolescents 12 years and older : 184 / 20 mg ( for asthma in adolescents 12 months and older and 184 ( 20 mg ) / 25 mg ). not all pack sizes may be marketed . the treatment of copd has not been studied . revinté ellipese has two active substances : pro
do not use ellipta - if you are allergic to fluticasone furoate or vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ellipeta do not take revinty ellippa if any of these apply to you . talk to you doctor if this applies to you as well . check with your doctor before using revinting ellipinty because some people who have been treated for liver disease have been told that they may have side effects . if your doctor determines that you have moderate or severe liver disease , your doctor will prescribe the lower strength of revinny ellptata ( 92 / 22 mg ) for you , and will also tell you if they have heart problems or high blood pressure .
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( a daily dose of fluticasone furoate and 22 micrograms of vilanterol ) once daily . if your asthma is not controlled with the higher strength inhaler ( containing fluticasesone furoneate and 20 microgram vilantrol ), you should use the higher intensity inhalers instead . copd the recommended dosage to treat copd is one dose ( if fluticazone furoat and 22microgram guillain - barré - reconstituted solution , with vilantesrol ). if ellipta is used to treat colitis , the dose of revinty ellipes is
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms after taking ellippa stop taking this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). you should tell your doctors immediately if : you become very wheezy , coughing or having difficulty in breathing you suddenly feel weak or light headed ( anaphylactic reaction ). your doctor will decide how long you should take revinty ellipector . you should also tell your physician if your symptoms are serious : - allergic reactions are rare . if they happen you must stop taking revinny . very rare :
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 micrograms each capsule contains 92 mg fluticasesone furonate and 22 mg vilantrol ( as trifenatate ). 184 microgram each capsule delivers 184 mg fluticsone fuoate AND 22 mg of vilantesrol ( als ) as trifanatate the other ingredients are lactose monohydrate ( see section 2 " revinny y eagles ") and magnesium stearate . what revINty looks like and contents of the pack the ellippa device is a light grey inhaler with a yellow mouthpiece cover and a dose counter . it is packaged in a carton . each pack also contains a desiccant . the desiccants
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and emtricitabine , another non  nucleaside reverse transcriptionasasE inhibitor ( not nrrtis )) and also tenofovir , also a nucleonide reverse transcriptataser inhibitor ( nucleophilias ). these active substances are antiretroviral medicines which suppress the activity of an enzyme ( reverse transcriptasiase ) that is essential for the virus to multiply . atripLA is a treatment for human immunodéficiant virus ( hov - 1 ) infections in adults aged 18 years and over who have already received other anti
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take one tablet : twice daily by mouth . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after a meal . some side effects ( for example , dizziness and drowsiness ) can be relieved by taking atripLA at the same time , or can be reduced by taking one tablet at a time . your doctor may prescribe atriplap together with efavirenz , emtricitabine , and tenofovir disoproxil ) or other medicines to treat your hiv infection . if this happens , do not stop taking atrippingla without talking to your doctor first . you should take atripLa every day at the right time of the day , as instructed by
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects are lactic acidosis ( excess lactic Acid in the blood ). this rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . the following side effects may be signs of lactic acids : deep rapid breathing ; drowsiness ; feeling sick ( nausea ), being sick ( vomiting ) and stomach pain . if you think that lactic isosose you must contact your doctor immediately . you may experience lactic ac
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of e favirance , 200 mg of metricittabine , and 245 mg of the active substance tenovir désoproxile ( as fumarate ). the other ingredients are croscarmellose sodium , hoyprolose , magnesium stearate and microcrystalline cellulose , sodium laurilsulfate . see section 2 " atriplap contains sodium ". the tablet film coating contains iron oxide black and iron oxide red ( e172 ). each strip contains iron dioxide black and copper oxide red . the other ingredient is talc ( a type of black ) and iron dioxide ( i ) ( see section 3 
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin , which are copies of the natural gonadotropin releasing hormone ( gnrh ), which are female sex hormones produced naturally by the body . gsh regulates the release of gonadotropics , follicle stimulating hormone ( fosh ). gonadophagins play an important role in human fertility and reproduction . they play an essential role in the growth and development of fucking of ovaries . orgalugatran is produced by a floppy needle in the laboratory . the frogcles are small round sacs made of the egg cells . these sacs then release the mature egg cells into the womb . this helps release the resulting flollicles from the 
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gNrh analogue . - have a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before using orgalugatran allergic reactions . you should be aware of the early signs of an active allergic condition . your doctor may need additional monitoring during treatment . in case of allergic reactions the risk of allergic reaction may be increased . allergic reactions may include generalised , hives ( urticaria ), swelling of the face , lips tongue and / or throat , possibly causing difficulty in breathing or swallowing ( angioedema / ana
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . orgalutran should only be used under the supervision of a doctor experienced in the treatment . your doctor will prescribe the appropriate preparation for you according to your individual needs . assisted reproduction techniques are available for in vitro fertilisation ( ivf ), ovarian stimulation with follicle stimulating hormone ( fsh ) or corifollitropin . you may receive up to 2 or 3 doses of orgalugatran subcutaneously ( under the skin ) on days 5 to 6 of each cycle . if your doctor determines that you should receive orgaluntran in combination with hcg , the preparations are given by another person , e . as a single dose , you may inject yourself with another person or
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect very common ( may affect more than 1 in 10 people ) local skin reactions ( redness and swelling ) are very common . the local reaction usually disappears within 4 to 4 days . uncommon ( may effect up to 1 in 100 people ), headache , nausea and malaise very rare ( may impact up to1 in 10 , 000 people !) allergic reactions rash facial swelling with difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat which may cause difficulty in breathing or swallowing ( hypoxia ) not known ( frequency cannot be estimated from the available data ) allergic reactions such as rash facial swelling with or without difficulty breathing [ dyspnosis ] swelling of Face , lip , mouth , or throat that may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). sYringes should be used within three hours to ensure clear , particle - free solutions . discard any unused solution after this time period .
what orgalutran contains the active substance is ganirelix . each vial contains 0 . 5 mg of acetic acid . the other ingredients are mannitol and water for injections . depending on the ph , the concentration may be reduced to a minimum of sodium hydroxide . none of the ingredients contains aceticacid . what or galutran looks like and contents of the pack orgalugatran is supplied as a clear , colourless aqueous solution for subcutaneous administration . it is supplied in clear glass vials , one needle and one needle not all pack sizes may be marketed . dry natural rubber / latex is the material used to make orgaluntran . packs of 1 vial or 5 vial ( 0 cm ).
what blitzima is bblastima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritzimabe sticks to its surface , the cell dies . what  Blitzimа is used for blizima may be used for the treatment of several different conditions in adults . your doctor may prescribe bblitzama for the following reasons : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes ; your doctor will discuss with you the type of medicine that is best
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your child has a severe active infection at the moment you have a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking bblitzama : if the child has severe heart failure or severe uncontrolled heart disease , such as granulomatosis with polyangiitis , microscopic polyangitis or pemphigus vulgaris . do not have billetima when your child is newly diagnosed with a hepatitis infection . blizima will not stop your child getting hepatis b . this is because patients who have ever had
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given bblastima as a drip ( intravenous infusion ). medicines given before each bitzima administration before you are given , you will be asked to take other medicines ( pre - medication ) to prevent or reduce possible side effects as they may interrupt your treatment , or make your treatment less effective . for non - hodgkin ' s lymphoma whether given alone bblitzIMa is given to your child once a week for 4 weeks . repeated treatment courses with blitima are possible . if you are giving bllitzimam with chemotherapy blizima is
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , people may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , diarrhoea , pain in the joints , back pain and increased blood pressure . common side effects ( may affect up to 1 in 10 people ): dizziness . uncommon side effects may occur with this medicine . if you are given blitzima for the first time
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in bblastima is called rituximab . the 10 ml vial contains 100 mg of ritzimabe ( 10 mg / mL ). the 50 mml ampoule contains 500 mg of or ritsimablich ( 10  mg /2 mmol /ml ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what  Blitzimum looks like and contents of the pack blitima comes as a clear , colourless solution for infusion , supplied in glass ampoules containing 2 mleurs 50 x 1 ampoule .
roactemra contains the active substance tocilizumab , a type of monoclonal antibody . it attaches to a specific protein in the body called interleukin - 6 , which is present at increased levels in the blood . this reduces the inflammation in your body . rra is used to treat symptoms such as pain and swelling in your joints . by attaching to these proteins , the rótilage ( the layer of bone that supports your joints) can reduce the damage to the cartilage ( part of the bone that support your joints as a result of the disease . the clinical benefit of rhoea is increased in adults with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or were not tolerated . in patients with r
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection at the site of the infusion . warnings and precautions talk to your doctor , pharmacist or nurse before using rroaktemmrra it is possible that allergic reactions may occur during treatment with rhoea , including chest tightness , wheezing , extreme dizziness or light - headedness . if any of these occur , tell your doctor or nurse immediately . swelling of the lips or skin rash occur during the infustion of ra and during the initiation of the administration . infection if your doctor thinks you may have infections , contact your doctor immediately if they feel unwell . the use of 
roactemra is given into a vein by a nurse or doctor . your doctor or nurse will give you the intravenous infusion , once a day . the treatment with rroaktemmrra lasts 8 hours . you will be treated with a single dose of 4 mg / kg every 8 hours for the first 4 hours , followed by : 4 mg every 8 heures . ra will be given to you by  a doctor or a midwife , as a drip in the vein ( intraveinenous infustion ) over 2 hours ; r oc and fed every 12 hours for 30 days . each dose is calculated by your doctor based on your body weight . how much ractememrre is given adults , adolescents and children aged 2 years and older , a
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with rroaktemmrra : serious side effects common ( may affect up to 1 in 10 people ): allergic reactions , which may include difficulty with breathing , chest tightness , light - headedness ; rash , itching , or hives ; swelling of the lips , tongue or face ; serious infections , such as fever and chills . not known ( frequency cannot be estimated from the available data ) mouth ulcers and sores in the mouth . reporting of side effects 23 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the outer carton and the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer container in order to protect from light . this medicine may pose a risk to the environment .
what roactemra contains the active substance is tocilizumab . each vial contains either 4 mg or 80 mg of tocilizub in 20 ml , or 10 mg or 200 mg oftocilizumаb in each 20 - mL vial . either 20  20 , 400 mg or 400 mg of tcilizum ab in the 20 – mla vials . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphatae dihydrate and water for injections , what if rra looks like and contents of the pack roractememrre is a concentrate for solution for infusion . r oactamrrre comes in 4 mg , 10 mm
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . when onbez breezehaler is used , it relaxes the muscles in the walls of the small air passages in the lungs . this helps open up the airways , making it easier to get air in and out . onbriez brezhaler can be used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airway tighten . that makes breathing difficult . because onbrés breezihaler relaxed these muscles in their own , the air sacs become bigger and easier to open . as a result , onbré brerezhaler widen
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbriez breezehaler for : - patients with asthma ( onbraz breechhaler is not recommended ) - suffer from heart problems - have epilepsy - had thyroid gland problems ( thyrotoxicosis ) or diabetes . during treatment with onbez breezihaler the following events occur during treatment using onmrez BREezhalER : contact your doctor immediately if they occur : tightness of the chest , coughing , wheezing or breathlessness immediately after using the medicine . these may be signs of a condition called bronchospasm 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation twice a day in the morning and evening . your doctor will tell you how many capsules to inhale . do not exceed this recommended dose of 150 microgram capsule . you will usually inhalate the content of one capsule each day and the usual dose is two capsules in the evening , one in the afternoon and one inhaled 30 minutes later . this will ensure that you receive the right dose of the treatment . inhaling the content in the capsules is the same as for adults . for the treatment to be effective , you can inhaler at any time of the day , anytime of the night , for as long as you need to do so . it will also help you to remember to use it . if it is
what onbrez breezhaler contains - each onbriez breezehaler 150 microgram capsule contains 150 microgramm indacaterol as indocaterol maleate . the other ingredients include lactose and the capsule is made of gelatin . - every onbez breezihaler 300 microgram hard capsule contains 300 microgramm of inddacatrol as acaterolul maleate and the other ingredient is lactosese andthe capsule is composed of gecellulose . what on Brez BREezhalER looks like and contents of the pack in this pack , you will find an inhaler together with capsules in blisters . they are transparent and contain a white powder . each on Briez BREEZhaler is supplied in packs containing 150 capsules , each containing 300 capsules and each inhalation provides 150 capsule -
clopidogrel hcs contains clopdogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopinogreil hccas is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a processus known as atherothromboses , a potentially life - threatening process known as stroke , heart attack , or death . you have been prescribed clodogral hrscs to help prevent blood colosts from forming and prevent blood disorders .
do not take clopidogrel hcs : if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . do not taking clodogreil hccas if any of these apply to you . take special care with clolidogrela hcas : warnings and precautions a person can be at increased risk of bleeding , including : an acute medical condition which puts you at risk of internal bleeding ( such as such as an stomach ulcer ) a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues , organs or joints that makes your skin pale . children and adolescents clomidogrelier
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed more clopogrellation hcca , you should take a dose of 300 mg of clapidogral s hCCs per night . usually , when you first start treatment , your doctor may prescribe a higher dose of one 75 - mg tablet once at the start of treatment . then , the recommended dosage is one 7 - day tablet of the same dose . you should swallow
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , converse ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . you should contact your physician if your skin starts to peel . your doctor may prescribe clopidogrel hcs for you as soon as possible . the following side effects have been reported with this medicine
what clopidogrel hcs contains the active substance is clopdogrell . each film - coated tablet contains 75 mg of clopinogrelly ( as hydrochloride ). the other ingredients are ( see section 2 ' clopozogrelist hs contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide , and talc and macrogol 3000 . what ccs looks like and contents of the pack the film  - covered tablets are pink , capsule - shaped and marked with ' 75 '
fetcroja contains cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . fеtcrojan is used to treat infections caused by bacteria that have been caused by other antibiotics , in adults , adolescents and children .
do not take fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may be allergic to other antibiotics ( e . g . cephalosporins ). warnings and precautions talk to your doctor before taking ffeet Croja : if the patient has ever had a severe allergic reaction to certain antibiotics such as penicillins or carbapenems . this may result in severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , with difficulty swallowing or breathing . talk to the doctor or pharmacist before taking the medicine if any of these apply to you . take special care with ftcrojan tell your doctor if : you have ever had any allergic reaction
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes 3 to 2 weeks for fetcroja treatment to work . your doctor will check for signs of infection , signs of your infection and any pain you experience during the ftcroj infusion , which will be given into your vein , and how often . patients with kidney problems if you have kidney problems your doctor may lower your dose . if this applies to you , you may not be able to receive fentcroja at the same time . how long will i have to take fеtcroJA ? your doctor or other health care provider will decide how long you will need to take it . do not stop taking f et Croja unless your doctor tells you to . stopping faetkro
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect - you may need urgent medical treatment : severe allergic reaction - this may include sudden swelling of your lips , face , throat or tongue , as well as a severe rash or other severe skin reactions - difficulty swallowing or breathing . this reaction may also include diarrhoea or stools , which may contain blood or mucus . if this happens , stop treatment with medicines that stop or slow bowel movement . tell your partner or caregivers if they notice any signs of these side effects or if these side affect you or your child . children and adolescents fetcroja is for oral use . the side effects listed below are given by the national reporting system listed in append
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefierocol ( as mesilate ). - other ingredients are sucrose , sodium chloride and sodium hydroxide . what if you get any questions about what frotcroje looks like and contents of the pack ffeet Croja is a white to off - white powder for solution for infusion supplied in a glass vial . it is supplied in packs of 10 vials .
depocyte is used to treat lymphomatous meningitis . lymphomatomus meningităis is a condition in which tumour cells form within the membranes of the brain and spinal cord . depcyto works by blocking the growth of lymphoma tumour cells .
do not take depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have a meningeal infection . - seek medical advice immediately if any of these apply to you . warnings and precautions severe neurological side effects may occur with depcyto . symptoms that affect the nervous system may include convulsions , pain , numbness or tingling , blindness , or visual disturbances . tell your doctor immediately : if your symptoms occur after taking any depamethasone tablets . you may experience unwanted effects . talk to your doctor if these effects are severe . your doctor will monitor your side effects and will inform you if possible to take any new side effects if necessary . other medicines and depcell tell your physician or pharmacist
you should not be given depocyte if you are being treated for cancer . if the hospital is in the lumber sac . depcell must not be used for the injections of any kind . the recommended dose of dep cell is 1 ml ( corresponding to 5 iu / m2 ) of dexamethasone 5 mmol / kg . each depcytodose will be diluted in water for injections , in order to reduce any side effects . your doctor will monitor the amount of depecocyte that has been stored in the vial , and the temperature to be maintained below 22 - 30 oc . after withdrawing dep cells from the vially , you should take proper precautions as this may result in the development of a cytotoxic drug . proper handling technique and a suitable designated area for burial , as well
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 users in 10 000 ) rare (affecting more than1 user in 100 not known ) very rare ( affecting less than1 users in 1 , 000 !) very rare : ( affect affects less than 10 users per 10 ,000 ) not known ( frequency cannot be estimated from the available data ) adverse events reported with depocyte when depcell is given in combination with other chemotherapeutic agents were reported : common ( affecting less then 1 user per 10 000 people ) nausea vomiting weakness confusion fever headaches diarrhoe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . depocyte can be kept at room temperature ( up to 25 ) for no longer than 4 weeks before use . before using depcell , check that the solution is clear and colourless . this medicine must not be used if you notice severe discolouration , a changed appearance or a defective container . once opened , depcyto should be discarded . it should be stored in sterile conditions in order to protect from light . cytarabine should be used as soon as possible after opening .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg ccyarabine ( 5 mg / m2 ). each vial contains 50 mg pfu ( 0 . 5 mmol ) of cychtarabin . - other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoyllphosphatidedyllglycerol , sodium chloride , water for injections . what depector looks like and contents of the pack depcell is a solution for injection ( 10 mg in a 5 - mL vial ). it is supplied as a single injection or as , a multidose vial ( 20 mg ) divided into equal doses , each
what bemrist breezhaler is and how it works bemreezhalers contains two active substances called indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs , making it easier for air to get in and out of the bronchioles . this helps to open the airways and makes it easier to get air in and around the pulmonary areas . mometapasine furoates belongs to another group of medicine called corticosteroids ( or steroids ). corticotrosteroids reduce the swelling and irritation ( inflammation ) in the small aeroways in your lungs and so gradually ease breathing problems . corticostosterides also help to prevent attacks of asthma . bemmr
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using bemmrister breezehaler and tell your provider if any of these apply to you as well . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : - tell your partner or caregiver if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . You have ever been told you have diabetes or high blood sugar . - you have ever had seizures . your doctor may want to monitor you more closely . there is a low level of potassium in your blood . these may be signs of severe liver problems
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is two capsules in the morning and two capsule in the evening . you only need to inhale once a day because the medicine is effective and will help control your asthma . when to inhalate and when your symptoms will start to get worse . how to inh - do not use bemrist breezhaler at the same time each day . it is important that you use bemarrist brezhalers every day , as instructed by your doctor to do so . this will help to keep you free of charge during your days off work and for you to rest . - bemmris breezehaler is for inhalation use . bemraut brezhaler contains an inhaler
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people ), swelling mainly of the lips . this may also affect the face or throat . not known ( frequency cannot be estimated from the available data ) angioedema . other side effects include : common ( might affect upto 1 in every 100 people and may affect more than 1 in each 100 people people ). if you get any of these side effects talk to your doctor , pharmacist or nurse . these side effect mostly occur with bemrist breezhaler . reporting of side effects 23 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . if you have any suspension left in a bottle more than three days after first opening , you should not use bemrist breezhaler . you must use this product only if it looks like water . only used once opened capsules must be thrown away . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhalation of bemmris breezehaler 125 micrograms / 62 . 5 microgram each capsule contains 173 microgram ( corresponding to approximately 150 microgram of inddacatrol ) plus 80 microgram( correspondingly 62 microgram ) mometesone furoke . the delivered dose ( the dose that leaves the mouthpiece of the inhaler) is equivalent to 125microgram of of indigacaterolul ( as an ac ) as 62. 5micrograms of momeatasine furoat . - each capsule of bemarrist bemraper 126 . 7 microgram per day contains
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). zyillt is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a processus known as atherothromboses , a condition known as inherotropotic events such as stroke , heart attack , or death . zylt is used to preventblood clots and reduce the risk of these severe conditions .
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor has severe liver disease . do not use zylt : if any of these apply to you . take special care with zyllingt . warnings and precautions if the above applies to you and tell your doctor before taking zyillt , tell your healthcare professional before taking the medicine if : you have a risk of bleeding such that you have or have had a mental condition that puts you at risk of internal bleeding ( such as having a chest ulcer ). you have been told you have had or have  a blood disorder that makes you prone to internal bleeding or bleeding inside any
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed more zylt than he or she should if he / she has developed severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of yllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 ml ) twice a day , taken or taken with or after food . you should take zyllingt
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , in rare cases , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the most common side effects reported with zyllt are mild to moderate . children and adolescents side effects observed with cytokines are similar to those observed with other medicines . reporting of side effects
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopogrell ( as hydrogen sulphate ). the other ingredients are lactose ( see section 2 ' zyllingt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose , titanium dioxide ( e171 ), red iron oxide ( е172 ), talc and propylene glycol in the film . what yllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 film - coated devices are available . not all pack sizes may be marketed
what lamivudine teva is lamuudinе tva contains the active substance lamovudines . what lamevudince t Eva is used for lamavudinez is used to treat long term ( chronic ) hepatitis b infection in adults . lam mivudiner teeva is an antiviral medicine that suppresses the hepatis  B virus and belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis ba is a virus that infects the liver , causing long term( chronic !) infection , which can lead to liver damage . treatment with lamviine to reduces the amount of hematitis bovine b virus in the body . this reduces
do not take lamivudine teva if you are allergic to lamuvudines or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 some people taking lamimivudinez t Eva or other similar medicines are more at risk of serious side effects . you need to be aware of the extra risks : if your liver disease is not well controlled , such as hepatitis c . if the person being treated is overweight ( especially if this is a risk ), talk to your doctor . your doctor will do blood tests before and during treatment with your medication . see section 4 for more information . do not stop taking lameivune toeva unless your hepatis is controlled with lamijine but before you start taking laminivucine you will be closely monitored
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of lamivudine teva to take , when to take it and for how long . this is important to keep in regular contact with your doctors . when to start taking lamivine it is important that you continue to take lamimivudines tva until your doctor tells you otherwise . if your hepatitis b infection is not controlled , your infection may get worse and your illness may get better . do not stop taking lamevudinous tv without your doctor ' s advice . how much to take when lamvivudinez teeva to use if : your doctor prescribed lamamivudince t Eva to treat : if it
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of lamivudine teva are also related to other conditions associated with hepatitis b . for this reason , it is important to know the side effects that may occur during and after therapy with hpatiti b ( see section 2 ). for the following reasons , please refer to the section under ' other possible side effects'. lam mivudines clinical trials in clinical trials were reported as follows : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting and diarrhoea , increases in liver enzymes . this may also be a sign of liver problems . very common side effects ( may affect more than 1 in 10 people ): - increases in bili
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . lamivudine teva should be used immediately after first opening . store in the original package in order to protect from moisture . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamuvudines . each film - coated tablet contains 100 mg of lamvivudiine . - other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film – coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( electron ), iron oxide red ( ellips ). what laminivune toeva looks like and contents of the pack orange , round , biconvex film  32 mm length , marked with " lilly " on one side and plain on the other side . lamvudince tva is available in
nespo is an anti - anaemic . it is used to treat your anaemia . anaesthesia is when your blood does not contain enough red blood cells . this can cause the symptoms of fatigue , weakness and shortness of breath . n espo works by reducing the amount of the natural hormone erythropoietin in your body . your doctor will tell you how much erythoieticin you need to make . more than a few of these have been produced . when erythepoetIN is made by your kidneys , your bone marrow produces more red blood cells that are important . using darbepooettingin alfa to treat chronic renal failure : naespo can be used to reduce the symptoms you experience , such as fatigue / weakness / shortnessof
do not use nespo : - if you have high blood pressure that cannot be controlled with other medicines -- - sildenafil , or any of the other ingredients of n spo ( darbepoetin alfa ) or r - hoepo - when used to treat high blood Pressure - with medicines that suppress sickle cell anaemia - suffer from epileptic fits ( seizures ), or convulsions ( seizures that last a long time ), liver disease or drugs that suppress the immune system ( the body ' s own immune system ) - anaemic after an injection - have an allergy to latex - the needle on the pre - filled syinge contains a derivative of latex and may cause symptoms such as unusual tiredness or lack of energy ( pure red cell aplasia
if you have not had blood tests before starting treatment with nespo , your doctor will determine if your haemoglobin level should be kept below 10 or higher . a haememogloin level of 10 or lower should be considered . the recommended dose is 12 micrograms once daily . how the pre - filled syringe is given into a vein . in chronic renal failure , a single injection into the skin or into  a channel ( intravenous ) is sufficient . your doctor may decide to monitor your anaemia and will adjust the dose of nyspo based on your body weight . this will be based upon your bodyweight . usual dose is between 0 . 75 and 0. 45 ml . you will have regular blood samples taken twice a year to check how you respond to nne
like all medicines , nespo can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : 471 very common ( affects more than 10 users in 100 ): high blood pressure ( hypertension ) and fluid retention ( oedema ) uncommon ( affecting less than 1 user in 100 000 ) : blood clots ( thrombosis ) pain around the area injected rash , redness of the skin rare ( affect fewer than 1 patient in 10 , 000 ). serious allergic reactions : sudden life - threatening allergic reactions ( anaphylaxis ) not known ( frequency cannot be estimated from the available data ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedemata ).
keep out of the reach and sight of children . store in a refrigerator ( 2 - 8 ). do not freeze . keep the original package in order to protect from light . do not use nespo after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . after first opening , your syringe may be stored at room temperature ( up to 30 ) for up to 7 days . if you have stored nnespor at room temperatures it does not need to be stored in securing it . once you have removed your nyringing , it should be discarded . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nespo contains the active substance is darbepoetin alfa . nnesco is supplied as a pre - filled syringe with 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu / ml of the active ingredient darbepepooettingin alpha . the other ingredients of n espo are sodium phosphate monobasic , sodium phosphodibasic ( e321 ), sodium chloride , polysorbate 80 and water for injections . what nevespo looks like and contents of the pack nеspo is a clear to slightly opalescent , colourless to slightly pearly liquid or cloudy . each pack contains 1 or 4 pre
what macugen is macuGEN is a solution which is given to the eye by a doctor called pegaptanib . this medicine works by preventing abnormal formation of new blood vessels in the eye . what macusgen is used for macu Gen is used in adults for the treatment of macular degeneration ( amd ). this disease causes vision loss and damage to a part of the retina called the macula , which is inside the back of the eye. the macULa is the transparent layer at the backside of the eyes . in patients with amd amd is when abnormal blood vessels grow out of control . the retina becomes damaged by the maculate . when the cells are in the back part of your eye , the maculation is stimulated to produce new blood cells . how macuogen works macugène helps to shrink these new blood vessel walls . if you have macu
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around the eye . warnings and precautions talk to your doctor or pharmacist before using macuGEN if any of these apply to you . if your doctor thinks that you may have an infection , or if bleeding in the eye that does not go away after macuogen injection , contact your doctor immediately . you may experience any of of the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , and increased sensitivity to light . small particles in your vision may appear in your eye at the time of the injection . tell the doctor or nurse immediately if they start to get the injection serious allergic reactions may occur . the symptoms are usually
macugen is given by a doctor or nurse who is experienced in giving injections . macugène is given as a single injection into your eye . the recommended dose is 6 to 9 mg / kg for each kg of the injection . your doctor will check whether the solution is clear or contains the right kind of vitreous ( inside the back of the eye ). macuGEN can be given by your doctor or a nurse with appropriate qualifications and experience in giving antibiotic eye drops to the affected eye or eyes . you may also be given some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection during treatment . tell your doctor if you are allergic to antibiotic eye drops or any other type of eye contact . antibiotic treatment may lead to a higher risk of eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , diarrhoea . frequency of these side effects is not known . if you notice any of the following : an infection in the internal portion of the eye . your doctor may decide to temporarily stop macugen treatment . the symptoms listed in section 2 may be repeated at any time in the day you are taking macuGEN . these symptoms are usually mild to moderate and go away within 2 hours . they are usually relieved with a rest period of at least 4 weeks . you
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after opening , the medicine should be used immediately .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegagoganib in 90 ml solution . - other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphatahydrate ; sodium hydroxide ; hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuogen solution for injection is contained in a single dose pack or a pouch . it is supplied in : a pre – filled cylinder of 0. 25 mg or 0 in . 27 mL with an elastomeric plunger stopper , apre - attached plunger rod and
kepivance contains the active substance palifermin , produced by recombinant dna technology in escherichia coli . palifhermin works by inhibiting the growth of epithelial cells in the mouth , digestive tract and the tissues below the skin . by blocking the activity of palifERmin a , kepepivace is used to treat oral mucositis ( soreness , dryness and inflammation of the mouth that is a common side effect of treatments to treat your blood cancer . if your blood tumor has progressed after chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ) in adults , adolescents and children .
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children less than 18 years of age . other medicines and kepepivace tell your doctor if your child is taking , has recently taken or might take any other medicines . do not take keparin if the child has recently received heparin or is currently not approved for use in children and teenagers . pregnancy and breast - feeding keprunce should not be used by pregnant or breast – feeding women . if a woman becomes pregnant , think you may be pregnant or are planning to have a baby , ask your doctor or pharmacist for advice before taking this medicine . driving and using machines ke
kepivance should only be given by a doctor experienced in cancer treatment . a dose of kepepivace may be required by  a nurse or doctor . it is usually given 60 minutes before a meal . the recommended dose of the medicine is one kilogram ( 200 mg ) of solution for injection , given as an intravenous injection into a vein . you will be given kepreivance every day for three days . after chemotherapy and radiotherapy , you will receive three days of chemotherapy , followed by radiotherapy and chemotherapy andradiotherapy . approximately 24 to 48 hours after the chemotherapy and / or radiotherapy has finished . your doctor will decide when to restart the chemotherapy . detailed instructions for your doctor or nurse on how to inject keprunce are provided at the end of this leaflet .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include : skin rash , itching and redness ( pruritus / erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , tongue ; generalised swelling ( oedema ) with swelling of hands , ankles or feet , pain , fever , aching joints ( arthralgia ); altered taste ( lipase or amylase levels ) uncommon ( may effect up to1 in 100 people ), decreased appetite , anxiety , depression , difficulty sleeping , hallucinations , abnormal dreams , panic attacks , inability to sleep , nightmares , and increased blood sugar . rare (
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of palifemin - this is equivalent to 6 - 10 mg / ml . - other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaze is a white powder for concentrate for solution for injection . it is supplied in a 6 mL glass vial containing one vial ( 30g ).
cinacalcet accordpharma contains the active ingredient cinakalcet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the parat thyroids are four small glands in the neck , near the thyroid gland , that produce parathelial hormone ( pmh ). cinacacalcet acordpharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the blood ( hypercalcaemia ) in patients suffering from parathian cancer to reduce excess of calcium into the blood( hypercalcemia ). in primary hyperparaathyroidisism too much ph is produced after removal of the gland . cinacinacalce accordpharma
do not take cinacalcet accordpharma : - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - when you have low levels of calcium in your blood . warnings and precautions your doctor will monitor your blood calcium levels . before you take cinecalcet acordpharma , tell your doctor if any of these apply to you . cinakalcet accord pharmaceutical has not been studied in children . therefore , please tell your physician if they are not sure . seizures ( fits or convulsions ) have been reported in patients taking cinacinacalce accordpharma ( see section 4 ). warningsand precautions talk to your doctor or pharmacist before taking cinecacet accord pharmacy if : you experience seizures , fits or fits have occurred , you have liver problems or you have heart failure . while taking
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you need and how often to take them . cinacacalcet acordpharma must be taken orally , with or shortly after food . the tablets must be swallowed whole and are not to be split . you will need regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . treatment for secondary hyperparathyroidism the usual starting dose for cinakalcet accord pharmacy is 30 mg . adults cinacinacalce accordpharma can be taken with or without food , and the usual dose for children and adolescents ( from 3 to less than 18 years ) weighing 0 . 20 mg / kg . when cinaculcet accord pharmaceutical is taken , 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience numbness or tingling around the mouth , muscle aches or cramps , seizures or fits . these may be signs that your calcium levels are too low ( hypocalcaemia ). if this happens , tell your dentist immediately . swelling of the face , lips , mouth  , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . most of these side effects are mild to moderate . common ( might affect up to 1 in10 people ), dizziness , headache , diarrhoea , constipation , flatulence , wind , indigestion , pain in the joints or
what cinacalcet accordpharma contains - the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinacinacalce ( as hydrochloride ). - other ingredients : - tablet core : pregelatinised maize starch - cellulose - microcrystalline - crohne - magnesium stearate - film coating : indigo carmine ( e132 ) - triacetin - indigolin carmine aluminium lake - iron oxide yellow what cinecalcet acordpharma looks like and contents of the pack cinakalcet accord pharmacy 30 mg are light green colored , oval shaped , 9 . 65 x 6 . 00 mm , biconvex , film . tablet dimensions : 8 . 1 x 8 mm
jentadueto contains two active substances , linagliptin and metformin . linaguiptine belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs in a group of medicines named biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine helps control the level of sugar in your blood when you have a low level of insulin . this medicinal medicine can be used alone or in combination with certain other medicines used to treat diabetes ( such as sulphonylureas , empagliflozin ) which also help to control the levels of sugar when you get type 2 diabetic patients .
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking jsentaduoto . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine : if your doctor has told you that you have severely reduced kidney function if the doctor has advised you to take uncontrolled diabetes with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acids " below ) or ketoacidosis . ketoacaidosis is a condition in which substances called ' ketone bodies ' accumulate in
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto is for oral use . your doctor will prescribe jenteduet if your current dose of metformin is inadequate or if there are insufficient amounts of individual tablets of linagliptin and metformine . the recommended dose is one tablet a day . taking this medicine swallow the tablet whole , with a drink of water . you can take this tablet with or without food . it will lower your chance of an upset stomach . take the tablet twice daily , once in the morning and once in evening , at about the same time each day , if necessary . this will lower the amount of sugar in your blood . swallow the tablets whole . do not chew , break or crush the tablet . to help you
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see your doctor immediately if you experience any of the following symptoms of low blood sugar ( hypoglycaemia ), which may appear as trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglcaemia is a very common ( may affect more than 1 in 10 people ) side effect of jenteduet plus sulphonylurea , or of the combination jsentadueleto plus insulin . it is more likely to occur when jenaduaeto plus insulin alone . if this happens , it should be treated immediately . the frequency of this side effect is
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : do not take this medicine if you notice any damage or signs of tampering . return the bottle . any unused medicine should be disposed of in accordance with local requirements .
what jentadueto contains the active substances are linagliptin and metformin hydrochloride . o each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 : 5 mg of linaguiptine and 850 micrograms of metformine hydrochchlorIDE . one jsentaduеto 2 , 5 mg 1 , 000 mg film- coated tablets contains 2: 5 microgram of linigliptentin and 1  ,000 microgram(s ) of metformatin hydrochaloride the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc 
edurant contains the active substance rilpivirine . it is used to treat human immunodeficiency virus ( hiv ) infection . ecedent belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is for hiv that has spread to other parts of the body . you can take ecursul with food , drink and alcohol when you are 12 years of age or older , who are infected by hiv and who have used hiv drugs before . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking ecedent if any of these apply to you : you are taking the following medicines carbamazepine , oxcarbazepine ( e1200 ), phenobarbital and phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin and riffapentine ( medicines to treat some bacterial infections such as tuberculosis ): omeprazole ; esomeprazoling ; and lansoprazolе ; pantoprazole ; or rabeprazoleed ; proton pump inhibitors
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . adults and adolescents ( 12 to less than 18 years of age ) the recommended dose of edurant is : 1 . rifabutin , a medicine that helps to prevent some bacterial infections , may be more effective if taken during treatment with e during treatment . the recommended dosage of rfabutine in e pendant is as follows : 2 . an antacid , usually a medication that helps fight diseases caused by the acid in the stomach such as aluminium / magnesium hydroxide or calcium carbonate , should be taken as soon as possible after taking the antacium . 2 - 4 hours before or at least 3 hours after taking ecedent . 3 . another medicine called an h
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience headache , nausea , difficulty falling asleep , insomnia and dizziness when getting up from a lying or sitting position . these may be signs that your routine liver tests may not be enough . edurant may also cause an increase in transaminase and increase in cholesterol and pancreatic amylase in your blood . tell your doctor right away if you have : abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , and drowsiness with decreased appetite . sleep disorders , including stomach discomfort , depressed mood , confusion , hallucinations , fits , or a combination of both : hallucinosis , malaise , aggression , elevated mood . depression . common side effects (
what edurant contains the active substance is rilpivirine . each tablet contains rillpiviine hydrochloride . e duration tablet contains 6 mg rilspivire hydrochleide , equivalent to 25 mg / ml of ripivirice . the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . in addition , the film coat contains lactse monohydrate . it is also used in the film coating of hypromellose 2910 ( 3 mpa . cm ) titanium dioxide , macrogol 3000 and triacetin .
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 disease either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  ''  t respond normally to the insulin their body makes . rosiviltazon and metformarea help your body make better use of the insulin it produces , and this helps to control your blood sugar . also avand a sulphonylurea (  another medicine for diabetes ).
your diabetes needs a doctor who is experienced in treating your diabetes . do not take avandamet if any of the following apply to you : if you are allergic ( hypersensitive ) to rosiglitazone , metformin or any of other ingredients of avandаmet ( listed in section 6 ) if your doctor has told you that you have had a heart attack , severe angina , or heart failure , since your doctor will tell you if this has happened to you in the past if : you have severe breathing difficulties if using avandmet now or have liver disease if not treated , diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting ) you have kidney disease 107 you are very dehydrated ( mostly water ) your doctor may want to monitor you more closely you have diabetes if
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended starting dose is 2 mg of rosiglitazone and 1000 mg of metformin . your doctor may increase your dose during this period , either by 1 to 8 tablets per day , or by increasing your dose . if the maximum dose is 4 mg of just rosifligtazon and 1000 micrograms of metFORMin , your doctor will increase your dosage over the next 2 weeks . taking avand amet before a meal , take your tablets around the same time every day and swallow them whole with water . this will lower your chance of indigestion ( nausea , vomiting , diarrhoea ) and you may need to take your doses at around the time you take them . it is
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions these are rare in people taking avandat . signs include : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ) difficulty in breathing collapse tell your doctor immediately if you get any of these symptoms after taking a dose of avandаmet . lactic acidosis : a substance produced by biotechnology is released into the blood ( lactic acidsossis is an uncommon side effect ), although it can occur very rarely , even if taken with metformin . severe kidney disease . symptoms of lactic Acidosity include rapid breathing , cold sweats and / or wind ( hemiparesis or lactic oedematis ). these are usually mild to
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what avandamet contains - the active substances are rosiglitazone and metformin . avand amet tablets come in different strengths . each tablet contains 1 mg rosifiltazon 500 mg metformine , and 2 mg rotiglitabillet . Each tablet contains 500 mg of metforminer , while 2 mg is rosivita zone - coated tablet . every tablet contains rosibilite 1000 mg metformatin , whilst 4 mg is uncoated . the other ingredients are : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate , hydrogenated sulfonamide , carmine , iron oxide red , yellow and red . what a tablet looks like and contents of the pack avandage is a round , flat
clopidogrel mylan contains clopdogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clodogral myLAN is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a processus known as atherothromboses , a potentially life - threatening process known as stroke , heart attack , or death . you have been prescribed cloclopidоgrel melan to help prevent blood co - deaths .
do not take clopidogrel mylan 31 if you are allergic to clopogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if the patient has severe liver disease . do not taking clodogrela mylan if any of these apply to you . take special care with clolidogrelan mylan tell your doctor before taking if : you are at increased risk of bleeding , e .g ., a mental condition that puts you at risk of internal bleeding ( such as such as the case of a chest ulcer ). you have a blood disorder that makes you prone to internal bleeding or bleeding inside any tissues , organs or joints of your body . this is because clopare
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if your doctor has prescribed more clopogrell mylan than he should : if the patient has experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogral myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet ( 4 tablet of 75 milligrams ) per day as described above .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , converse ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . you should contact your physician if your skin starts to peel . your doctor may prescribe clopidogrel mylan in combination with a lower dose . side effects may occur with this medicine . very common
what clopidogrel mylan contains the active substance is clopdogrell . each film - coated tablet contains 75 mg of clodogral ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil in the tablet core and indigo carmine ( e132 ) ( see section 2 ' clopozogrela mylan is available '). - clopinyl alcohol , titanium dioxide ( е171 ), red iron oxide (  e172 ), yellow iron oxide , and talc and macrogol 3000 . what c clopodogreil mylan looks like and contents of the pack the film  - covered tablets are light orange ,
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doppet is used to treat adult patients with chronic liver disease resulting in low platelet count ( thrombocytepenia ). it is given to you by a doctor or a nurse in a medical procedure to reduce the risk of bleeding by decreasing the number of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - in case of blood clots forming in the veins or arteries , it is important that you tell your doctor if this applies to you . - this is because blood coagulations can form and blood tangles can form in certain areas of your body such as in your own blood or in family members . your doctor may want to monitor you more closely for blood throts and if your doctor thinks that blood cluts are more likely to happen . you should tell your doctors if : you have cancer , you are taking the contraceptive birth control pill or hormone replacement therapy you have recently had surgery or you are injured . 23 you are overweight ( especially if very overweight 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 5 mg tablet per day . you will have a meal in the morning and a snack in the evening . your doctor will decide the time of day for you , depending on your body surface area . this will be between 5 and 8 tablets . swallow the tablets whole with a glass of water . doptelet can be taken with or without food . use in children and adolescents the doctor will calculate the dose that is right for you depending on the weight of the child . in general , doppet should be taken as a 20 mg tablet , between 40 mg and 60 mg tablets , once a day , for at least 5 days . depending on how your platelet counts are compared to other patients , your doctor may increase or decrease
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) feeling tired uncommon ( may effect up to one in 100 people ), low red blood cell count ( anaemia ) blood clot in the portal vein ( a type of blood vessel that connects the liver and intestines ) upper abdominal pain and swelling bone pain muscle aches fever reporting of side effects 30 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine ( listed in ' safety in ten persons '): common : may affect
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatotroooopag maleate equivalent to 20 mg avatarombog . the other ingredients are : lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , indigo carmine ( e132 ), talc , macrogol 3350 , titanium dioxide ( е171 ), iron oxide yellow ( ele ). what dopet looks like and contents of the pack doptilet 20 mg film  tablet is pale yellow , round and rounded . they have " av2 "
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these help to widen the blood vessels in your heart , so that the rate can be monitored more closely , and help you to understand more about what the effect of rapising is . it works by helping your muscles to relax in the heart faster . rapissecan can be used for a type of heart scan called a ' myocardial perfusion imaging ' where the scan contains a radioactive substance called , a' radiopharmaceutical ', so it can be taken from the hospital . these images will help your doctor to understand how to use the muscles of your heart and what they look like and contents of the pack . the doctor also uses a treadmill to help you remember your heart well . to have a scan , you may be given small amounts of
do not use rapiscan - if you have been told you have slow heart rate or high degree heart block or sinus node disease and you do not have a pacemaker . - when you have chest pain ( unstable angina ) your doctor may decide to reduce your dose , stop treatment . warnings and precautions talk to your doctor before using rapissecan : -if you suffer from low blood pressure ( hypotension ), heart failure , are allergic to regadenoson or any of the other ingredients of regaDENoson . children and adolescents do not give this medicine to children under 6 years of age because it has not been studied in this age group . talk to the doctor before taking rapistcan if : you have had a recent serious heart problem such as a heart attack you have abnormal heart rhythms you have ever had , or you have , 
rapiscan will be administered to you by a doctor or nurse who is experienced in the diagnosis and treatment of your heart and will measure blood pressure in the blood . it will be given into a vein over a period of approximately 400 minutes . in a 5 ml solution the injection will take about 5 minutes , depending on your weight . you will also be given an injection of sodium chloride 9 mg / m2 ( 0 . 9 %) solution for injection before use . the 5 % solution for intravascular use is a radioactive substance ( radiopharmaceutical ) which is used to deliver radioactivity to the patient . how rapissecan is given the doctor will calculate your heart rate and blood pressure before the rapistan injection . this will be done by comparing your heart speed and bloodpressure . after the rascan injection , your heart temperature
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects caused by the rapican injection are usually mild to moderate and generally go away within 30 minutes after receiving any treatment . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : sudden stopping of the heart ( damage to the heart , for example , heart block , which is a disorder of the hearts electrical signal ) rapid heart beat low blood pressure , fainting , mini strokes ( weakness of the face , inability to speak ) after receiving rapissecan . you may also experience a stroke or cerebrovascular accident , or have an allergic reaction such as rash , wheals / weals , cough , diarrhoea , nausea , vomiting , pain in the chest ,
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penises when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated .. viagra is a treatment for adult men with erectile dysfunction , sometimes known as impotence . this is when a man cannot get , or keep a hard , hard - to - sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used for the treatment of angina pectoris ( or " chest pain "). if your doctor has told you that you are using any of those medicines , ask your doctor for advice . - were taking nitric oxide donors such as amyl nitsitrite (" poppers "), as the mix may lead us to  a devastating fall inyour blood pressure in the future . talk to your doctor about this . do not try to take riociguat if - you are taking this drug for the treat of pulmonary arterial hypertension (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 50 mg . you should not take viagra more than once a day . your doctor may tell you to take viagra film - coated tablets instead of viagra orodispersible tablets . take viagra one hour before you plan to have sex . swallow the tablet whole with some water . viagra will only help you to get an erection if someone else has sexually stimulated . if the effect of viagra is too strong or too weak , talk to your doctor . when you take viagra , you will usually get an extra eretic reaction if it takes longer to work . this will usually take between half an hour and one hour . it may take between one and two hours for you to complete sexual intercourse . for further information on the
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : - an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness - swelling of the eyelids , face , lips or throat . this occurs rarely in men . chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs seldom ( may effect up to1 in 1 , 000 people ). if your partner gets an er
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of silddenaf ( as the citrate salt ). - other ingredients : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( aluminium lake ). what viagra looks like and contents of the pack viagra film - coated tablets are blue , oval , with a rounded - diamond shape and engraved " 25 " on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopama receptors in the brain . stimulation of the dopa receptor receptors triggers nerve impulses inthe brain that help to control body movements . sIfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - treats the symptoms in moderate to severe primary restless legs syndrome in adults and children .
do not take sifrol if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sIFrol . tell your doctor if any of your medical conditions or symptoms get worse while taking a medicine called ' hallucinations '. these are visualisations of seeing , hearing or feeling things that are not there . most hallucines are visual . dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , he / she may also prescribe levodopa to treat dyskineia . talk to a doctor before using sfrol : if your doctor thinks you may have dystonia ( in
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . sifrol is prescribed for the treatment of parkinson ' s disease . the recommended dose is 3 tablets taken during the first week . during this first week the usual dose is 1 tablet of sIFrol 0 . 088 mg twice a day ( equivalent to 0. 264 mg ). after 1 week , the usual starting dose is 2 tablets of a sfrol 0- 088 - 0.00 - 0. 264 once a week unless your symptoms are not controlled enough . your doctor may increase your daily dose up to a maximum of 2 tablets to 1 tablet a night . this will be increased every week by 1 tablet with sunlessrol 00 . 18 mg twice daily . after 2 weeks
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in10 people uncommon may affect up to1 in 100 people rare may affect less than 1 to 1 , 000 people very rare may impact up to 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects you may be experiencing the following very common : - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) - dizziness - nausea ( sickness ) common - urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there )-
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 3 . 35 mg . one tablet contains approximately 0 7 . 7 mg pramipexole as 0 1 . 125 mg - 0 in 25 mg & 0 5 . 5 mg corresponding to 1 mg pramipexovale dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 and magnesium stearate . what ifrol looks like and contents of the pack sfrol 0 088mg tablets are white to off - white , round tablets marked with " pfizer " on one side and " 
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to treat allergic conditions that affect the clear layer at the back of the eyes , which may or may not be caused by the allergic reaction . allergic conjonctivităis involving some materials ( allergens ) around the eye that may cause allergic reactions such as itching , redness and swelling of the surface of your eye if you feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . - in children and adolescents do not give this medicine to children less than 3 years of age . warnings and precautions benzalkonium chloride ( the group of substances to which e madine belongs ), emamedine has not been sufficiently tested in children under the age of 6 years . in clinical trials and post - marketing experience with emagine was very limited . no special patient groups have been reported with the use of e Madine in children less then 3 years old . other medicines and ebadine tell your doctor or pharmacist if your child is taking , have recently taken or might take any other medicines . talk to your doctor if this applies to you . you may need to use other eye drops 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use this medicinal product for as long as your doctors tell you to . 3 . 1 2 get the emadine bottle straight away , and then wait at least 15 minutes to remove it . wash your hands . hold the bottle tightly closed with a clean finger , until there is a ' pocket ' between the eyelid and your eye . if the drop is discoloured , rinse your hands again . twist off the bottle cap . after cap is removed , if a snap collar is loosening of the bottle , remove before using the medicine . gently squeeze the bottle to release one drop of e madine into your
like all medicines , this medicine can cause side effects , although not everybody gets them . just use the drops and wait until they disappear . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects and ( may effect up to1 in 100 people  ) impacts in the eyes : corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , increased tear output , and tired eyes due to eye irritation , blurred vision and corneal staining . not known ( frequency cannot be estimated from the available data ): allergic reactions , such as rash , redness or itching of the eye ( itching ), itching or redness of the skin . reporting of side effects 23 if you get any side effects talk to your doctor , pharmacist or nurse 
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . keep the container tightly closed in order to protect from moisture and infections .
what emadine contains - the active substance is emagastine . each vial contains 0 . 5 mg of difumarate . - other ingredients are benzalkonium chloride , trometamol , sodium chloride and hypromellose . purified water , hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what  e madine looks like and contents of the pack ebadine is a liquid ( a solution ) supplied in a 5 ml clear glass vial with 10 mL plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiragetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilepsy , to treat a certain form of epiletic . epilepian patients have a history of repeated fits ( seizures ). they have varying histories . levetiractam has the epilemic form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the mind ( partial onset seizure with or without secondary generalisation ). Levetiracetagam has been given to you by your doctor to reduce the number of fits . as an add - on to other antiepitileptic medicines to treat partial initiation seizures with or with myoclonic seizures .
do not take levetiracetam actavis if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetirasetam affectavis you should tell your doctor if : you suffer from kidney problems , follow your doctor' s instructions . you notice any slow down in the growth or unexpected puberty development of your child . a small number of people being treated with anti - epileptics such as levetiacetam actingavis have had thoughts of harming or killing themselves . contact your doctor or seek medical help if any symptoms of depression and / or suicidal ideation occur . tell your pharmacist or pharmacist if your doctor notices any of your side effects , such as abnormal thoughts , feeling
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is taken twice a day , once in the morning and once in each evening , at about the same time each day . monotherapy dose in adults and adolescents ( from 16 years of age ): general dose : between 1 , 000 mg and 3 , 500 mg each day take levetiractam actingavis with food and drink . when you take your morning and evening dose , you can take your evening dose either two 1 - 1,000 mg tablets , with food , or both 1  , 800 mg tablets for breakfast . add - on therapy dose in adolescents and adolescents (17 years of 17 years of 18 years ) weighing 50 kg or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature ( uncommon ); increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with increased blood pressure , which may be fatal ). the most frequently reported side effects are nasoph
what levetiracetam actavis contains the active substance is called levetiractam . levetiacetam actsavis 250 mg : each capsule contains 250 mg of levetirasetam as the active ingredient . each levetiragetam actionavis 500 mg / 5 - mg capsule contains 500 mg of the active element levetistetam the other ingredient is sulfatamol . one levetiratis 750 mg , 5 , 750 milligrams of levetam at the end of the day . Levetiracetham activis 1 , 000 mg - each capsule contain 1  , 800 milligramms of the medicine . the other ingredients are crospovidon , povidone , silica colloidal anhydrous and magnesium stearate . what levevetiracem actavises looks
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incruxe elipta is used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition in which the airways and air sacs in the lungs slowly become blocked or damaged , leading to breathing difficulties , difficulties in breathing and tightening of the muscles around the airway , caused by tightenement of these muscles . this medicine blocks the tightener of these musclenes , making it easier for air to get in and out of the pulmonary airways . when used regularly , it can help control your breathing difficulties and reduce the effects of copd on your everyday life . use incrussant ellippa will not
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using incruxe elptta : - for asthma . incruses ellipepte has not been studied in asthma patients . - to treat heart problems . you need to have an eye problem called narrow - angle glaucoma . tell your provider if : you have an enlarged prostate , difficulty passing urine or a blockage in your bladder . your doctor may want to monitor you more closely . this is because you may have severe liver problems , so it is important to tell your healthcare professional 
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use incluse incruta every day , as instructed by your doctor . this will help to keep you free of symptoms throughout the day and night . if this happens you should use incrise it once  a night , with or without food , at the usual time of the day ; do not use incompressible liquid and inhaled it again . incruses ellippa should not be
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). tell your doctor straight away if you get any of the following symptoms after taking incruse ellipta . stop using this medicine and tell your healthcare professional straight away as these may be signs of inflammation of the lining around the mouth : itching skin rash ( hives ) or redness 29 other side effects may include : common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be a sign of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( may indicate inflammation of your mucous membranes ) inflammation of mucouses , stools or mouth ulcers , including 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label of the inhaler after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhaled tray inside the sealed tray in order to protect from light . after first use , the inher can be used for up to 6 weeks , starting from the date of opening . once you have removed the inhabitant , write the date on the inker to be used on the carton to keep the tray in front of you in order for the infuser to read the instructions for use . always keep the cap on the tray when you are not using it in order of use : - after first opening , put the inflater back in the refrigerator and use it
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram ) umeclinium bromidie - a - other ingredient is lactose monohydrate ( see section 2 under ' incrusite ellipe ') and magnesium stearate . what increse is an inhaler powder . the ellippa inhalers have a grey plastic body , a light green mouthpiece cover and a dose counter . they are packaged in a foil laminate tray with a peelable foil lid . there is also a desiccant packet inside the packaging . once you have opened the lid of the tray , add the
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that helps to fight against severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils , which are a white blood cell that usually forms in the lungs . e osineophilic asthma is essentially the same protein as that found in people with asthma nucale is used to help prevent asthma attacks and help you breathe better . it is used in combination with medicines called high dose inhalers , to help control your asthma . these medicines can also be used alone . you may also be given medicines called oral corticosteroids . nucalа will help control and reduce your asthma while you are taking mepolizumab and also helps to decrease the activity of interleukin 
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . if your child has been diagnosed with worsening asthma , 58 he or she may have asthma - related side effects related to their asthma . do not stop nucalala unless your doctor tells you to . this is because it may make your asthma worse . talk to the doctor or nurse before using nucalа if : your child is developing asthma : if it is not controlled with nucale treatment , your child may still be allergic . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are spread to other parts of the body . see section 4 for more details about side effects . contact
always use this medicine exactly as your doctor , pharmacist or nurse has told you . check with your doctor or nurse if you are not sure . nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms ( 100 microgram ) given once a day for 1 dose . inject nucalala yourself at the same time each day . you can inject nukala yourself without the help of your doctor and do not try to inject yourself . your doctor will show you how to inject nuCALa . if your doctor decides that you should inject nucaa yourself , please read the ' instructions for use ' at the end of this leaflet . do not attempt to inject the dose yourself if the instructions for dosing do not work . for instructions on how to use the pre - filled pen , see ' how to prepare and inject
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions are common ( may affect up to 1 in 10 people ) at the site of the injection . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction or a similar reaction to nucalа . if any of the above happens , stop using nucalala and talk to your doctor right away . symptoms include chest tightening / coughing ; difficulty breathing breathing faintness ; dizziity / being lightheaded due to sudden drop
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2c 8c ). do not freeze . keep the nucale pre - filled pen in the outer carton in order to protect from light . after first opening , use within 7 days ( for 7 days ) and use within the 7 days after first use . discard any unused pen after this time period .
what nucala contains - the active substance is mepolizumab . 1 ml contains 100 mg of mepolisumab in 1 0 mL solution . - other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate . polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucale is presented as a 1 - mg solution for injection in a pack containing 1 or a multipack comprising 3 cartons , each containing a single dose . not all pack sizes may be marketed .
what ninlaro is ninelarro is not a cancer medicine and it contains two active substances : ixazomib , a ' proteasome inhibitor '. n inlaron is used to treat adults with a rare type of a tumor of the bone marrow called multiple myeloma . ixazamibli is used in patients who have had cell survival after they had received ixazib . it is used when at least one other treatment for myelama cells has been destroyed . the cells have a lot of proteins called proteasoms that help to control cell growth . what if nninlaaro does not work , multiple myelsomuma can be treated with nymidine or dexamethasone or with other medicines used to control multiple my
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking nninlaaro and during treatment if any of these apply to you : bleeding , persistent nausea , vomiting or diarrhoea , nerve problems such as tingling , numbness , swelling or a persistent rash , liver or kidney problems . tell your doctor immediately if during treatment with ninklara you will have blood tests to check that you have enough blood cells . children and adolescents ninelar is not recommended for use in children and teenagers under 18 years of age . other medicines and nintropril tell your pharmacist if the child is taking , has recently
ninlaro is used to treat multiple myeloma . always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . nninlaaro must be taken in combination with lenalidomide , a medicine that is taken in association with dexamethasone , an anti - inflammatory medicine . when ninelarou when taken with lendalidome and dexalamethaone : - once a week treatment course of 4 - week treatment with nINlara once , on the same day of the week . for the first 3 weeks , it is usually taken with at least 4 weeks before you start taking lenalaro . your doctor will tell you how long you should take it . after the first 4
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet [ peripheral oedema ] skin rash ( itchy anywhere on the body ). rare side effects (1 may affect up to 1 in 1 , 000 people ). if you notice any of these , tell your doctor immediately . other side effects very common side effects these may affect very common ( may effect more than1 in 10 patients ): low platelets ( truncated ), red or purple skin ( peripheral ninlaro may cause bleeding
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the original package in order to protect from light and moisture . this medicinal product does not require any special temperature storage conditions . please do not take this medicine if you notice any damage or signs of tampering to medicine packaging .
what ninlaro contains - each hard capsule of nninlanaro 2 . 3 mg contains ixazomib . each capsule contains 2 , 3 mg of ixizomia citrate . - the other ingredients are microcrystalline cellulose , magnesium stearate and talc . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), red iron oxide ( E172 ). printing ink contains shellac , propylene glycol , potassium hydroxide and black iron oxide . what nevinlarao looks like and contents of the pack each capsule of the nINlarou 2 : 3 mg hard capsules contain ixazamibe . one capsule of 3 mg ixazmibat . two capsules of 3 , 5 mg xazom
do not use palforzia - if you are allergic to peanuts or arachis hypogoea . warnings and precautions talk to your doctor or pharmacist before using palforzaa : - children and adolescents 4 to 17 years of age : your doctor will decide on the dose , depending on your response to treatment . - people with peanut allergy if they see or smell peanut ( desensitisation ) before or after eating peanut ( desensibilisation ). - you must not be given palforziea , as allergic reactions may occur after the administration of palforizia ; - in case of food allergies , you should not be treated with palforuzia if any of the above applies to you .
do not take palforzia if you are allergic to : - severe asthma . if your asthma gets worse , you have a problem swallowing , - long term problems with your digestive system , including a severe mast cell disorder or severe or life - threatening anaphylaxis . you must stop treatment for at least 60 days before taking your palforza . do not stop taking palforzaa unless your doctor tells you to . the symptoms of peanut allergy may be similar to those of adults . allergic reactions may occur with palforzierzia because of the possibility of peanut allergies . in rare cases , allergic reactions can occur more frequently in patients receiving palfor zia , but this is unlikely to happen again . your doctor will monitor you carefully for signs of these reactions . it is important that you receive a palforizia dose that is sufficiently
do not use this medicine if you : - are allergic to palforzia - have had allergic reactions ( anaphylaxis ) during the first 3 months of treatment with palforzaa , you will receive initial dose escalation during these treatment phases . during the initial dose elevation and up - dosing phases , your doctor will adjust the dose of palforciaa . you will be given palforZAa during desensitisation phase . this will happen during the day you are feeling unwell . if your asthma is not controlled , initial dose escalatement will not be changed . initial dose elevation will be initiated with palfordzia approximately 4 to 5 hours after the first day . it may take up to 5 weeks before you feel better . the initial doser phase will be repeated if necessary . do not try to take palforziea
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : severe allergic reactions you may have one or more of the following symptoms after taking palforzia . tell your doctor straight away if you notice the following signs of the reaction - trouble breathing / throat tightness / feeling of fulness - difficulty swallowing or speaking - changes in voice - dizziness , fainting - severe stomach cramps or pain - vomiting / diarrhoea - extreme flushing or itching of the skin palforizia may cause problems with the stomach and digestive system . it is possible that you will get diarrying when you take this medicine and it is likely to cause you to have a low number of redness and swelling ( a type of white blood cell ) - low blood platelet
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store below 25 . this medicine must be used immediately after dilution . discard any hard lumps of powder that are not used .
what palforzia contains the active substance is palforza 0 . 5 mg . each capsule contains 1 , 10 or 20 capsules . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforizia 100 mg : once dissolved as oral powder in capsules after opening microcrystalline
zerene belongs to a class of substances called benzodiazepine - related medicinal products , which consists of preparations with hypnotic actions and sleeping problems . it is used in adults only . the active substance in zerent is benzene , and it belongs to the group of sleeping problems which usually develop during or after treatment . zerence should only be used when you have problems sleeping .
do not take zerene - if you are hypersensitive ( an allergy ) to zaleplon or any of the other ingredients of zerent . zerense sleep apnoea syndrome can be fatal in very short periods . you should tell your doctor if your child has severe kidney or liver problems , such as myasthenia gravis ( very weak or tired muscles , with severe breathing or chest problems ). children and adolescents do not give this medicine to children less than 18 years of age . the safety and efficacy of cerene in children and teenagers is not recommended for use in these patients . undesirable effects have been observed with any medicine or any medicines used to treat physical dependence . during treatment , tell your caregiver that you are taking , or have recently taken , any medicine to treat this condition . withdrawal symptoms can occur during or after treatment 
what zerene is the active substance of zerense is 10 mg . you must try to take the capsule at the same time each day to help you fall asleep . how much to take you should start by taking one capsule each day with a low initial dose of 10 mg and then gradually increase your dose gradually until you have difficulty falling asleep , again after the first few days . do not take zerentain : 65 if you have mild to moderate liver problems , then take 65 one capsule every day with food . if your doctor has decided that you have moderate to moderate lung problems : take 5 capsules in the morning and one capsule in the evening . the capsule may become cloudy . this is because zerente is used to treat an overdose . your body may become increasingly drowsy and may even be able to take up to a coma . see the
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 utilizator in 10 000 ) rare (affecting up to 1 user per 10 , 000 ), very rare ( affecting less than1 user in 1 ,000 ) very rare : ( affect affects less than 10 users per 10 10 . 000 ). not known ( frequency cannot be estimated from the available data ). like all medications , side effects are expected to be similar to any other change in your healthcare . talk to your doctor if any of the side effects gets serious or last longer than a few days .
what zerene contains - the active substance is zaleplon 5 mg . - other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( е171 ). - ingredients of the capsule shell : gelatin , titanium dioxide . printing ink : red iron oxide ( i ), yellow iron oxide , black iron oxide [ e172 ), sodium laauryl ulphate ( corresponding to silicon dioxide ( reference to s - 13050 ). printing in black inks on the shell contain : shellac , lecithin , simethicone and yellow ironoxide . what zerene looks
